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The First Decade of Croatian Dermatovenerological So ci ety
of Croatian Med i cal As so ci a tion
Ten years ago, we founded the jour nal Acta
Dermatovenerologica Croatica (ADC) and Cro atian 
Dermatovenerological So ci ety (CDS). It was the re -
sult of our de cades-long de sires, ef forts, and above
all, love we shared for our field of ex per tise, derma -
tovenerology. Time has passed quickly and this
year, we cel e brate the 10th an ni ver sary of both the
Jour nal and the So ci ety. On that oc ca sion, let us
take a brief look back at the his tory of both.
A mile stone in the de vel op ment of dermato ve -
nerology in Croatia was the foun da tion of the
Derma tovenerological Sec tion of the Cro atian Med -
i cal As so ci a tion (CMA) at the Sis ters of Mercy Uni -
ver sity Hos pi tal in Zagreb, on No vem ber 22, 1920.
Aleksandar Blaškoviæ was the first pres i dent of
Dermatovenerological Sec tion, and the first sec re -
tary was Kamilo Farkaš. The Sec tion was ac tive
from the very be gin ning, and by 1928, it had al ready 
or ga nized 20 meet ings. In the 1929-1940 pe riod,
the Sec tion mem bers met as many as 109 times. It
was also the pe riod when the idea of start ing a jour -
nal of Dermatovenerological Sec tion first ap peared. 
In 1929, Franjo Kogoj (1894-1983) was elected
new pres i dent, and Sreæko Bošnjakoviæ (1900-
 1947) took the po si tion of the sec re tary.
The first Con gress of dermatovenerologists was 
or ga nized in Split in 1930, and the next one in
Zagreb in 1933. In 1940, the Sec tion changed its
name into Cro atian Dermatovenerological So ci ety.
Kogoj re signed from the po si tion of pres i dent in No -
vem ber 1941 and Janko Božiæ took over. Vladi mir
Abramoviæ was the sec re tary dur ing 1941/2-1944
pe riod. Af ter the Sec ond World War, the ac tiv ity of
the So ci ety was en liv ened again and Franjo Kogoj
(1945-1963) ac cepted the po si tion of So ci ety’s
pres i dent once again, whereas Dušan Jakac acted
as the sec re tary. The new era of the So ci ety was
also marked by or ga ni za tion of var i ous sym po sia
and con gresses. From 1965 to 1970, Šime
Èajkovac was the pres i dent of the So ci ety, and
Zorislav Žmegaè  was the sec re tary. The first sci en -
tific meet ing of dermatovenerologists in the post war 
pe riod took place in Zagreb on No vem ber 23-26,
1950, and was at tended by col leagues from all Re -
pub lics of ex Fed eral Re pub lic of Yu go sla via. The
Cro atian Sec tion of Dermatovenerologists of the
Cro atian Med i cal As so ci a tion, which had three
branches – Zagreb, Rijeka, and Split – was a mem -
ber of the As so ci a tion of Dermatovenerologists of
Yu go sla via. Ac a demician Franjo Kogoj or ga nized
the sec ond post war Con gress in Zagreb in 1966,
whereas Prof. Dušan Jakac, Con gress pres i dent,
or ga nized the next one that took place in Rijeka/
Opatija in 1973. An other im por tant event took place 
in 1974: the jour nal Acta Dermatovene rologica
Iugoslavica was launched, for which much credit
goes to Prof. Janez Fettich and Prof. Aleksej
Kansky from Ljubljana. Cro atian dermatovenerolo -
gists par tic i pated in the foun da tion of Acta Derma -
tovenerologica Iugoslavica and had pub lished
many of their re search and pro fes sional ar ti cles in
that jour nal un til 1992.
The Home land War, which started in 1991 on
the ter ri tory of Croatia, led to deep po lit i cal changes
and Croatia be came an in de pend ent state. The
Cro atian Med i cal As so ci a tion re signed from the Yu -
go slav Med i cal As so ci a tion and con tin ued to func -
tion as an in de pend ent in sti tu tion. The Cro atian
Dermatological So ci ety (CDS) was founded again
on the ini tia tive of Prof. Ivan Dobriæ. It hap pened on
May 29, 1992 at the De part ment of Dermatovene -
rology, Zagreb Uni ver sity Hos pi tal Cen ter, and Prof. 
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Vladi mir Èajkovac was elected pres i dent of the
tem po rary CDS Man aging Board. At an other meet -
ing on July 10, 1992, the reg u lar CDS board was
elected ac cord ing to the Cro atian Med i cal As so ci a -
tion Stat ute for Founding Med i cal So ci ety, and Prof.
Vladi mir Èajkovac was con firmed as pres i dent.
Mem bers of the Board came from each of the four
CDS branches – Zagreb, Rijeka, Split, and Osijek.
Dur ing the pres i dency of Prof. Vladi mir Èajkovac
(1991-1999), and Jasna Lesiæ as the sec re tary, the
CDS Zagreb branch awarded Prof. Ruzicka and
Prof. Plewig (Ger many).
The past 10 years of the Cro atian Dermatovene -
ro logical So ci ety of Cro atian Med i cal As so ci a tion
have been char ac ter ized by its strong in de pend ent
ac tiv ity. The first Con gress of Cro atian dermatove -
ne rologists with in ter na tional par tic i pa tion (17
coun tries), or ga nized by Prof. Vladi mir Èajkovac,
was held in Zagreb, May 15-17, 1998. On No vem -
ber 12, 1999 Prof. Jasna Lipozenèiæ be came
elected CDS pres i dent and Mirna Šitum the sec re -
tary. Dur ing the pres i dency of Jasna Lipozenèiæ, the 
So ci ety changed its name into Cro atian Dermato -
ve ne ro logical So ci ety, and five Sym po sia and two
Congresses with in ter na tional par tic i pa tion were or -
ga nized, as well as four Con tin u ous Med i cal Ed u -
ca tion Courses. The sec ond Con gress of Cro atian
dermatovenerologists, “New High lights in Derma -
tovenerology”, with in ter na tional par tic i pa tion of 17
coun tries, was held in Opatija, May 16-19, 2002.
Dermatohistorical ses sions are reg u lar part of
Cro atian Dermatovenerological So ci ety meet ings.
Our col leagues from abroad have been sup port ing
the ac tiv i ties of Cro atian Dermatovenerological So -
ci ety, con trib ut ing to its de vel op ment and im prove -
ment. In 2001 and 2002, the So ci ety awarded Prof.
Ring from Mu nich, and Prof. Holubar from Vi enna
for spe cial con tri bu tions.
Cro atian Dermatovenerological So ci ety had an
im por tant and far-reach ing in flu ence on the de vel -
op ment of dermatovenerology in Croatia. Its mem -
bers put a lot of ef fort and en thu si asm into their ac -
tiv i ties and work, and some, like Franjo Kogoj, be -
came even in ter na tion ally rec og nized. Ac a de mi -
cian Franjo Kogoj was one of the most prom i nent
mem bers of the So ci ety and twice its pres i dent.
Many Cro atian dermatovenerologists were ea ger to 
con tinue his work not only at their de part ments of
dermatovenerology in Zagreb, Rijeka, and Split, but 
also in the So ci ety. The Cro atian Dermatovenero -
logical So ci ety still has four branches (Split, Rijeka,
Zagreb, and Osijek); its 180 mem bers ac tively par -
tic i pate in Con gresses on na tional and in ter na tional
level. Pres i dents of four CDS branches to gether
with the Or ga nizing and Sci en tific Con gress Board
are in charge of or ga ni za tion of the next in ter na -
tional dermatovenerological con gress, “Top i cal
Pro ce dures, In no va tions and Mis treat ments”,
which will be held in Plitvice/Croatia, May 29-31,
2003. An other event that CDS is or ga niz ing is the
Sym po sium on “Cur rent State on Pso ri a sis and
Naphtalanotherapy”, which will take place in Ivaniæ
Grad, Croatia, on Sep tem ber 19, 2003.
New elec tions for CDS Board of the Cro atian
Dermatovenerological So ci ety (2003-2007), sched -
uled for No vem ber 21-22, 2003, will take place in
Zagreb dur ing the Con tinuing Med i cal Ed u ca tion
Course ti tled “Sex ually Trans mitted Dis eases and
In fec tions”. I hope the So ci ety will stay as ac tive as
it has been all this time, to re main the part of the Eu -
ro pean Acad emy of Dermatovenerologists, In ter na -
tional League of Der ma tol ogy, and In ter na tional So -
ci ety of Der ma tol ogy.
Ten Years of Acta
Dermatovenerologica Croatica
The idea of launch ing an of fi cial Jour nal of Cro -
atian Dermatovenerological So ci ety (CDS) was first 
born in 1930’s, but had to wait al most 60 years to be 
re al ized. It even tu ally hap pened at As sem bly of
Del e gates of the In ter na tional League of Derma -
tologic So ci ety in New York, June 15, 1992 (Cro -
atian del e gates were Prof. Dobriæ and Prof.
Gligora). The same year, on May 29, the Cro atian
Dermatological So ci ety (CDS) was founded. At that
meet ing, Prof. Èajkovac and Prof. Dobriæ ar tic u -
lated on be half of their col leagues the need for CDS 
to have its own of fi cial jour nal. And thus, the pro -
cess be gan of found ing the of fi cial jour nal of the So -
ci ety, Acta Dermatovenerologica Croatica (ADC).
The elected ADC Ed i to rial Board con cluded the
pur pose, field of in ter est, and con tent of the first
ADC is sue by the end of De cem ber 1992. The Jour -
nal was to be pub lished in Eng lish lan guage with
sum mary in Cro atian. The first is sue of ADC (Vol. 1,
No. 1) was pub lished at the be gin ning of 1993 un -
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der the su per vi sion of the fol low ing mem bers of Ed i -
to rial Of fice: Vladi mir Èajkovac, Ed i tor-in-Chief;
Ivan Dobriæ, As so ci ate Ed i tor-in-Chief (un til Vol. 3,
No 1-2, when Aleksandra Basta-Juzbašiæ took
over); Dragomir Budimèiæ, Tech ni cal Ed i tor (un til
Vol. 1, No 4, when Branka Marinoviæ took over un til
Vol. 4, No 2, and af ter wards Mirna Šitum); and
Branko Barièeviæ, sec re tary of ADC (un til Vol. 4, No
2, when Branka Marinoviæ took over and still ob -
tains the func tion). Ed i to rial Board con sisted of 8
mem bers, and Ed i to rial Coun cil of 8 mem bers. The
Editorial Of fice was lo cated at the De part ment of
Dermatovenerology, Sis ters of Mercy Uni ver sity
Hos pi tal, Zagreb, un til the year 1993, when it moved
to Uni ver sity Hos pi tal Cen ter Zagreb, Šalata 4.
The first is sue (Vol. 1, No 1, 1993) con sisted of
the Let ter of the Ed i tor-in-Chief Prof. Èajkovac; Let -
ter of the Associate Ed i tor-in-Chief Prof. Ivan
Dobriæ; three orig i nal sci en tific ar ti cles; two pro fes -
sional ar ti cles, or case re ports; one re view; two re -
ports; an nounce ments; and in struc tions to au thors.
It was a very good is sue to be gin with. Pub lisher of
ADC for the last 10 years has been Grafoplast
(1993-2003). From 2003, the ADC will be pub lished 
by “Medicinska naklada” in Zagreb.
The deep est grat i tude is owed to the con tri bu -
tors Prof. Èajkovac and Prof. Dobriæ, mem bers of
the Ed i to rial Board, who suc ceeded in giv ing us
such a qual ity pi lot is sue of 41 pages.
The ADC had been pub lished in Eng lish lan -
guage with sum mary in Cro atian un til Vol. 8, No 1,
2000, when it was de cided not to in clude the sum -
ma ries in Cro atian any more. Since 2000 (Vol. 8, No
1), the Ed i tor-in-Chief has been Prof. Jasna
Lipozenèiæ, and Hon or ary Ed i tor-in-Chief has been
Prof. Vladi mir Èajkovac. In 2000, the ADC changed
its front page, ta ble of con tent page, and tech ni cal
im age, and started bring ing in for ma tion on the CDS 
ac tiv i ties and an nounce ments of Sym po sia, Con -
gresses, and Courses of in ter est to its au di ence.
The first is sue in 1998 (Vol. 6, No 1) brought the
Fi nal Pro gram and Ab stract book of the First Cro -
atian Con gress of Dermatovenerologists with In ter -
na tional par tic i pa tion Zagreb, which was held on
May 15-17, 1998. Next year (Vol. 7, No 1, 1999),
Pro gram and ab stracts of Sym po sium New Trends
in Immunodermatology were pub lished, as well as
ab stracts of Sym po sium of Dermatologic On col ogy
Past, Pres ent, Fu ture: Epi der mal tu mors (Vol. 7, No
3, 1999) that was held in Zagreb, on Sep tem ber 17,
1999. Pro gram and Ab stract book of 5th Alpe-
 Adria-Dan ube So ci ety of Sex ually Trans mitted Dis -
eases Work shop with An nual Meet ing of the Cro -
atian Dermatological So ci ety, Opatija, Oc to ber
29-31, 1999, was printed in No 4, Vol. 7, 1999. Ab -
stracts of the Con tin u ous ed u ca tion Sym po sium on
Ne vi and Ma lig nant mel a noma, Zagreb, No vem ber
12, 1999, were printed in No 1, Vol. 8, 2000. Is sue
ded i cated to the In ter na tional Sym po sium on Pe di -
at ric Dermatovenerology, which took place in
Zagreb, Sep tem ber 15-16, 2000, was printed in No
3, Vol. 8, 2000. Pro gram and Book of ab stracts of
In ter na tional Sym po sium The Cur rent Trends in
Dermatomycology, Dubrovnik, June 16-17, 2000,
were printed in No 2, Vol. 8, 2000. Pro gram and ab -
stracts of In ter na tional Con gress on Skin Changes
and the Face and Re gional Sym po sium of the In ter -
na tional Acad emy of Cos metic Der ma tol ogy: Faces 
Old and New were pub lished in No 3, Vol. 9, 2001.
The pro gram and ab stracts of the Sec ond con gress 
of CDS with in ter na tional par tic i pa tion, New High -
lights in Dermatovenerology, Opatija, May 16-19,
2002 were pub lished in No 2, Vol. 10, 2002. Only
the pro gram and lec tures in extenso from Con tin u -
ous Med i cal Ed u ca tion Course “Cu ta ne ous Lym -
phoma”, Zagreb, March 16, 2001 were printed in a
sep a rate Book. At that time, the prin ci pal aim of the
Jour nal was to pro vide the mem bers of the CDS
with pro fes sional ar ti cles, re views, and orig i nal ar ti -
cles of in ter est to prac ti tio ners. How ever, we soon
came un der pres sure to ad just the Jour nal’s con -
tent pro file so as to make it ac cept able for in clu sion
in in dex ing da ta bases, such as Excerpta Medica
(EM). In 1994, the ADC was in cluded in EM da ta -
base. Dur ing the last ten years, the ADC has been
pub lished quar terly, with only Vol. 3 (No 1-2) and
Vol. 4 (No 3-4) bring ing dou ble is sues due to fi nan -
cial rea sons. There have been 280 manu scripts ac -
cepted for pub li ca tion in ADC, whereas 35 were re -
jected (to day’s re jec tion rate is 20%). In vol umes
that con tained Con gress ab stracts, the mean num -
ber of pa pers was 25, whereas the num ber of ab -
stracts was much larger (80 ab stracts on av er age)
(Vol. 6, No 1, 1998; and Vol. 10, No 2, 2002).
The ADC is a peer-re viewed jour nal, with a re -
viewer pool con sist ing of 148 re view ers, ex perts in
dif fer ent med i cal spe cial ties of whom 50% are from
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abroad (Eng land, Ger many, USA, Ja pan, Aus tria,
and It aly).
The ADC has pub lished manu scripts by au thors
from Eng land, Ger many, Czech Re pub lic, Po land,
Hun gary, USA, Ja pan, Brazil, Aus tria, and Spain.
The mean num ber of pa pers pub lished per year is
30-35.
Over the years, Ed i to rial Board has grown from
8 to 11 mem bers from abroad.
In 2000, we ap plied for in clu sion in In dex
Medicus/MEDLINE, the in dex ing da ta base of Na -
tional In sti tute of Health, Bethesda, USA. Out of
22,000 jour nals that the Na tional In sti tute of Health
re ceives ev ery year, MEDLINE in cludes only 4,000, 
and the ADC (graded 3,9) be came one of them. The 
in clu sion of ADC in MEDLINE in the be gin ning of
2001 gave us the op por tu nity to be come rec og -
nized in the world and it ex tremely in creased our
vis i bil ity; since then, we have had many re quire -
ments for ad di tional off prints of ADC ar ti cles. Since
2001, we have also been pre par ing the pub li ca tion
of ADC in XLM tagged elec tronic for mat (S.
Frketiæ), while plans for the ADC web-site are well
un der way.
In the last two years, there have been novel col -
umns in tro duced in the reg u lar con tent of the Jour -
nal: Marko Polo (S. Fatoviæ-Ferenèiæ from Vol. 9,
No 4, 2001, on ward), Let ter to the Ed i tor, and News
(be gin ning with Vol. 10, No 1, 2002). In times when
med i cine/der ma tol ogy is deemed as go ing in di rec -
tion of de hu man iza tion, we chose to en rich the con -
tent of the jour nal with texts that mir ror per sonal
coun ter part in ev i dence-based pa pers. His tor i cal
ar ti cles, for ex am ple, are in vited to en liven and re -
veal our his tor i cal roots: Marko Polo col umn is in -
tended to be re flec tive prose itin er ary, whereas Let -
ters to the Ed i tor has been in tro duced to get a feed -
back on pa pers pub lished in ADC or else where.
The pur pose of ADC News is to in form the read ers
on all CDS ac tiv i ties and pro fes sional events in the
coun try and abroad.
Editing these three col umns, the ADC News,
Let ter to the Ed i tors, and Marko Polo since 2001
has been a chal lenge, but I be lieve we now have a
pe ri od i cal that has suc cess fully grown in stat ure
and scope to meet the mem ber’s needs. That be ing 
said, let me in vite all of you who would be will ing to
par tic i pate ac tively in the prep a ra tion of ADC on
daily ba sis to join us. All in ter ested are kindly asked
to con tact the Ed i to rial Board (jasna.lipozencic@
zg.tel.hr).
The prin ci pal aim of the Jour nal was to pro vide
the mem bers of CDS with a bal ance of ed i to ri als,
re views, and orig i nal ar ti cles of in ter est to prac ti tio -
ners. Over the de cade, we have had the priv i lege of
re ceiv ing a vast amount of re search re views not
only from Eu rope, but also from all over the world.
We hope we have en cour aged our au thors, es pe -
cially those in ex pe ri enced and as pir ing, to pub lish
their work and share their knowl edge and ex pe ri -
ence with the au di ence world wide.
It has been a priv i lege for me to be the Ed i -
tor-in-Chief of the ADC for the past four years, and
to see it be come a firmly es tab lished pe ri od i cal.
This would not have been pos si ble with out the
mem bers of the ADC Ed i to rial Board and sec re tary
Branka Marinoviæ. With out the ed i tor found ers in
1993, their ded i ca tion, pro fes sion al ism, and hard
work of all of us in the past 10 years, the ADC would
not be the pub li ca tion that it is to day. How ever, a lot
of credit goes to our re viewers as well, whose sharp 
crit i cism and use ful ad vice helped our au thors to
fur ther im prove their ar ti cles. It takes a lot of time to
re view an ar ti cle and many or our re view ers have
spared their valu able time to do it thor oughly and
pro fes sion ally. Also, there is Mrs. Gordana Duèkiæ,
who joined the Ed i to rial staff in 2002 and whose
task, among other things, is to make sure that our
ref er ees and ed i tors main tain the dead lines. Fur -
ther more, be gin ning this year, Aleksandra Mišak is
the new lan guage ed i tor and Marko Kljakoviæ-
 Gašpiæ in charge of the lay out and makeup of the
Jour nal.
On be half of the Ed i to rial Board of ADC and my -
self, I wish fur ther suc cess to our Jour nal and thank
all our Ed i to rial mem bers, au thors, ref er ees, and
pub lisher for their ef forts and help in mak ing the
ADC a rec og niz able pe ri od i cal in the field of derma -
tovenerology.
Jasna Lipozenèiæ
ADC Ed i tor-in-Chief 
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Dušan Jakac:  The Life in Dermatovenerolgy 
Stella Fatoviæ-Ferenèiæ, Jasna Lipozenèiæ
SUMMARY This is a story of Dušan Jakac, one of the most prom i -
nent Cro atian dermatovenerologists. Born in 1906, he is also our
old est dermatovenerologist and cer tainly among the old est in Eu -
rope. His life and ex pe ri ence con sti tute a trea sure of in for ma tion
on dermatovenerology in the re gion, which mo ti vated us to ask him 
for an in ter view. In his life, Jakac ex pe ri enced the time when Eu -
rope saw its un rest and wit nessed the shift of dread ful ep i dem ics
such as Span ish flue, syph i lis, and re cently AIDS. He has ob -
served dif fer ent di ag nos tic ap proaches, their ben e fits and fail ures, 
and prac ticed var i ous ther a peu tic ap proaches, never for get ting to
take care of their side ef fects. Jakac’s ca reer  il lus trates the med i -
cal and cul tural times in a strik ing way. We met him at his apart -
ment in Zagreb, where he lives now and where he an swered
promptly and en thu si as ti cally all our que ries. Thanking him
warmly, we can truly state that talk ing to Dušan Jakac was a unique 
ex pe ri ence for both the his to rian of med i cine and the derma to ve -
ne rologist.
Written sources, pic to rial doc u men ta tion and
other ma te ri als give us the pos si bil ity to learn about
past pe ri ods. How ever, us ing such meth ods many
el e ments re main ne glected, for ex am ple, per sonal
views, in sti tu tional re la tion ships, cul tural or his tor i -
cal set tings, in di vid ual per spec tives, etc. For this
rea son, in ter view is the op ti mal choice to com ple -
ment his tor i cal data or of ten lim ited writ ten sources. 
It is a rare chance to meet peo ple who have ded i -
cated their lives to their pro fes sion and who have
lived long enough to be able to turn back and re as -
sess all what was their daily prac tice. Thus, it is a
great ad van tage to have the pos si bil ity to share with 
them these ex pe ri ences and per sonal un der stand -
ing of the past pe ri ods.
Meet ing Dušan Jakac, talk ing to him, learn ing
from his life’s ex pe ri ence have pro vided us with an
ex cel lent op por tu nity to look into a long pe riod of
time in which dermatolovenerology in Croatia was
strongly de vel op ing. This text is there fore our con -
tri bu tion to the ef forts at re-en act ing the per spec -
tives and thoughts, thereby to il lus trate the pro file of 
an ex tremely mod est, none the less amaz ing derma -
to venerologist of ours. 
Dušan Jakac was born in Veli Mlun near Buzet,
to day’s cen tral Istria, on June 3, 1906. This was ex -
actly a hun dred years af ter Alibert had pub lished his 
At las De scrip tion des Mal adies de la Peau and the
same year when Fritz Schaudinn (1871-1906), the 
dis cov erer of Treponema pallidum died. In the
6
Acta Dermatovenerol Croat 2003;11(1):6-9 HIS TORY OF MED I CINE
Correspodending au thor:
Stella Fatoviæ-Ferenèiæ, MD, PhD
As sis tant Pro fes sor
Cro atian Acad emy of Sci ences and Arts
In sti tute for the His tory and Phi los o phy of Sci ences
Di vi sion for the His tory of Med i cal Sci ences
Zagreb, Croatia
stella@hazu.hr
Re ceived: 15. 11. 2002.
Ac cepted: 17. 01. 2003.
same year, the Croato–Ser bian co ali tion was cre -
ated, which re mained in power un til the fall of the
Habs burg Mon ar chy. When Jakac en tered the
six-year el e men tary school in Buzet, Istria was on
its way to im prov ing its po lit i cal as well as eco nomic
sit u a tion, and it was one of the bright est pe ri ods of
its his tory. Vine yards, ol ive and fruit groves were
cul ti vated; the ex port of salt was ris ing, par tic u larly
with the in land parts of the Austro-Hun gar ian Mon -
ar chy. The eco nomic prog ress ex panded largely
through three im por tant har bors of Rijeka, Pula and
Trieste. Great at ten tion was paid to ed u ca tion in
Istria since the time of bishop Juraj Dobrila and
much en thu si asm was put into it (1). As the re sult of
such de vel op ments, many schools were opened,
with clas sics high school in Pazin as most prom i -
nent of them. 
Dur ing the om i nous year of 1918, when Jakac
en tered the clas sics high school in Pazin, sev eral
tur bu lent events di rected his life to other places,
away from his lov ing Istria. Also in 1918, the con ti -
nu ity of the Cro atian state was in ter rupted, the Cro -
atian Diet was abol ished and parts of the Cro atian
na tional ter ri tory such as Istrian pen in sula, Rijeka,
Zadar, and some is lands had to be sur ren dered to
It aly. It was also the year when the dread ful pan -
demic of flu known as Span ish in flu enza spread
and its oc cur rence in Istria had great im pact on the
peo ple’s lives. The clas sics high school in Pazin
was closed and its stu dents were re ferred to other
places. Jakac hence found him self first in Karlovac
and not long there af ter in Zagreb, where he grad u -
ated from high school in 1927 (2). It was the pe riod
of de pri va tion of Cro atian iden tity, the pe riod when
Stjepan Radiæ’s Cro atian Peas ant Party was the
leader of re sis tance to Ser bian he ge mony, and re -
gard ing der ma tol ogy, the pe riod when Franjo Kogoj
was study ing in Strasbourg at Lucien Pautrier and
de scribed his pus tule (3). 
Clas si cal ed u ca tion and pro fi ciency in sev eral
lan guages en abled Jakac to choose and en ter the
Med i cal School in Padua in 1928, where he com -
pleted the first two years. Al though re mark ably suc -
cess ful in pass ing ex ams, he left Padua for po lit i cal
rea sons. He con tin ued his med i cal ed u ca tion first in 
Ljubljana (fifth se mes ter) and then in Zagreb, where 
he grad u ated on Jan u ary 31, 1934. Dur ing 1935, he 
served one-year in tern ship as a sec ond ary phy si -
cian in dermatovenerological clin ics at the Zagreb
County Workers’ In sur ance De part ment. In par al lel, 
he vol un teered at the Deparment of Dermatovene -
ro logy, Zagreb School of Med i cine, which had been
well es tab lished by the time and led by Franjo
Kogoj. The Sec tion of Dermatovenerology, es tab -
lished in 1920, had al ready been very ac tive and its
ac tiv ity was grow ing with a prom i nent aim to de -
velop dermatovenerology through pro fes sional and
sci en tific ef forts of its mem bers (pre vent ing and cur -
ing ve ne real dis eases and pros ti tu tion). The first
con gress of dermatovenerologists was or ga nized
in Split in 1930, and the next one in Zagreb in 1933
(4). In 1935, when the In ter na tional Con gress of
Der ma tol ogy pre sided by Louis Nékám was held in
Bu da pest, and when Gerhard Domagk, a No bel
Prize win ner (1895-1964), pub lished his ex per i -
ments with Prontosil, Jakac was adopted as mem -
ber of the Cro atian Med i cal As so ci a tion (CMA) and
started his ac tiv i ties at the Sec tion of Dermato -
venerology. Dur ing the Great De pres sion and just
when the World War II was im mi nent, he had com -
pleted spe cial iza tion in dermatovenerology (1939)
but did not get po si tion at the De part ment of Derma -
tovenerology in Zagreb un til 1943, when he was ap -
pointed as sis tant (2). 
His in ter est grew slowly to wards venerology and 
oc cu pa tional dermatoses. To un der stand why such
in ter ests oc cu pied a young dermatovenerologist as
Jakac, one should know that he con sid ered it im -
por tant to be ac quainted with the main move ments
in med i cine, em brac ing a vi sion of so cial iza tion, a
line of think ing which re lated to the pub lic health
move ment. It aimed to in cor po rate wider ques tions
such as in come, em ploy ment, life style, pro fes sion,
psychosocial econ omy, etc. Ve ne real dis eases,
which kept busy the ma jor ity of dermatovenerolo -
gists, had al ready be come a pop u lar arena for ver i -
fi ca tion of such con cepts, while oc cu pa tional dis -
eases were on their way to es tab lish a place for
them selves. Jakac’s pa per on the im por tance of cu -
ta ne ous dis eases at the so cial in sur ance level, pub -
lished in 1938, was there fore def i nitely up-to-date to 
the cur rent con cepts of so cial med i cine of the early
20th-cen tury Eu rope. It ap peared in No. 11 of
Lijeènièki vjesnik, an is sue ded i cated ex clu sively to
var i ous dermatologic top ics, on the oc ca sion of the
10th an ni ver sary of the Zagreb De part ment of Der -
ma tol ogy (5). At the same time, it was a pe riod in
which Kogoj and his as sis tant Bošnjakoviæ car ried
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out their stud ies on palmoplantar keratodermias,
chal leng ing other in ves ti ga tors abroad. This topic
was linked ex clu sively to the is land of Mljet. Ever
since, it has been in spir ing der ma tol o gists,  in clud -
ing Jakac who pub lished a pa per on palmoplantar
keraodermias in the 1960s (6). 
Re spected by his col leagues, Jakac was fi nally
of fered em ploy ment by Kogoj at the De part ment of
Dermatovenerology in Zagreb. How ever, he chose
to go to Rijeka where he was given an op por tu nity
to chair the Braæa Sobol Gen eral Hos pi tal De part -
ment of Dermatovenerology (a de cree from the
Min is try of Health from Sep tem ber 1946). Al beit, it
was not an easy task to ac com plish be cause no de -
part ment for dermatovenerology had ex isted there
be fore. Jakac ac cepted the po si tion with en thu si -
asm and ded i ca tion, and was also close to his be -
loved Istria again. He pi o neered by found ing
derma tovenerology in Rijeka as an ac a demic dis ci -
pline de spite all ad ver si ties of the time. In 1957 he
was ap pointed head of the Uni ver sity De part ment
of Der ma tol ogy and chair of the dis ci pline at the
newly founded Med i cal School of Rijeka. Dur ing
that pe riod he de vel oped his in ter est in many di rec -
tions and pub lished pa pers on photodermatoses,
side ef fects of var i ous ther a pies, Stevens-John son
syn drome, im por tance of vi ta mins in der ma tol ogy,
cases of sodoku, thalassotherapy, skin can cer, etc.
(2). His in ter ests ev i dently went in par al lel with
dermatovenerology de vel op ments and new re sults
in im mu nol ogy. 
In 1961 he was ap pointed as so ci ate pro fes sor
and in 1965 pro fes sor of dermatovenerology. Jakac 
wid ened his ex per tise in pro fes sional dermatoses
at var i ous Eu ro pean med i cal cen ters, par tic u larly in
Dortmund. He also vis ited many over seas clin i cal
de part ments such as New York, Cairo, Tu nis, Bei -
rut, etc. As mem ber of the Dermatovenerological
Sec tion, Jakac con tin ued par tic i pat ing in var i ous
con gresses, events and other ac tiv i ties, and was
even prin ci pal or ga nizer of the con gress that took
place in Rijeka/Opatija in 1972. The in ter na tional
rep u ta tion of Dušan Jakac, the Con gress Pres i dent
in Opatija, as well as the fame of Franjo Kogoj, who
was hon or ary pres i dent, con trib uted un doubt edly to 
the at ten dance by rep u ta ble dermatovenerologists
from 11 coun tries (4). 
Dur ing the 1959-1965 pe riod, Jakac was vice-
 dean, dean and then vice-dean again of the Med i cal 
School in Rijeka. He was mem ber of the ed i to rial
boards of sev eral Cro atian jour nals such as Arhiv za
higijenu ra da i toksikologiju and Medicina. He pre -
sided the CMA Sec tion of Dermatovene ro logy in
1981-1983, and As so ci a tion of Dermatovenerolo -
gists of Yu go sla via 1969-1972. He re tired on Jan u -
ary 1, 1977. How ever, he re mained ac tive and lin -
ked to dermatovenerology at both na tional and in -
ter na tional level. Even re cently, at the open ing cer -
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e mony of the Sec ond In ter na tional Con gress of the
Cro atian Dermatovenerologists “New High lights in
Dermatovenerology”, Opatija, May 16-19, 2002, it
was a plea sure and honor to ad dress Pro fes sor
Dušan Jakac, a doyen of dermatovenero lo gy, for
hav ing hon ored us by his pres ence and his oc ca -
sional ad dress to the Con gress au di ence (Fig 1).
His clas si cal ed u ca tion, his skills in dermato -
venerology as well as his for eign lan guage pro fi -
ciency made him a typ i cal Eu ro pean in tel lec tual
shaped in the first half of the 20th cen tury (Fig. 2).
His spirit and open ness let him ap pear ami a ble,
friendly and con tem po rary as any one of us would
wish. His long ca reer and pro fes sional leg acy place
him among the few role-model der ma tol o gists of
the 20th-cen tury Croatia (Fig. 3). 
Ref er ences
1 Radetiæ E. Istra pod Italijom (pretisak). Zagreb:Tiskara
C. Albrecht (Petar Acinger), 1944.
2 Fatoviæ-Ferenèiæ S. Jakac Dušan. Hrvatski biografski
leksikon Vol. 6. Zagreb: Leksikografski zavod Miroslav
Krleža (in press). 
3 Holubar K. Franjo Kogoj and the spongiform pus tule.
Am J Dermatopathol 1985;7:191-5.
4 Lipozenèiæ J, Fatoviæ-Ferenèiæ S. Cro atian Dermato ve -
ne ro logical So ci ety In: Herzogova J et al., eds. Mil len -
nium dermatologicum: Eu ro pean hand book of derma to -
logical so ci et ies. 1st edi tion. Prague: Olga Èermakova
for Prague Acad emy, 2002. 
5 Jakac D. Znaèenje kožnih bolesti, naroèito obrtnih, u
socijalnom osiguranju. Lijeè Vjesn 1938; 60:684-7. 
6 Jakac D. Palmo-plantarna dermatofitija i njena terapija.
Medicinski glasnik 1960;15:10.
Reklama E. V. Fellera, poèetak XX stoljeæa. (Iz kolekcije S. Fatoviæ- Ferenèiæ)
Iden ti fi ca tion of Malassezia Spe cies Iso lated from Scalp
Skin of Pa tients with Pso ri a sis and Healthy Sub jects
Asja Prohiæ
De part ment of Dermatovenerology, Sarajevo Uni ver sity Hos pi tal Cen ter, Sarajevo, Bosnia
and Herzegovina
SUMMARY The role of Malassezia spe cies in pso ri a sis is still un -
de ter mined, but sev eral re ports have as so ci ated these lipophilic
yeasts with the de vel op ment of skin le sions in pso ri a sis. The aim of 
our study was to an a lyze the prev a lence of Malassezia spe cies in
the scalp le sions of pa tients with pso ri a sis and as sess the dis tri bu -
tion of the spe cies ac cord ing to pa tient sex, age, and du ra tion of
the dis ease. Forty psoriatic pa tients with scalp in volve ment and
the same num ber of clin i cally healthy in di vid u als were in cluded in
the study. The sam ples were ob tained by scrap ing the skin sur face 
of the scalp of all sub jects and then in cu bated on mod i fied Dixon
agar. The yeasts iso lated were iden ti fied by their mor pho log i cal
and phys i o log i cal prop er ties ac cord ing to Guillot et al method.
M.globosa in its yeast phase was a pre dom i nant spe cies (55%),
fol lowed by M.slooffiae (18%) and M.restricta (10%), the lat ter be -
ing the most com mon spe cies iso lated from healthy scalp skin. We
found sig nif i cant dif fer ence in the dis tri bu tion of Malassezia spe -
cies be tween psoriatic and healthy scalp skin and in the dis tri bu -
tion of Malassezia spe cies ac cord ing to the se ver ity of the scalp in -
volve ment.
KEY WORDS Malassezia; my col ogy; pso ri a sis; scalp
Lipophilic yeasts of the ge nus Malassezia are
com men sals of the microbiota found on nor mal skin 
of many warm-blooded ver te brates, but they are
also as so ci ated with sev eral skin dis eases and
even sys temic in fec tions (1). By means of mo lec u -
lar meth ods the ge nus was tax o nom i cally re vised
and en larged to seven spe cies – in ad di tion to
M.furfur, M.pachydermatis, and M.sympodialis, four 
new taxa have been de scribed, namely M.slooffiae, 
M.globosa, M.obtusa, and M.restricta (2-4). M.pa -
chy der matis is the only non lipid-de pend ent spe -
cies. It is con sid ered zoophilic, be cause it is mainly
iso lated from an i mals (5), whereas the re main ing
six spe cies are oblig a tory lipophilic and found pri -
mar ily in hu mans. 
The eti o log i cal role of Malassezia yeasts in
pityriasis versicolor is un ques tioned; the or gan ism
found in the le sions is pre dom i nantly in its mycelial
phase (6-8). It seems that M.globosa (6-9) and
M.sympodialis (10,11) are the spe cies most fre -
quently as so ci ated with pityriasis versicolor le sions. 
In other skin dis eases, such as seborrheic der ma ti -
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tis, Malassezia folliculitis, con flu ent and re tic u late
papillomatosis, atopic der ma ti tis, and pso ri a sis,
nei ther the num ber of yeasts nor their mor phol ogy
seems re lated to the skin le sions, their ap pear ance
or ex ac er ba tion.
There is ev i dence that pso ri a sis is prin ci pally a
T-cell me di ated skin dis ease (12). How ever, lit tle is
known about the ini tial stim u lus that leads to the ab -
nor mal T-cell ac ti va tion. Strep to coc cal in fec tion can 
trig ger guttate pso ri a sis or ex ac er bate chronic pla -
que pso ri a sis, pos si bly through the re lease of bac -
te rial superantigenic tox ins (13,14). The lym pho -
cytes spe cific for group A strep to coc cal superanti -
gens were iden ti fied from guttate psoriatic le sions
(15) and they re acted both with strep to coc cal M
pro tein and a skin de ter mi nant, pos si bly a vari ant of
ker a tin (16). It was also dem on strated that T cells
with dif fer en tial re ac tiv ity to var i ous mor pho log i cal
vari ants of Malassezia yeasts were pres ent in
psoriatic skin le sions, but they were not spe cific for
the dis ease (17).
The ben e fi cial ef fect of both oral and top i cal
ketoconazole, fol lowed by re duc tion of yeasts, in di -
cates that Malassezia yeasts may rep re sent an -
other an ti genic stim u lus in pso ri a sis (18,19). Al -
though this antimycotic drug may act through a di -
rect mode of ac tion, it has also been shown that it
can sup press Malassezia-in duced pro lif er a tion of
lym pho cytes in psoriatic pa tients and thus re duce
the re sponse to the an ti genic stim u la tion in skin le -
sions (20).
The pur pose of our study was to an a lyze the
prev a lence of Malassezia spe cies in the scalp skin
of psoriatic pa tients and to ex am ine if the range of
spe cies var ies with pa tient sex, age, and du ra tion of 
the dis ease.
PA TIENTS AND METHODS
Pa tients
This pro spec tive study was con ducted at the
De part ment of Dermatovenerology, Sarajevo Uni -
ver sity Hos pi tal Cen ter, Sarajevo, Bosnia and
Herzegovina, be tween April and De cem ber 2001.
Forty pa tients with pso ri a sis (18 women and 22
men; age range, 7-72 years) and the same num ber
of clin i cally healthy in di vid u als (20 women and 20
men; age range, 13-76 years) were in cluded in the
study. All pa tients with pso ri a sis had chronic sta -
tion ary plaque le sions with scalp in volve ment. We
in cluded only those in di vid u als who had not used
any top i cal or oral treat ment in pre vi ous two
months. All par tic i pants gave their in formed con -
sent in ac cor dance with the re quire ments of the In -
sti tu tional Eth ics Com mit tee. 
Sam ples
All sam ples con sisted of scales and scrap ings
from the scalps of both psoriatic pa tients and
healthy sub jects. Col lected sam ples were di vided
into two por tions – one for mi cro scopic ex am i na tion
and the other for cul ture.
Mi cro scopic ex am i na tion of the sam ples was
per formed af ter the treat ment with 30% so lu tion of
po tas sium hy drox ide (KOH) and Parker blue ink.
The sam ples for cul ture were in oc u lated on
mod i fied Dixon agar con sist ing of 3.6% malt ex -
tract, 0.6% my co log i cal peptone, 2.0% des ic cated
ox bile (Sigma Chem i cal Co. Ltd, Dorset, UK), 1%
Tween 40, 0.2% glyc erol, 0.2% oleic acid, 0.05%
chloramphenicol, 0.05% cycloheximide, and 1.2%
agar pH 6.0. The me dium was al ways used within
one week of prep a ra tion and the cul tures were in cu -
bated at 32°C for seven days. 
Iden ti fi ca tion of Malassezia yeasts
Malassezia spe cies were iden ti fied ac cord ing to
the scheme es tab lished by Guillot et al (21), and
their mac ro scopic and mi cro scopic fea tures and
phys i o log i cal prop er ties were re corded. The mac -
ro scopic fea tures of the pre dom i nant col o nies in -
cluded their shape, size, color con sis tency, and the
char ac ter is tics of the me dium around them. Mi cro -
scopic fea tures of the yeast cells in cul tures were
de scribed af ter lactophenol stain ing and in cluded
the pre dom i nant mor phol ogy, size, and bud ding
base of the yeasts. To as sess the phys i o log i cal
prop er ties of the yeasts, catalase re ac tion was
used. A drop of hy dro gen per ox ide (30% so lu tion)
was added to a cul ture smear on a glass slide. The
pro duc tion of gas bub bles, in dic a tive of re lease of
ox y gen, was con sid ered a pos i tive re ac tion.
Uti li za tion of Tween com pounds was done ac -
cord ing to the test orig i nally de scribed by Guillot et
al (21) and later mod i fied by Gupta et al (10,11).
Sus pen sion of the iden ti fied yeasts (2 mL) was in -
oc u lated on Sabouraud glu cose agar. The sus pen -
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sion was pre pared by trans fer ring a loopful of ac -
tively grow ing yeasts into 5 mL of ster ile dis tilled wa -
ter. The inoculum was spread evenly over the sur -
face of a plate. Each plate was di vided into four sec -
tions and 5 mL of Tween 20, 40, 60, and 80 were
added into a hole made in the cen ter of each sec -
tion. Uti li za tion of Tweens was as sessed by the de -
gree of growth and/or re ac tion of the lipophilic
yeasts around in di vid ual holes.
Sta tis tics
Chi-squared test with Yates’ cor rec tion for a
small sam ple size was car ried out to de ter mine the
sta tis ti cal sig nif i cance of dif fer ences in pro por tions.
We used a sta tis ti cal soft ware pack age Minitab
13.0. Sig nif i cance level was set at p<0.05.
RE SULTS
Di rect Mi cros copy
Di rect mi cro scopic ex am i na tion of psoriatic scalp
scales showed the pres ence of yeast cells in 34
(85%) pa tients, but short fil a ments were ob served
only in 8 (20%). Spher i cal and large yeast cells with
a nar row bud ding base were found in 19 (56%) pa -
tients, to gether with fil a ments in 5 cases. Smaller
yeast cells, oval or cy lin dri cal in shape, were seen
in 15 (44%) cases. In 6 (15%) slides nei ther yeast
cells nor hyphae were ob served (Ta ble 1).
In the scales from healthy scalp skin, yeast cells
were ob served in 21 (53%) pa tients, whereas the
re main ing 19 (47%) cases were neg a tive. Short fil a -
ments were seen in only one pa tient. Oval and cy -
lin dri cal yeast cells dom i nated; they were found in
14 (35%) cases. Spher i cal yeasts were re corded in
7 (18%) slides.
No sig nif i cant sta tis ti cal dif fer ences were found
in the di rect mi cro scopic find ings from psoriatic and
healthy scalp skin (Ta ble 1).
Cul tures
Malassezia yeasts were found in 37 (93%) sam -
ples taken from scalp skin of psoriatic pa tients (Ta -
ble 2). The most fre quently iso lated spe cies was
M.globosa found in 22 (55%) pa tients, fol lowed by
M.slooffiae (18%), M.restricta (10%), M.furfur (8%),
and M.sympodialis (3%). Two spe cies, M.pachy -
der ma tis and M.obtusa, were not iso lated. The per -
cent age of neg a tive cul tures was 8%.
The re sults of cul ture ob tained from healthy
scalp skin were pos i tive for Malassezia yeasts in 26 
(65%) cases. The pre dom i nant spe cies was M.res -
tricta, found in 12 (30%) pa tients and the prev a -
lence of other spe cies was 18% for M.globosa, 10% 
for M.sympodialis, 5% for M.slooffiae, and 2% for
M.furfur. The re main ing 14 (35%) cul tures showed
no growth of the col o nies.
Sta tis tically sig nif i cant dif fer ences were found in
the dis tri bu tion of the spe cies iso lated from psoriatic 
and healthy scalp skin – cul tures from healthy skin
were neg a tive more fre quently (healthy/psoriatic
skin ra tio, 4.7). Also, M.sympodialis was more fre -
quent in the healthy scalp skin cul tures (re spec tive
ra tio 4.0). Other spe cies were more com monly pos i -
tive in psoriatic scalp skin cul tures – M.slooffiae ra -
tio 3.5, M.globosa ra tio 3.1, and M.restricta and
M.furfur ra tio 3.0 (Ta ble 2).
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Ta ble 1. Direct mi cros copy of scales from psoria tic 
and healthy scalp skin*
Psoriatic scalp skin Healthy scalp skin 
Microscopic finding  F  M  S  F  M  S
Yeast cells and
 filaments  4  4  8  1  0  1
Yeast cells only 13 13 26 11  9 20
Negative  1  5  6  8 11 19
Total 18 22 40 20 20 40
*F- female; M – male.
Ta ble 2. Malassezia spe cies ob tained from scalp
skin of pa tients with pso ri a sis and nor mal sub ject
Psoriatic scalp skin Healthy scalp skin 
Malassezia species   F  M  S   F   M   S
M. globosa 10 12 22  3  4  7
M.slooffiae  3  4  7  0  2  2
M. restricta  3  1  4  8  4 12
M. furfur  1  2  3  1  0  1
M. symodialis  1  0  1  1  3  4
M. obtusa  0  0  0  0  0  0
M. pachyderm.  0  0  0  0  0  0
Negative  0  3  3  7  7 14
Total 18 22 40 20 20 40
Dis tri bu tion of Iso lated Spe cies
Ac cord ing to Rel e vant Pa ram e ters
Eigh teen sub jects were women (45%), twenty-
 two men (55%), with a women/men ra tio 0.8. No
sta tis ti cally sig nif i cant dif fer ences were found be -
tween sexes in the spe cies iso lated (Fig. 1).
Ac cord ing to age, pa tients were di vided into five
groups, as fol lows: <15 (n=3; 8%), 16-30 (n=7;
18%), 31-45 (n=13; 33%), 46-60 (n=8; 20%), and
>61 years of age (n=9; 22%). No sta tis ti cally sig nif i -
cant dif fer ences were found in the spe cies iso lated
in these five groups (Fig. 2).
Four groups were formed ac cord ing to the du ra -
tion of the pso ri a sis: less than one year (n=2; 5%),
be tween 1 and 5 years (n=13; 33%), be tween 5 and 
10 years (n=7; 17%), and more than 10 years
(n=18; 45%). There was no sta tis ti cally sig nif i cant
dif fer ence among these four groups in the dis tri bu -
tion of the spe cies iso lated (Fig. 3).
Pa tients were di vided into three se ver ity groups
ac cord ing to the ex tent of scalp in volve ment, as fol -
lows: a) mild – seborrheic-like clin i cal pat tern char -
ac ter ized by a fine dif fuse scal ing and er y thema
cov er ing the scalp (n=3; 7,5%); b) mod er ate – dis -
crete plaques, or typ i cal plaques of pso ri a sis that
oc cur through out the scalp, of ten with a pre di lec tion 
for hair mar gins (n=34; 85%); and c) se vere – gen -
er al ized plaque, or con flu ent in volve ment of the
scalp with thick, scaly pso ri a sis (n=3; 7,5%). We
found sta tis ti cally sig nif i cant dif fer ence in the dis tri -
bu tion of Malassezia spe cies iso lated in three se -
ver ity groups – M.restricta, M.furfur, M.sympodialis
and neg a tive cul tures were found only in pa tients
with mod er ate scalp in volve ment, whereas M.glo -
bosa and M.slooffiae were found more fre quently in
pa tients with mod er ate than in pa tients with mild or
se vere ex tent of scalp in volve ment (Fig. 4).
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Fig ure 1. Malassezia spe cies dis tri bu tion from psoriatic























Fig ure 2. Malassezia  spe cies dis tri bu tion from psoriatic

















Fig ure 3. Malassezia spe cies dis tri bu tion from psoriatic
















Fig ure 5. Malassezia spe cies dis tri bu tion from psoriatic














Fig ure 4. Malassezia spe cies dis tri bu tion from psoriatic
scalp skin ac cord ing to the se ver ity/ex tent of the scalp
in volve ment.
We found no sta tis ti cally sig nif i cant dif fer ence in
the dis tri bu tion of iso lated Malassezia yeasts ac -
cord ing to di rect mi cros copy find ings: yeast cells
and fil a ments (n=8; 20%), yeast cells only (n=26;
65%) and neg a tive (n=6; 15%) (Fig. 5).
DIS CUS SION
Rivolta (22) made the first as so ci a tion of the
lipophilic yeasts and pso ri a sis in 1873. He re ported
on round dou ble-con toured bud ding cells in the epi -
der mis of a pa tient with pso ri a sis and named them
Cryptococcus pso ri a sis. The role of Malassezia
yeasts in pso ri a sis is still un de ter mined, but there
are sev eral re ports in di cat ing that these mi cro or -
gan isms are able to elicit psoriasiform le sions in
both hu man and an i mals. Rosenberg et al (23) re -
ported that, af ter heavy dense sus pen sions of
Malassezia were ap plied to the shaved rab bits skin, 
le sions both grossly and mi cro scop i cally sim i lar to
pso ri a sis de vel oped. The same group claimed to be 
able to in duce pso ri a sis-like le sions ex per i men tally
in 10 pa tients with pso ri a sis and 10 con trols us ing
patch test ing with Malassezia. Al though a Koebner
phe nom e non could not be ex cluded, their hy poth e -
sis was that pso ri a sis was pro duced by Malassezia
yeasts through ac ti va tion of the al ter na tive path way 
of com ple ment, and also ac ti vated by other mi cro -
or gan isms and endo tox ins (24).
Elewski (25) re ported of a pa tient de vel op ing
guttate pso ri a sis in sites of Malassezia folliculitis. In
this case, pus tules trans formed into guttate le sions
prior and dur ing erythromycin ther apy but re solved
when ketoconazole was ap plied. Al though this
trans for ma tion could also be Koebner phe nom e -
non, this case re port sup ported the pro posal that
pso ri a sis may be in cluded in Malassezia-as so ci -
ated dis eases.
The iden ti fi ca tion of Malassezia yeasts to a spe -
cies level is of no di ag nos tic value in skin dis eases,
as the same spe cies form an in te gral part of nor mal
cu ta ne ous microflora in hu mans. How ever, it is of
great im por tance to de ter mine which spe cies are
as so ci ated with cer tain skin dis ease and whether
the spec trum var ies with clin i cal data, body site, or i -
gin of the pop u la tion, etc. The re sults of the in vi tro
sus cep ti bil ity stud ies have shown vari a tions in sus -
cep ti bil ity of the seven Malassezia spe cies to keto -
conazole, variconazole, itraconazole, and terbina -
fine. Strains of M.furfur, M.globosa, and M.obtusa
were more tol er ant to terbinafine than other spe -
cies, whereas M.sympodialis was found to be highly 
sus cep ti ble (26). There fore, cor rect iden ti fi ca tion of
Malassezia spe cies is re quired for the se lec tion of
ap pro pri ate antifungal ther apy.
We found that the pre dom i nant spe cies in pso ri -
a sis vulgaris le sions from the scalps of our pa tients
was M.globosa, iso lated in 22% of cases. This spe -
cies has been re cov ered reg u larly from nor mal as
well as dis eased skin (9,10). M.globosa in its myce -
lial phase has been con firmed to be the caus ative
agent of pityriasis versicolor (7,8). Data from United 
King dom on re cov ery of yeasts from scalp showed
that M.globosa was the most fre quent spe cies in
both adults and chil dren (27). In our study, yeast
cells pre dom i nated (64%), whereas fil a ments were
ob served in 23% of the scrap ings from which
M.globosa was iso lated. This find ing sug gests that
M.globosa in its yeast phase is the com mon est spe -
cies in psoriatic skin, at least from scalp. M.sloo -
ffiae, first iso lated from an i mals, can be found oc ca -
sion ally on hu man skin (7,10). In our study, it was
the sec ond most fre quent spe cies (18%). The re -
main ing three spe cies, M.restricta, M.furfur, and
M.sympodialis, were re cov ered in lower fre quen -
cies, as a part of nor mal hu man cu ta ne ous flora (1).
In con trast to psoriatic scalp skin, M.globosa
was re cov ered less fre quently from healthy scalp
skin, whereas M.restricta was the com mon est
Malassezia spe cies. This spe cies is iso lated reg u -
larly from the scalp and face of pa tients with
seborrheic der ma ti tis and nor mal in di vid u als, but
seems to be un com mon on the trunk (7,9,10). Al -
though M.sympodialis is re ported as one of the
most fre quent res i dents of healthy and dis eases
skin from trunk and scalp (6-11), in our study it was
rarely iso lated ei ther from psoriatic pa tients or from
healthy sub jects.
M.obtusa and M.pachydermatis were not re cov -
ered from any of our sam ples ei ther from psoriatic
or from healthy scalp skin. How ever, M.obtusa is
con sid ered to be very rare and only in fre quently iso -
lated from the cases of pityriasis versicolor, atopic
der ma ti tis (10), and seborrheic der ma ti tis (9). M.pa -
chydermatis is con firmed to be clearly adapted to
an i mals, al though it has been in volved in some sys -
temic hu man in fec tion (28). The pres ence of this
spe cies on hu man skin is rare and tran sient, oc cur -
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ring pos si bly by trans mis sion from an i mal pets and
en vi ron men tal sources (29,30).
The pa tients with pso ri a sis showed a low neg a -
tive cul ture rate com pared with the healthy sub -
jects.
Our re sults are in agree ment with re port of
Gupta et al (10), who found that M.globosa was the
spe cies most fre quently iso lated from psoriatic
scalp skin, but strik ing dif fer ence was found in the
re cov ery per cent ages: a sig nif i cantly lower pos i tive
cul tures from scalp were ob served in Can ada
(28,6%) than in our study (92.5%), and con se -
quently the spe cies in their study were iso lated in a
lower fre quen cies.
CON CLU SION
Our re sults sug gest that M.globosa, and M.sloo -
ffi ae, M.restricta and M.sympodialis less fre quently,
rep re sent the cu ta ne ous yeasts flora from psoriatic
scalp skin. There is still no con vinc ing ev i dence of
the role of Malassezia yeasts in pso ri a sis. The iso -
la tion of Malassezia yeasts from psoriatic le sions
does not nec es sar ily mean that they are patho -
genic, but their role in the se ver ity and ex tent of le -
sions can not be ex cluded. Fur ther stud ies on larger
num ber of pa tients are needed to clar ify the re la -
tion ship be tween Malassezia spe cies and pso ri a -
sis.
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Terbinafine Exacerbates Psoriasis: Case Report with a
Literature Review
Jacek C. Szepietowski
De part ment of Der ma tol ogy and Venereology, Uni ver sity of Med i cine, Wroclaw, Po land
SUMMARY Oral terbinafine is a widely used antifungal agent. Ad -
verse ef fects oc cur in about 11% of pa tients tak ing terbi nafine. A
rare case of the ex ac er ba tion of pre-ex ist ing pso ri a sis af ter oral
terbinafine treat ment is re ported. A 63-year-old male pa tient with
sta ble pso ri a sis vulgaris de vel oped ex ten sive tinea cruris. For this
rea son, he was treated with oral terbinafine 250 mg/day and top i cal 
1% terbinafine cream. Af ter 6 days of this ther apy, a wide spread
flare-up of pso ri a sis de vel oped. Oral terbi nafine was dis con tin ued, 
and the pso ri a sis was treated with top i cal corti co ste roids and
tacalcitol. Tinea cruris was cured with top i cal terbinafine. This case 
points out that terbinafine can in flu ence the course of pso ri a sis.
More over, the lit er a ture data in di cate that terbinafine may not only
ex ac er bate pre-ex ist ing pso ri a sis, but may also be re spon si ble for
de novo de vel op ment of pso ri a sis. There fore, oral terbinafine
should not be con sid ered the first line drug for su per fi cial fun gal in -
fec tions in pso riatic in di vid u als.
KEY WORDS: antifungal; terbinafine; safety pro file; pso ri a sis
INTRODUCTION
Terbinafine is an antimycotic agent of the ally -
lamine class, with a high fun gi cidal ac tiv ity against
all dermatophytes (1,2). The drug was first in tro -
duced in 1991 and is now mar keted world wide
(1,3). It is avail able both in oral and top i cal for mu la -
tions (1,3). Sev eral stud ies have con firmed terbi -
nafine to be highly ef fec tive in the treat ment of fun -
gal in fec tions of the skin, nails, and hairs (4-6). In
1996, more than 5 mil lion pa tients re ceived oral
terbinafine, mostly for the treat ment of onycho my -
cosis (7,8). Five years later, in 2001, it was es ti -
mated that 18 mil lion pa tients world wide took oral
terbinafine (9). Al though the new gen er a tion oral
antifungal agents are quite safe, ad verse ef fects
may some times ap pear (10). A sur vey of more than
25,000 pa tients re ceiv ing oral terbinafine for dif fer -
ent rea sons re vealed that the in ci dence of its ad -
verse ef fects is as high as 11% (7).
There are few re ports de scrib ing ex ac er ba tion
of pre-ex ist ing pso ri a sis af ter tak ing oral terbina fi -
ne. The case of sta ble pso ri a sis that flared af ter
start ing terbinafine ther apy, pre sented in this re port
along with a short re view of lit er a ture on terbina fi -
ne- in duced pso ri a sis, could add to the gen eral
knowl edge on the prob lem.
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CASE REPORT
A 63-year-old male pa tient was ad mit ted to our
De part ment be cause of erythematous le sions on
up per in ner thighs and groins, with min i mal scal ing
lo cated in the groins. The le sions ap peared a week
be fore the ad mis sion and were very itchy. More -
over, the pa tient had suf fered from sta ble pso ri a sis
vulgaris for the pre vi ous 3 years. The fam ily his tory
of pso ri a sis was neg a tive and the pa tient had not
re quired any antipsoriatic treat ment for at least one
and a half years be fore the erythematous le sions
ap peared.
On ex am i na tion, he pre sented with ex ten sive,
sharply de mar cated erythematous plaques lim ited
bi lat er ally to the groins and up per in ner thighs. The
le sions showed an ac tive edge with pe riph eral scal -
ing. Small psoriatic papules with sil very-white
scales were lo cated sym met ri cally on the el bows,
knees, and spo rad i cally on the extensor sur face of
the lower legs. The pso ri a sis area and se ver ity in -
dex (PASI score) was cal cu lated as 2.2 points.
The clin i cal di ag no sis of tinea cruris was con -
firmed by di rect my co log i cal ex am i na tion (20%
KOH with ad di tion of DMSO), which showed typ i cal
dermatophytic hyphae. The pa tient was put on oral
terbinafine 250 mg/day and top i cal 1% terbinafine
cream was ap plied to the af fected ar eas in the
groins twice daily. In the first 5 days of terbinafine
ther apy, he re ported marked re lief of itch ing. How -
ever, on day 6, a wide spread flare-up of the pso ri a -
sis de vel oped. A dif fuse erythematous pap u lar
erup tion was pres ent on the trunk, up per and lower
ex trem i ties. No pus tules were ob served. The PASI
score in creased up to 12.4 points. As the cu ta ne ous 
le sions were clin i cally typ i cal for pso ri a sis, histo -
pathological ex am i na tion was not per formed. The
pa tient’s gen eral con di tion was good, ba sic blood
lab o ra tory tests showed no ab nor mal i ties. Two
days af ter the first signs of the ex ac er ba tion of pso -
ri a sis, the pa tient dis con tin ued oral terbianfine; top i -
cal terbinafine ther apy was con tin ued twice daily.
The psoriatic erup tion im proved with top i cal ap pli -
ca tion of 0.05% betamethasone dipropionate twice
a day over three weeks. Af ter wards, top i cal 4mg/g
tacalcitol once a day was pre scribed to con trol pso -
riatic le sions. Tinea cruris cleared with top i cal terbi -
na fine and af ter two and a half weeks, only re sid ual
er y thema was vis i ble. On a fol low-up visit, about 3
months af ter in tro duc tion of antifungal ther apy,
there were no le sions in the groins, but psoriatic
papules were still pres ent on the trunk, el bows,
knees, and lower legs. The pso ri a sis was def i nitely
more se vere than be fore oral terbinafine ther apy
(PASI score, 3.6 points). The pa tient con tin ued top i -
cal tacalcitol treat ment.
DISCUSSION
Terbinafine shows highly se lec tive ac tiv ity aga -
inst fun gal squalene epoxidase, which is the rea son 
for its rel a tively be nign side-ef fects (9,11). In sev -
eral stud ies, the tolerability of terbinafine was rated
by most pa tients (88-98%) as “very good” or “good”
(11). In a postmarketing sur veil lance study, ad verse 
ef fects oc curred in about 11% of pa tients tak ing oral 
terbinafine, whereas side-ef fects pos si bly, or prob -
a bly, re lated to terbinafine were found in 6% of pa -
tients (7). The most com monly re ported side ef fects
were gas tro in tes ti nal symp toms, fol lowed by cu ta -
ne ous re ac tions. The fre quency of terbinafine-re -
lated cu ta ne ous side ef fects was es ti mated at 1.4%
(7). The most com mon terbinafine-re lated com -
plaints be ing dif fer ent clin i cal man i fes ta tions of
rash, pru ri tus, ur ti caria, and ec zema (7,12). More
se vere, even se ri ous, cu ta ne ous re ac tions af ter
treat ment with oral terbinafine were re ported only
spo rad i cally. They in cluded fixed drug erup tions, er -
y thema multiforme, Stevens-John son syn drome,
toxic epi der mal necrolysis, and angio-edema
(8,9,11). I agree with the opin ion of Gupta et al (8)
that the in creas ing use of terbinafine may re sult in a
wider spec trum of ad verse ef fects, in clud ing cu ta -
ne ous re ac tions as well.
Ac cord ing to the PubMed da ta base search re -
sults, by Au gust 2002 only 6 ar ti cles had been pub -
lished de scrib ing 10 pa tients with flare-ups of pre vi -
ous pso ri a sis or pso ri a sis de novo af ter tak ing
terbinafine (Ta ble 1). In 1995, Wach et al (13) first
re ported a fe male pa tient who de vel oped a se vere
er y thema anulare centrifugum-like psoriatic erup -
tion with sin gle pustular le sions 5 days af ter start ing
oral terbinafine 250 mg/day for onychomycosis.
The le sions, lo cal ized on the trunk and ex trem i ties,
com pletely re solved 2 weeks af ter dis con tinu a tion
of terbinafine and treat ment with oral pred ni sone.
Shortly af ter this re port two psoriatic pa tients who
ex pe ri enced ex ac er ba tion of pso ri a sis 26 and 6
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days, re spec tively af ter be ing on terbinafine treat -
ment were re ported (8). A year later, Gupta et al
(14) de scribed two psoriatic pa tients with terbinafi -
ne- ex ac er bated pso ri a sis. Their pso ri a sis flared 12
and 17 days af ter be gin ning of antifungal ther apy. In 
the next pa tient with sta ble plaque-type pso ri a sis
pustular psoriatic le sions ap peared 21 days af ter
tak ing terbinafine. More over, ad di tional pa tient de -
vel oped pso ri a sis de novo on day 27 of terbinafine
ther apy (14). Pauluzzi and Boccucci (16) de scribed
in verse pso ri a sis in duced by terbinafine, while oth -
ers re ported de vel op ment of pustular pso ri a sis for
the first time in ad di tional two pa tients af ter 14 and
10 days of the oral terbinafine ther apy (15,17). It is
likely that terbinafine in duced pso ri a sis in even
more pa tients than it has been re ported. Gupta et al
(8) and Le Guyadec et al (17) were aware of 24 pos -
si ble sim i lar cases (data ob tained from the World
Health Or ga ni za tion).
The la tency pe ri ods be tween ad min is tra tion of
sus pected agents and the flare-up or de novo de -
vel op ment of pso ri a sis were clas si fied into three
groups: short (<4 weeks), in ter me di ate (4-12
weeks), and long (>12 weeks) (14). The an a lyzed
cases sug gest that terbinafine should be put into
the first group with the short est la tency pe riod of 5
days, like nonsteroidal anti-in flam ma tory agents
(14). Sim i larly to pre vi ously re ported pa tients with
terbinafine-in duced pso ri a sis, no prov o ca tion
test with oral terbinafine was per formed in our pa -
tient. So far, the mech a nism of pso ri a sis ex ac er -
ba tion due to terbinafine in take has re mained
un known.
The ma jor ity of pa tients who de vel oped terbi -
na fi ne-in duced pso ri a sis took this oral antifungal
agent be cause of onychomycosis. How ever, in
some pa tients, terbinafine was pre scribed only for
clin i cally sus pected onychomycosis with out my co -
log i cal con fir ma tion (4,6,9,15). A widely ac cepted
rule is that my co log i cal ex am i na tion must give a
pos i tive re sult be fore ther apy with oral antifungal
drugs, in clud ing terbinafine, can be started (10).
The pa tient de scribed in this case re port re ceived
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1 female 56 +  5 onychomycosis single
Wach et al,
1995 (13)
2 male 70 + 26 onychomycosis no
Gupta at al,
1997 (8)
3 male 52 +  6 onychomycosis no
Gupta et al,
1997 (8)


















7 male 34 + 12 onychomycosis no
Gupta et al,
1998 (14)




















11 male 63 +  6 tinea cruris no
Szepietowski
(present case)
oral terbinafine to con trol tinea cruris di ag nosed by 
di rect my col ogy. This is the first pa tient with
terbinafine-in duced pso ri a sis who de vel oped pso -
ri atic le sions dur ing the course of tinea cruris ther -
apy.
Sev eral cases of terbinafine-in duced pso ri a sis
showed to be very dif fi cult to con trol, with some of
them re quir ing hos pi tal iza tion and/or sys temic corti -
costeroid ther apy (13-15). One of these pa tients de -
vel oped wide spread pustular erup tion, fe ver, and
lab o ra tory ab nor mal i ties (in creased white cell count 
and dis or dered liver func tion tests) (15). In the pa -
tient de scribed in this case was in good gen eral
con di tion with out any blood ab nor mal i ties and his
pso ri a sis sig nif i cantly im proved with po tent top i cal
corticosteroid and tacalcitol. How ever, the PASI
score was 3 months af ter start ing terbinafine ther -
apy higher than be fore the dis ease ex ac er ba tion.
Re sis tance to the ther apy of pso ri a sis in duced by
drugs, such as antimalarial agents, corticostero ids
or lith ium, has been re ported (14,18). The above
men tioned pa tients with terbinafine-in duced pso ri a -
sis in di cate that pso ri a sis ex ac er bated by terbina -
fine could also be dif fi cult to treat.
Sev eral pa tients de vel oped pustular pso ri a sis
(14,15,17). Pustular erup tion is a known ad verse ef -
fect of oral drugs (18). As many as 5 pa tients have
been re ported who de vel oped acute gen er al ized
exanthematous pustulosis – an en tity of ten in dis tin -
guish able from acute gen er al ized pustular pso ri a -
sis - as so ci ated with oral terbinafine (19-22).
To the best of my knowl edge, no re ports have
been pub lished of pso ri a sis ex ac er ba tion af ter
treat ment with other oral antifungal agents, such as
itraconazole, fluconazole or ketoconazole. In ter est -
ingly, itraconazole has even been sug gested to be
ben e fi cial in sebopsoriasis (23) and palmoplantar
pustular pso ri a sis (24). More over, ketoconazole
could po ten tially af fect pso ri a sis in seborrheic ar -
eas of skin di rectly by an antifungal ac tion or in di -
rectly by sup press ing fun gal an ti gen-in duced lym -
pho cy te- me di ated im mune re sponses af fect ing the
skin (25).
In con clu sion, terbinafine, in con trast to other
oral antifungals, may be re spon si ble for the ex ac er -
ba tion or de novo de vel op ment of pso ri a sis, fre -
quently pustular pso ri a sis. Al though it is widely
used in psoriatic pa tients (mainly for onychomyco -
sis) with out any ad verse ef fects (26), the cases of
terbinafine-in duced pso ri a sis in di cate that oral
terbinafine should not be con sid ered a first line drug 
for su per fi cial fun gal in fec tions in psoriatic in di vid u -
als.
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Pso ri a sis Vulgaris and Ar thri tis Psoriatica Gra vis Mutilans
1Pero Vr´ogiæ, 2Aida Pašiæ, 1Tea Podobnik-Takaè
1Naftalan Spe cial Hos pi tal for Med i cal Re ha bil i ta tion, Ivaniæ Grad, Croatia
2Department of Der ma tol ogy and Venerology, Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb,
Croatia
SUMMARY A 33-year-old man with gen er al ized vul gar pso ri a sis
type I and psoriatic ar thri tis was ad mit ted to the Naftalan Spe cial
Hos pi tal on Feb ru ary 21, 2000. He was im mo bile and com plained
of se vere pain in all his joints. Since the pa tient had suf fered from
the dis ease for 10 years with out show ing any im prove ment af ter
dif fer ent ther a pies, his cu ta ne ous and joint le sions grad u ally wors -
ened and even tu ally re sulted in ge n e r a l i zed pso ri a sis and mu ti lat -
ing ar thri tis. Nev er the less, the pa tient was dis charged from our
hos pi tal in better con di tion. To avoid such se vere con se quences of 
psoriatic ar thri tis, we be lieve that pa tients with ei ther type I or type
II pso ri a sis should un dergo lo co mo tor sys tem screen ing. It would
sig nif i cantly de crease the num ber of un rec og nized and undiagno -
sed cases of psoriatic ar thri tis and al low their early treat ment, and
pre ven tion of more se vere forms. Ad min is tra tion of new ther a peu -
tic agents, e.g. Alefacept (IgG1 fu sion pro tein), Etanercept (in hib i -
tor of TNF ac tiv ity), and Efalizumab (monoclonal an ti body that
blocks the leu ko cyte integrin CDIIa/CD18(LFA-1), could pro vide
suc cess ful man age ment of the dis ease in fu ture.
KEY WORDS psoriatic ar thri tis; pso ri a sis; cell mi gra tion in hi bi tion;
             in fec tion
IN TRO DUC TION
Pso ri a sis is an in flam ma tory dermatosis,
which de vel ops due to ge netic sus cep ti bil ity and
af fects 1-3% of the pop u la tion (1-4). Al though
pso ri a sis may oc cur at any age, it is most com -
mon at the age of 20, and oc curs 3-4 years ear lier
in women than in men. In 75% of pa tients, the on -
set of pso ri a sis oc curs be fore the age of 40 (4,5).
Fa mil ial clus ter ing of the dis ease has been doc u -
mented in about 30% of pa tients (2). Vul gar pso ri -
a sis of a chronic sta tion ary type (chronic plaque
pso ri a sis) shows an equal sex dis tri bu tion (2,4).
Based on the age at on set, fa mil ial af fec tion,
and as so ci a tion of pso ri a sis with some HLA an ti -
gens, es pe cially HLA Cw6, pso ri a sis can be di vided 
into two types: type I and type II. Type I is char ac ter -
ized by early oc cur rence, pos i tive fam ily his tory,
and as so ci a tion with HLA an ti gens, whereas type II
is char ac ter ized by late oc cur rence, no fam ily his -
22
Acta Dermatovenerol Croat 2003;11(1):22-28 CASE RE PORT
Correspondendence to:
Pero Vržogiæ, MD
“Naftalan” Spe cial Hos pi tal for
Med i cal Re ha bil i ta tion 
Omladinska 23a
10310 Ivaniæ Grad, Croatia
Re ceived: 18. 12. 2002
Ac cepted: 18. 02. 2003.
tory, ungual le sions, and as so ci ated ar thri tis. More -
over, ac cord ing to the lat est ge netic stud ies of gene
ex pres sion (psors1, psors2, psors3) and sig nif i cant
oc cur rence of par tic u lar chro mo somes at the spec i -
fied gene loci (6p, 17q, 4q), there could also be type
III pso ri a sis (4-6,8).
Al though pso ri a sis may af fect any skin re gion,
the pre di lec tion sites are the scalp, el bows, knees,
and sa cral re gion. Nails can also be in volved.
Arthropathic pso ri a sis, or psoriatic in volve ment of
joints, oc curs in 10% of pa tients (2,9-13). The ba sic
le sion is a papule or plaque with sil ver-whit ish
scales. There are var i ous clin i cal forms of pso ri a sis, 
such as pso ri a sis in placibus, pso ri a sis guttata,
pso ri a sis nummularis, pso ri a sis geographica; pso -
ri a sis inversa, pso ri a sis erythrodermica, pso ri a sis
pustulosa, pso ri a sis cum pustulatione, pso ri a sis
palmoplantaris; and ar thri tis psoriatica as so ci ated
with HLA-B27 (1,6,7).
Psoriatic ar thri tis is a spe cific type of ar thri tis that 
can ei ther start slowly, with mild symp toms, or de -
velop quickly. Gen erally, pa tients com plain about
one or more of the fol low ing symp toms: dis com fort,
stiff ness, pain, throb bing, swell ing, and ten der ness
in one or more joints, re duc ing the joint mo tion.
When psoriatic ar thri tis starts early in life, the prog -
no sis is poor. Af fec tion of dis tal joints (clos est to the
fin ger nail or toe nail), lower back, wrists, knees, or
an kles with swell ing of the fin gers and toes pro -
duces a sau sage ap pear ance of the af fected fin -
gers. Morn ing stiff ness and tired ness are fre quent.
Nail changes may also oc cur, e.g., pits in the nail
bed. In flam ma tion of the eye, such as con junc ti vi tis, 
is rare (9,10).
The di ag no sis of psoriatic ar thri tis is made on
the ba sis of med i cal his tory, phys i cal ex am i na tion,
lab o ra tory find ings (e.g., an ti body test ing), and
x-rays of the symp tom atic joints. Dif fer en tial di ag -
no sis in cludes rheu ma toid ar thri tis, gout, and
Reiter’s syn drome, which are sim i lar to psoriatic ar -
thri tis and may oc cur with pso ri a sis. How ever, the
an ti body gen er ally pres ent in rheu ma toid ar thri tis is
usu ally not found in the blood of pa tients with
psoriatic ar thri tis, whereas anal y sis of the fluid ob -
tained from the af fected joints can help dis cern be -
tween gout and psoriatic ar thri tis (11).
Psoriatic ar thri tis may de velop at any age, but
usu ally be gins be tween the age of 30 and 50. A
num ber of fac tors seem to be as so ci ated with the
de vel op ment of ar thri tis, es pe cially he red ity. Re -
cent stud ies have shown that some ge netic mark -
ers are more com mon in peo ple who de velop pso -
riatic ar thri tis, and im mune sys tem is also be lieved
to play a role. Some bac te ria, as well as tra uma,
were iden ti fied as the pos si ble trig ger ing fac tors
(11-13).
There are five types of psoriatic ar thri tis: sym -
met ric ar thri tis and polyarthritis, asym met ric ar thri -
tis, dis tal interphalangeal pre dom i nant (DIP) ar thri -
tis, spondylitis, and ar thri tis mutilans (13,14). Nar -
rowing of the joint cav i ties, mar ginal ero sions, and
periarticular os teo po ro sis de velop, de pend ing on
the type of psoriatic ar thri tis. The di ag no sis is made
by a ra di ol o gist, and rheumatologist is in charge of
the treat ment.
CASE RE PORT
A 33-year old man from Narta, near Èazma, was 
ad mit ted to our hos pi tal due to pso ri a sis vulgaris
and psoriatic ar thri tis in Feb ru ary 21, 2000. He was
im mo bile, sub feb rile, and com plained of se vere
pain in all the joints. Pa tient’s med i cal his tory re -
vealed that the pa tient’s mother suf fered from pso ri -
a sis and car ci noma of the uterus, which was sur gi -
cally treated. The pa tient’s fa ther was an al co holic,
whereas his youn ger brother was healthy. The pa -
tient had no other se vere dis ease in his his tory. Of
child hood dis eases, he had had mea sles and
varicella. The pa tient did not smoke and did not
con sume al co hol over the pre vi ous 10 years (be -
fore, he had oc ca sion ally drunk beer or wine).
The dis ease started 10 years ago, with the ap -
pear ance of typ i cal psoriatic le sions on the scalp.
As early as 2-3 months af ter ward, he had ar thritic
at tack ac com pa nied by fe ver of up to 38 °C: the
interphalangeal joints of his fin gers and toes
swelled, as well as an kle joint and knee joint. The
cu ta ne ous and joint le sions wors ened over years
and re sulted in gen er al ized pso ri a sis and mu ti lat ing 
ar thri tis. Be tween 1991 and 1993, the pa tient was
treated ir reg u larly for 3-4 months with me dium
doses of pred ni sone in com bi na tion with sulfasala -
zine and nonsteroidal anti-in flam ma tory agents
(NSAR), but with out any suc cess. In 1993, the pa -
tient re ceived methotrexate and NSAR for 2
months, but this ther apy had to be dis con tin ued be -
cause of hepatic le sion. Auropan (gold salt) and
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NSAR he re ceived the same year also proved in ef fi -
cient. In 1994, oral pred ni sone was re in tro duced,
but it had to be dis con tin ued due to the de vel op -
ment of Cush ing’s syn drome. The pa tient had also
been re ceiv ing antimalarial drug, chloroquine tab -
lets, but could not re call for how long. Then, he
turned to al ter na tive med i cine. In 1996, he be came
bed-rid den and re mained on home care, tak ing
high doses of an al ge sic drug Fortral (pentazocin)
and NSAR with out any med i cal con trol.
On Feb ru ary 21, 2000, the pa tient was re ferred
to the “Naftalan” Spe cial Hos pi tal for the treat ment
of his dis ease, with very poor clin i cal con di tion of his 
skin and joints, and re mained hos pi tal ized un til
March 27, 2000.
On ad mis sion, he was im mo bile, con scious,
sub feb rile (37.2 – 37.6 °C), eupneic, and cardially
com pen sated. He com plained of se vere pain in all
his joints, for which he was tak ing Fortral (3x1 tab -
let) daily, along with NSAR-indomethacin. Vis i ble
mu cosa was well-perfused, and gen eral neu ro logic
sta tus nor mal, with no neu ro logic events. Phys i cal
ex am i na tion showed nor mal eyes and ears, heart
and lungs. His blood pres sure was 130/80, ab do -
men meteoristic at the tho rax level, with out any
patho logic changes pal pa ble. The liver and spleen
were nor mal on pal pa tion.
Dermatologic Sta tus
The en tire skin was atro phic and erythematous.
Dif fuse scal ing with in fil trates was found on the
scalp, with vis i ble er y thema on the face. Er y thema
with squames of a coin size was found mar gin ally
on the fore head, and er y thema only intertriginously
on the neck (Fig. 1). Axillary skin was also red dish,
partly mac er ated, whereas large squamous le sions
along with er y thema spread over the extensory
sides of the ex trem i ties (Figs. 2 and 3).
Squames with rhagades and crusts were pres -
ent on the pal mar sur faces of both hands. The skin
was lat er ally in flamed, with pustular ne crotic pla -
ques along both thighs and thick, in fil trated squa -
mes and crusts. On both lower legs, the skin was in -
flamed and atro phic, with ad her ent squames and
crusts. The skin of both feet showed necroses with
pustular ne crotic plaques. Un der the dried dis -
charge, swell ing of abun dant ne crotic pustular con -
tent could be seen on both dor sal and plan tar sides
of both feet. The nails showed de for mi ties and were 
cov ered with dried pu ru lent dis charge. Interdigitally, 
the skin was sticky and of bad odor. The intertrigi -
nous folds, in gui nal and gluteal re gions showed in -
flam ma tory changes and macerations, with gluteal
re gion cov ered with abun dant squamous in fil trates
and crusts.
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Fig ure 1. Dif fuse scal ing and erythematous skin of the
body.
Fig ure 2. Erythematous and large squamous le sions on
the lower ex trem i ties.
Fig ure 3. De tail of erythematous and large squamous le -
sions along dis tal extensory sides.
Lo co mo tor Sta tus
The pa tient was im mo bile, ly ing on his back. He
could not sit in de pend ently, even with sup port, and
could not turn aside. Both temporomandibular joints 
were pain ful, and yawn ing lim ited. The cer vi cal and
lum bar spine mo tion was min i mal and pain ful.
There were contractures of both shoul ders and
both el bows. Both radiocarpal joints were swol len
and pain ful, with min i mal mo tion. Pain and de for mi -
ties of small joints of the hand were also found, with
fin gers in flexion contracture (Fig. 4).
The hips were in flexion contracture, with mo tion 
block, and the knees swol len, mal formed, ex treme -
ly pain ful on pal pa tion and mo til ity, and also in
flexion contracture. Both an kles and dorsa of the
feet were swol len, and toes in flexion contracture
showed sau sage-like thick en ing.
Lab o ra tory Find ings
His lab o ra tory find ings on Feb ru ary 28, 2000,
were as fol lows: ESR 108; leu ko cytes 6.4; eryth ro -
cytes 3.24; he mo glo bin 105; hematocrit 322; plate -
lets 399; PCT 277; granu lo cytes 75%; lym pho cytes
18.8%; monocytes 3.1%; nonsegmented 3% (rough
gran ules in most granu lo cytes); BG 4.9; urea 1.5;
uric acid 258; AST 17; ALT 12; so dium 152.1; po tas -
sium 4.99; and urine find ings nor mal.
Mupirocin sen si tive Pro teus mirabilis was iso -
lated from the bac te ri o logic swab of a foot le sion.
X-ray
Oblique pos te rior-an te rior pro jec tion of cer vi cal
spine showed com plete ankylosis of small joints.
Pos te rior-an te rior pro jec tion of tho racic spine did
not re veal any ma jor patho logic al ter ations, where -
as pos te rior-an te rior pro jec tion of lumbosacral spi -
ne in su pine po si tion showed right-sided con vex
scoliosis. Intervertebral spaces seemed to be pre -
served, whereas small joints were af fected with an -
ky losis. X-ray of the hips and pel vis showed anky -
losis of the coxofemoral ar tic u la tions with pro trud ing
acetabula bi lat er ally (Fig. 5). The right shoul der x-ray 
ob tained with the pa tient ly ing down with out grid
showed de min er al iza tion of the head of the hu merus 
and scap ula. X-ray of the clenched right hand
showed de for mi ties of prox i mal pha lan ges of all fin -
gers, with subluxation. The left hand also showed
de for mi ties of prox i mal pha lan ges and sub luxation
of the metacarpophalangeal ar tic u la tions (Fig. 6).
There was a patho logic frac ture of the dis tal ul nar
bone and along car pal bones. On a sin gle x-ray of
the right knee in oblique pro jec tion ar tic u la tion fis -
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Fig ure 4. De for mities of small joints of the hand, with fin -
gers in flexion  contracture.
Fig ure 5. X-ray of the hips and pel vis showed ankylosis of
the coxofemoral ar tic u la tions with pro trud ing acetabula bi -
lat er ally.
Fig ure 6. De for mities of prox i mal pha lan ges and sublu -
xation of the metacarpophalangeal ar tic u la tion.
sures could not be dif fer en ti ated (Fig. 7). X-ray of
the right foot in oblique pro jec tion showed se vere
skel e tal de min er al iza tion with in flam ma tory changes 
of the articulatory ar eas of the tibia, de for mi ties of
the ta lus and tar sal bones, and ankylosis of the me -
tatarsophalangeal ar tic u la tions bi lat er ally (Fig. 8).
Ther apy
Daily baths in KMnO4, an ti bi otic oint ments
(Betrion, mupirocin) and neu tral creams (Belobase) 
were abun dantly ap plied lo cally, in com bi na tion with 
the Beloderm corticosteroid cream (betametha -
sone dipropionate), 5% sal i cylic oint ment in emol -
lient, zinc ox ide paste, oil com presses, and 5% sal i -
cylic oil on the scalp.
Oral an ti bi otic ther apy ad min is tered for 11 days
con sisted of 625 mg (3x1 tab let) Klavocin (amoxi -
cillin with clavuronic acid) daily, but it had to be dis -
con tin ued due to di ar rhea. Through out his hos pi tal
stay, the pa tient re ceived NSAR (Lubor – piroxicam
tab lets) and Fortral (pentazocin) 3x1, which he had
been us ing be fore ad mis sion, as well as Praxiten
(oxazepam) and Apaurin (di az e pam). NSAR
(Lubor) was also ad min is tered intra mus cu larly for
15 days.
This com bined ther apy slowly but steadily re -
sulted in con sid er able re gres sion of cu ta ne ous le -
sions, with grad ual epithelization (Fig. 9). Fortral
was suc cess fully with drawn and sub sti tuted by oral
Tramal (tramadol) 2-3x1 tab lets a day. In ad di tion,
phys i cal ther apy with pas sive move ments was in -
tro duced, al low ing for ac tive move ment and en -
abling the pa tient to con tinue ex er cis ing at home.
On dis charge from the hos pi tal, the pa tient was
rec om mended to con tinue with the fol low ing ther -
apy: ap pli ca tion of Betrion oint ment with ban dage
on the re main ing non-epithelialized ar eas of the
skin, daily wash ing of both feet in KMnO4, very
care ful hy giene of other skin ar eas with the use of
Belobase, and ap pli ca tion of 30% Beloderm in
Belobase on the pos si ble mi nor psoriatic le sions on
the back and in the gluteal re gion. The zinc ox ide
paste was ap plied only on par tic u lar ar eas of the
trunk to pre vent the pos si ble decubitus (ul cers) for -
ma tion. Belosalic (betamethasone dipropionate
with sal i cylic acid) lo tion twice a week was rec om -
mended for the scalp, in ad di tion to wash ing it with
Oronazol (ketoconazole) sham poo.
The pa tient was ad min is tered Methotrexate
(methotrexate), 7.5 mg/week, with transaminase,
ESR and CBC con trol test ing ev ery 2 weeks. He
used Lubor (piroxicam), 20 mg 1x1, Praxiten 15 mg
2x1 tbl daily, and Tramal as needed.
Al though con trol ex am i na tions by the pa tient’s
doc tor, vis it ing nurse care, and phys io ther a pist’s
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Fig ure 7. Right knee with out ar tic u la tion fis sures.
Fig ure 8. De for mities of the ta lus and tar sal bones and
ankylosis of the metatarsophalangeal ar tic u la tions bi lat -
er ally.
home vis its were rec om mended, the pa tient failed
to do phys i cal ther apy and visit an or tho pe dic sur -
geon for ad di tional treat ment.
DIS CUS SION
The aim of this re port was to high light the im por -
tance of screen ing for joint dis ease in pa tients with
pso ri a sis type I or II. Al though our pa tient de vel -
oped pso ri a sis type I, the his tory of the dis ease, its
ex tent, and early de vel op ment of ra dio log i cally ev i -
dent joint in volve ment dem on strate the char ac ter is -
tics of psoriatic arthropathy. We be lieve that ap pro -
pri ate screen ing for joint dis ease in pa tients with
pso ri a sis has im por tant im pli ca tions for clin i cal
prac tice and ge netic stud ies. Lit er a ture data show a 
high prev a lence of undiagnosed psoriatic arthropa -
thy in pa tients with pso ri a sis (15). The prev a lence
of symp tom atic sacroileitis is of par tic u lar in ter est.
The pa tients with joint in volve ment are older than
those with pso ri a sis alone. In our pa tient, the on set
of both pso ri a sis and psoriatic ar thri tis oc curred ten
years be fore ad mis sion, with bi lat eral sacroileitis,
in flam ma tory back ache, pe riph eral joint in flam ma -
tion, and pos i tive fam ily his tory of both pso ri a sis
and ar thri tis. Pre vi ous un suc cess ful ther apy im -
posed the need of a new ther a peu tic ap proach, e.g.
ad min is tra tion of TNFa block ade and re duc tion of
many proinflammatory cytokines, ad he sion mol e -
cules, and de struc tion fac tors.
In our pa tient, the on set of vul gar pso ri a sis type
I, as so ci ated with HLA DR7 and DR6, oc curred at
age 23. The dis ease took a very se vere course, with 
par al lel in volve ment of skin and joints. Dur ing the
10-year pe riod, the val ues of ESR ranged from 80
to 110. He had been hos pi tal ized on sev eral oc ca -
sions at dif fer ent de part ments, i.e. at De part ment of
Der ma tol ogy and Venerology, Zagreb Uni ver sity
Hos pi tal Cen ter; De part ment of Phys i cal Med i cine
and Re ha bil i ta tion; Dubrava Uni ver sity Hos pi tal;
Naftalan Spe cial Hos pi tal in Ivaniæ Grad; and De -
part ment of Or tho pe dics in Lovran.
The pa tient was ad min is tered var i ous drug treat -
ments, which could be prop erly traced from his
med i cal re cords. The pa tient failed to com ply with
ther a peu tic rec om men da tions. Methotrexate, taken 
over all for 2-3 months, had to be dis con tin ued be -
cause of in creased transaminases. Oral corticoste -
roids also had to be dis con tin ued be cause the pa -
tient de vel oped se vere Cush ing’s syn drome.
Since the pa tient de vel oped a neg a tive at ti tude
to wards of fi cial med i cine, as ev i denced by his re -
fusal to seek med i cal help for the past 4-5 years, the 
dis ease pro gressed to its ter mi nal stage: im mo bil ity, 
in flam ma tory ac tiv ity and strong pain in the af fected
joints. The poor out come re sulted from the pa tient’s
psy cho log i cal pro file. The con se quence of all these
fac tors was to tal and per ma nent dis abil ity in the
most pro duc tive age.
Hope fully, the new ther a peu tic ap proach with
Alefacept (hu man LFA-3/IgG1 fu sion pro tein), ad -
min is tered in tra ve nously at a dose of 7.5 mg per
week for 12 con sec u tive weeks, will soon be come
the treat ment of choice for psoriatic ar thri tis and
pso ri a sis (15). Alefacept has been shown to im -
prove the clin i cal joint score, skin pso ri a sis, and
T-cell sub sets in synovial fluid (16, 17). Etanercept
(Enbrel1), an in hib i tor of TNF ac tiv ity, given as
monotherapy at a dose of 25 mg s.c. twice a week,
may prove use ful in the man age ment of pso ri a sis
(18). Infliximab, a chi me ric anti-TNF-a an ti body and 
Etanercept neu tral ized rhTNF-a ef fec tively (18).
Efalizumab, a monoclonal an ti body, blocks the leu -
ko cyte integrin CD11a/CD18 (LFA-1) in pa tients
with pso ri a sis vulgaris (19).
In con clu sion, the case we pre sented points to
the sig nif i cant role of an early di ag no sis and timely
treat ment of psoriatic ar thri tis, with in di vid u al ized
ap proach to and proper ed u ca tion of each pa tient to 
pre vent per ma nent de bil i tat ing le sions. In our pa -
tient, his un fa vor able psy cho logic pro file con trib -
uted to the poor out come of the dis ease.
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Fig ure 9. Con sid er able re gres sion of cu ta ne ous le sions
with epithelization.
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The Baboon Syndrome Due to Nickel
Tomasz Kolodziej, Jacek C. Szepietowski, Julita Sikora, Rafal Bialynicki-Birula
De part ment of Der ma tol ogy. Uni ver sity of Med i cine, Wroclaw, Po land
SUMMARY The “ba boon syn drome” is a rare vari ant of sys temic
con tact der ma ti tis and is char ac ter ized by gen eral exan thema
with par tic u lar in volve ment of but tocks and flex ures. Here we
pres ent a 25-year-old fe male with con tact al lergy to nickel, who
de vel oped ba boon syn drome af ter sys temic ad min is tra tion of
this al ler gen.
KEY WORDS nickel hy per sen si tiv ity; sys temic con tact der ma ti tis; ba boon
            syn drome.
IN TRO DUC TION
Hematogenous con tact ec zema, the 4th type of
al lergy re ac tion, may be caused by a sys tem at i cal
ex po sure to an al ler gen of a per son pre vi ously sen -
si tized to it. The term “ba boon syn drome” is a vari -
ant of such ec zema char ac ter ized by gen eral exa n -
thema, with par tic u lar in volve ment of but tocks,
which may re sem ble the red gluteal re gion of a ba -
boon (1). Dif fuse er y thema also in volves anogenital 
area, up per in ner side of the thighs, and arm pits (1).
CASE RE PORT
A 25-year-old woman with pre vi ously proven
con tact al lergy to nickel was re ferred to our De part -
ment be cause of itchy and pain ful gen er al ized rash
that had de vel oped 2 days be fore ad mis sion. Sev -
eral days be fore de vel op ing skin le sions, she had
been ex posed to com po nents that might have con -
tained nickel: she had eaten sig nif i cant amount of
canned beans, drunk tap wa ter, and in haled va pors
of wa ter-based paints.
Phys i cal ex am i na tion re vealed erythematous,
ma culopapular, sym met ri cally dis trib uted patches
in volv ing sa cral re gion and lat eral as pects of trunk,
but tocks, anogenital area, groins, and the ma jor
flex ural ar eas (Figs. 1-3).
There were also nu mer ous ves i cles on her left
wrist where she had worn a watch be fore hy per sen -
si tiv ity to nickel de vel oped (Fig. 4).
She was treated with in tra ve nous in jec tion of hy -
dro cor ti sone (5 days, from 200 mg to 50 mg), sys -
temic antihistaminics, and mild top i cal corticoste -
roids. This treat ment re sulted in pro nounced clin i cal 
im prove ment within 3 days. The le sions dis ap pe -
ared com pletely af ter 7 days of ther apy. Three
weeks later patch test ing re vealed a highly pos i tive
re ac tion to 1-%-nickel sul fate.
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DIS CUS SION
Sys temic ex po sure to con tact al ler gen, such as
wa ter-based paints, may cause var i ous hy per sen -
si tive skin re ac tions, such as gen er al ized erup tions, 
palmo-plan tar dyshydrotic le sions (pompholyx),
and con tact-type der ma ti tis with dif fer ent dis tri bu -
tion, mostly in volv ing hands and rarely in volv ing
ano genital re gion, flex ures, and but tocks (ba boon
syn drome) (1,2). The on set of the ba boon syn -
drome is acute, rang ing from sev eral hours to 2-4
days af ter sys temic ex po sure to the al ler gen (3).
The mi cro scopic find ings are not spe cific and
show sparse su per fi cial and perivascular lympho -
cytic and histiocytic in fil tra tion. There is no in volve -
ment of the epi der mis and no signs of leukocy -
toclastic vasculitis (4).
The rea son of such an un usual dis tri bu tion of
ec zema in the ba boon syn drome is un clear. Oc clu -
sion by un der wear and sweat ing are more prom i -
nent in those re gions, but their in flu ence is only
spec u la tive. 
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Fig ure 1. The ba boon syn drome due to nickel. Flex ural
exanthema.
Fig ure 3. The ba boon syn drome due to nickel. Er y thema
of un der pants area.
Fig ure 2. The ba boon syn drome due to nickel. Skin le -
sions re sem ble the ba boon red but tocks.
Fig ure 4. The ba boon syn drome due to nickel. Nu mer -
ous ves i cles on the pa tient’s wrist, where she had worn a
hand-watch be fore she de vel oped hy per sen si tiv ity to
nickel.
The ba boon syn drome has been de scribed in
over 20 re ports, al though in some it was de scribed
as ec zema with flex ural pat tern (5). Sys temic ex po -
si tion to mer cury (1,6) and an ti bi ot ics, par tic u larly
amoxicillin (4,7), pres ent the most com mon causes
of the syn drome. The ba boon syn drome de vel ops
par tic u larly of ten af ter ex po sure to mer cury and
mer cury deri vates, such as an ti sep tics used in new -
borns (1,6). Cases of the syn drome due to ex po si -
tion to terbinafine (8), in tra ve nous hu man immuno -
globulins (9), and hydroxyurea (10) were also de -
scribed, but very rarely.
To the best of our knowl edge, there has been
only one re port of ba boon syn drome pro voked by a
sys temic ex po sure to nickel (1) be fore ours. It
seems that this pat tern of ec zema is not char ac ter -
is tic for this al ler gen.
The fre quency of ba boon syn drome is un known. 
This con di tion is prob a bly of ten over looked, al -
though it should be con sid ered in the dif fer en tial di -
ag no sis of erythematous erup tions in flex ural ar eas
and on the but tocks.
CON CLU SION
Ba boon syn drome is a rare form of sys temic
con tact der ma ti tis. The fre quency of ba boon syn -
drome is un known be cause it is rarely in cluded into
dif fer en tial di ag no sis of erythematous erup tions.
Our case of ba boon syn drome pro voked by nickel is 
the first one ever re corded in our coun try.
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Skin Photodamage and Lifetime Photoprotection
Ivana Nola, Lena Kotrulja
De part ment of Dermatovenerology, Sis ters of Mercy Uni ver sity Hos pi tal, Zagreb, Croatia
SUMMARY Ul tra vi o let (UV) ra di a tion is a very small part of the elec -
tro mag netic ra di a tion spec trum, re leased and trans ported from the 
source in the form of pho tons. Dis posal of these pho tons within the
skin causes cu ta ne ous photoda mage, which leads to clin i cal, his -
to logic, and bio chem i cal changes. Aging is a com plex pro cess
char ac ter ized by cel lu lar at tri tion, de creased cel lu lar re serve ca -
pac ity, and com pro mised abil ity to per form nor mal cel lu lar func -
tion. In trin sic ag ing, which steadily de vel ops with time, is linked to
chrono logic age; it is the re sult of a ge netic pro gram. Photoaging,
on the other hand, de vel ops as a con se quence of UV ra di a tion-in -
duced de gen er a tive changes in the skin. In trin sic ag ing is a uni ver -
sal, in ev i ta ble pro cess, whereas photoaging is nei ther uni ver sal
nor in ev i ta ble and can be pre vented. UV ra di a tion can also sup -
press the im mune sys tem in both lo cal and sys temic way and lead
to si mul ta neous and se quen tial bio chem i cal events that ul ti mately
cause photocarcino genesis. There fore, ev ery day use of prod ucts
that pro tect against UV ra di a tion is nec es sary to pre vent acute and 
long- term photodamage (clin i cal and cel lu lar changes) lead ing to
photoaging, photoimmuno sup pression, and photocarcinoge nesis.
KEY WORDS  skin; skin ag ing; sun light; sunscreening agents; ul tra vi o let rays
INTRODUCTION
Photoaging de notes mac ro scopic and mi cro -
scopic skin changes, which de velop as a con se -
quence of chronic so lar ra di a tion. Photoaging has
unique and dis tinc tive fea tures, quite dif fer ent from
nor mal ag ing. With the ex cep tion of se nile angio -
mas, which nor mally ac com pany ag ing and de -
velop on the trunk ar eas, prac ti cally all ma jor skin
tu mors orig i nate from photoaged skin (1).
In the 20th cen tury, nat u ral light and UV ra di a -
tion from ar ti fi cial sources were thought to be good
for both our psy che and our skin, and that, by gen -
er at ing a healthy look ing tan, they en hance the
photoprotective prop er ties of mel a nin in our skin.
Yet, ex ces sive ex po sure to this life-sup port ing ra di -
a tion can be very dam ag ing to the skin of those in di -
vid u als whose nat u ral photoprotective de fenses
are poor (2,3).
De spite the fact that the in ci dence of skin can cer 
is in creas ing in the West, the pro tec tion from sun -
light, the pri mary cause of skin can cer, is still largely 
ig nored by the pub lic. The rea sons for such an at ti -
tude are dic tates of fash ion, the ease of ac cess to
the sun, and the in creas ing lon gev ity of the pop u la -
tion. Even if so lar pro tec tion soon be comes the
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norm, there is noth ing that can be done to re verse
the dam age al ready done (3).
THE NATURE OF ULTRAVIOLET
RADIATION
So lar ul tra vi o let (UV) ra di a tion and vis i ble ra di a -
tion, which to gether com prise a very small part of
the elec tro mag netic ra di a tion spec trum, are en ergy
re leased and trans ported from the source, usu ally
the sun, as pho tons. Cu ta ne ous photodamage oc -
curs as the con se quence of the dis posal of these
pho tons within the skin. UV ra di a tion ex po sure var -
ies ac cord ing to al ti tude, geo graphic lat i tude, sea -
son, time of day, and prox im ity to snow or wa ter
(1,2).
The UV ra di a tion from sun, which spans wave -
lengths from 100 to 400 nm, is di vided into three
wave bands: UVB (280-315 nm), UVA (315-400
nm), and UVC (100-280 nm) (2).
UVC ra di a tion is heavily ab sorbed by mo lec u lar
ox y gen, ozone, and wa ter va por in the up per at mo -
sphere and does not reach the ter res trial sur face in
mea sur able amounts. It is the most po tent UV ra di -
a tion in terms of dam age it in flicts on liv ing ma te rial
(3).
UVA is ad ja cent to vis i ble light and makes 95%
of so lar ul tra vi o let ra di a tion. It is sub di vided into two
re gions: short-wave UVA, or UVA II (320-340 nm),
and long-wave UVA, or UVA I (340-400 nm) (1-3).
UVA pen e trates much deeper into the skin, con trib -
utes sub stan tially to chronic sun dam age, and can
have im mu no logic ef fects. Lon ger wave lengths of
UVA pen e trate cloud cover, light cloth ing, and un -
tint ed glass rel a tively eas ily and thus may in duce
mod er ate con tin u ing skin dam age over lon ger pe ri -
ods, even when UV ra di a tion ex po sure is not ob vi -
ous (4). UVA is par tially re spon si ble for a sun- in du -
ced er y thema (Morison). It is also called “long-wave 
UV ra di a tion”, or “black-light”, be cause it can not be
seen (5,6).
UVB is the most im por tant com po nent of sun -
light for hu man skin. Al though it does not pen e trate
as deeply as UVA, nor does it in ter act as vig or ously
with the epi der mis as UVC, UVB com bines the
depth of pen e tra tion and re ac tiv ity with macromo -
lecules in a way that makes it bi o log i cally the most
po tent por tion of the UV spec trum in terms of short-
and long-term con se quences (3). UVB is sig nif i -
cantly at ten u ated by dense clouds, close-weave
cloth ing, and win dow panes. Ab sorp tion and scat -
ter ing in the at mo sphere oc cur when the sun is low,
at high lat i tude dur ing the win ter months, and in
early sum mer morn ings and eve nings (4).
UVB is great est in the sum mer, whereas UVA is
more con stant over the year (1). Eighty per cent of
UVB and 70% of UVA ra di a tion oc cur be tween
10:00 a.m. and 2:00 p.m. (5).
Vis i ble light (400-760 nm) prob a bly plays an in -
sig nif i cant role in photodamage, as well as in fra red
ra di a tion (760-1,700 nm) (4).
So lar ra di a tion in ci dent upon the Earth’s at mo -
spheric en ve lope is ei ther re flected or trans mit ted
and at ten u ated (2) by gas mol e cules and wa ter
drop let scat ter ing, ozone ab sorp tion, and ox y gen
ab sorp tion (1).
Thus, the ma jor source of the dam ag ing ef fects
of sun light is the UV por tion of the spec trum be -
tween 290 and 400 nm (UVB and UVA). The dif fe r -
ent UV wave lengths pen e trate the skin to dif fer ent
depths and have dif fer ent bi o logic con se quences
(4).
PHOTOREACTIONS IN TISSUE
So lar ra di a tion seems to cause two types of re -
ac tion – one is ben e fi cial and the other is harm ful.
Photoreactions in volv ing pho to syn the sis, vi sion, vi -
ta min D syn the sis, kill ing of patho gens, photothe -
rapy, and photochemotherapy, are con sid ered
good and ben e fi cial, but sun burn, skin can cer,
drug- or chem i cally-in duced phototoxic and photo -
allergic re ac tions and mu ta tions are rec og nized as
harm ful (1,2).
Un der stand ing light as pho tons that must be ab -
sorbed by mol e cules of tis sue de ter mines photo -
biologic re sponses. With the ab sorp tion of en ergy, a 
mol e cule reaches the ex cited state. The mol e cule
that ab sorbs the en ergy from the pho ton is called
chromo phore, and the bi o logic pro cess it self is de -
ter mined by the en ergy of the pho ton and the char -
ac ter is tic wave length of the UV ra di a tion (1). 
Our un der stand ing of light-chromo phore in ter -
ac tion in the skin is still in com plete. DNA is thought
to be the prin ci pal skin chromo phore; it can ab sorb
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and be mu tated di rectly by UVB. Other en dog e nous 
chromo phores that may ab sorb UV ra di a tion in -
clude NADH/NADPH, triptophan, ri bo fla vin, and
me l a nin. Ab sorp tion of UVA ra di a tion by these
chromo phores may lead to the re lease of re ac tive
ox y gen spe cies, such as sin glet ox y gen, hy dro gen
per ox ide, and superoxide an ion. These re ac tive ox -
y gen spe cies may cause ox i da tion of lipids and pro -
teins that, in turn, may af fect DNA re pair, in duce
ma trix metalloproteinases, pro duce dyspigmenta -
tion, and re sult in skin photoaging and carcinoge -
nesis (7). Ac cord ing to many au thors, ox y gen ated
free rad i cals play a sig nif i cant role in skin ag ing and
de vel op ment of can cer as well as in in flam ma tory
skin dis or ders, such as ec zema and pso ri a sis (8).
An ti ox i dant cel lu lar sys tems re sort to micro nut ri -
ents, such as vi ta mins and oligoelements work ing
through metalloenzymes, zinc and cu prum super -
oxide dismutase (Zn-Cu SOD), and se le nium-gluta -
thione peroxidase (Se-GSH Px) (9). How ever, in
some dis eases or fol low ing en vi ron men tal stres -
ses, these sys tems can be over loaded. In such sit u -
a tions, ox y gen ated spe cies are li a ble to ini ti ate
chem i cal or struc tural mod i fi ca tions of pro tein, nu -
cleic ac ids or mem brane lipids lead ing to changes
in the mor phol ogy and func tion of the cells (1,10).
Urocanic acid has been re ported to be a chro -
mo phore for UVA I ab sorp tion (11). It is a de riv a tive
of histidine and pro duced by keratinocytes. The ac -
tion spec trum for sin gle ox y gen gen er a tion af ter ex -
ci ta tion of trans-urocanic acid is sim i lar to the UVA
ac tion spec trum for photodamage in an i mal mod -
els. This sug gests that UVA ex ci ta tion of trans-uro -
canic acid may ini ti ate changes that lead to pho to -
aging of the skin (12,13).
Many im mu no logic as says have been used to
mea sure UV-in duced im mune sup pres sion, in clud -
ing tumor re jec tion, con tact and de layed hy per sen si -
tiv ity re sponses, an ti body pro duc tion, and changes
in the num ber and func tion of epi der mal Langerhans’ 
cells (6). How ever, UV di rectly af fects the func tion of
epidermal cells, in clud ing melano cytes and kera -
tinocytes. Many of its ef fects are me di ated via in -
duc tion of sol u ble me di a tors. In ad di tion to cytoki -
nes, neuropeptides are pro duced by many dif fer ent
cells, in clud ing ep i the lial and in flam ma tory cells,
and are part of the net work of me di a tors reg u lat ing
im mune and in flam ma tory re ac tions (1,10).
Keratinocytes have re cently been shown to pro -
duce propiomelanocortin in ad di tion to sev eral
other neuropeptides, such as sub stance P, vaso -
intesti nal pep tide, calcitonin gene-re lated pep tide.
Propiomelanocortin is the pre cur sor for adreno cor -
ti cotropin (ACTH), beta-en dor phin (b-E), beta-li po -
tropic hor mone (b-LPH), and mela no cyte- sti m u lat ing 
hor mones (a-, b-, and g-MSH). The pre cur sor of
propiomelanocortin un der goes cleav age via pro -
teolytic ac tiv i ties of the fam ily of proho rmone- con -
vert ing en zymes, which have also been found to be
ex pressed in keratinocytes (14). The im mune sys -
tem plays an im por tant role in UV carcino genesis
by con trib ut ing to host re sis tance against tu mor
growth. In di vid uals sen si tive to UVB-in duced im -
muno suppression are at an in creased risk of the
de vel op ment of skin can cer. Thus, both UV-in duced 
DNA al ter ation and im mune reg u la tion are im por -
tant for cu ta ne ous carcinogenesis. UV ra di a tion al -
ters an ti gen-pre sent ing cell func tion ei ther di rectly
by af fect ing epi der mal Langerhans’ cells or in di -
rectly by in duc ing keratinocytes to re lease immuno -
mo dulatory cytokines (15).
THE REASONS FOR SKIN AGING –
INTRINSIC AGING AND
PHOTOAGING
There are two rea sons for skin ag ing. One is nat -
u ral ag ing, or in trin sic ag ing, which is a uni ver sal
and in ev i ta ble pro cess linked to our chronologic
age (10). The other and most com mon rea son for
skin ag ing are ex ter nal fac tors. Ex po sure to UV ra -
di a tion is the great est source of skin dam age, while
en vi ron men tal pol lut ants, cig a rette smoke, al co hol,
and heavy met als all play sig nif i cant roles (4,10).
In trin sic ag ing
The chro no log i cal de gen er a tive changes in the
skin are ge net i cally pre de ter mined and steadily de -
velop with time. Aging is the re sult of a ge netic pro -
gram. Dur ing cell mi to sis, the en zyme DNA poly -
mer ase can not rep li cate the fi nal base pairs of each 
chro mo some and the re sult is the short en ing of the
ter mi nal por tion of the chro mo some af ter each cell
di vi sion. Thus, crit i cally short telomeres com pro -
mise the tran scrip tion and sig nal cel lu lar se nes -
cence or apoptosis. Telomere short en ing may thus
be viewed as an in ter nal “clock” that pre de ter mines
the func tional life span of the cell (16).
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Clinically, chro no log i cally aged skin ap pears dry, 
pale, and finely wrin kled, with a cer tain de gree of
lax ity and a va ri ety of be nign neoplasms.
At tis sue level, the changes re sult ing from
chronologic ag ing oc cur in the dermis and epi der -
mis. The most con sis tent and strik ing change of in -
trin sic cu ta ne ous ag ing is flat ten ing of the der mo-
 epi der mal junc tion, re flect ing in part the re duc tion of 
the proliferative pool of keratinocytes that are lo -
cated in rete ridges. Re gard ing the stra tum cor -
neum, nei ther av er age thick ness nor its de gree of
com pac tion ap pear to change with age. The rate of
for ma tion of neu tral lipids, those that con trib ute to
the bar rier func tion of the stra tum corneum, is
slower. Also, there is a pro gres sive de crease in
melanocyte den sity (2).
How ever, the main mod i fi ca tions due to chrono -
logic ag ing oc cur in the dermis, the sup port ive el e -
ment of the skin, a tis sue re spon si ble for the me -
chan i cal prop er ties of the skin (12,13). The mod i fi -
ca tions take place in the extracellular ma trix. These
mod i fi ca tions al ter the dermis ar chi tec ture and thus
the me chan i cal prop er ties of the skin: ri gid ity, elas -
tic ity, and re sil ience. Such al ter ations to the extra -
cellular ma trix re sult in the for ma tion of wrin kles
(10). 
So, the char ac ter is tic of in trin sic ag ing is epi der -
mal thin ning, and the op po site holds for photoaging, 
where the epi der mis thick ens in re sponse to chro -
nic stim u la tion (1,10).
Photoaging
Skin photodamage re fers to the ad verse cu ta ne -
ous changes in duced by ex po sure to UV ra di a tion.
Photoreactions lead to clin i cal, histologic, and bio -
chem i cal changes (1). UVB ra di a tion pro duces the
most harm ful ef fects. Acute ad verse ef fects of UVB
ra di a tion in clude in flam ma tion, sun burn, pig men ta -
tion changes, and hy per pla sia. Chronic ad verse ef -
fects of UVB in clude photoaging, immuno sup -
pression, and photocarcinogenesis, in clud ing squ -
a mous cell, basal cell and mel a noma skin can cers.
UVB ra di a tion is re spon si ble for 98% of de layed er -
y thema de vel op ment (17). UVA ra di a tion is also
linked to acute and chronic skin in jury. Acute dam -
age pro duced by UVA in cludes er y thema (to a
much lesser ex tent than by UVB), photoallergic re -
sponses, and phototoxic re ac tions. Chronic UVA in -
ju ries in clude photoaging and photocarcinogenesis
(1).
Apart from acute sun burn in flam ma tion as so ci -
ated with sec ond ary skin tan ning, thick en ing, im -
mu no logic dys func tion, and vi ta min D pro duc tion,
these changes have two dis tinct cu mu la tive clin i cal
man i fes ta tions: skin photoaging and skin can cer
(10).
The pro pen sity for so lar dam age de pends upon
the pa tient’s skin type, the cu mu la tive ex po sure to
ul tra vi o let light, the in ten sity of ex po sure, and the
years of ex po sure (1,10).
Peo ple with skin types 1 and 2 are most sus cep -
ti ble. A red-headed, blue-eyed, fair-skinned in di vid -
ual who burns and freck les eas ily is most prob a bly
at risk, but ap pear ances are de cep tive. Al though
dark-haired, brown-eyed, and ol ive-skinned peo ple
are usu ally ex empt, it is their re sponse to sun light
that mat ters. If they burn, their skin type may be 1 or
2, there fore, they be long to a high risk group. UV in -
duced skin can cer does not oc cur in the Ne gro type
of skin (type 5) (1).
The amount of ex po sure is im por tant. The link
be tween sun light and skin can cer was first es tab -
lished in sail ors. Thus, so lar keratoses and squa -
mous cell car ci noma oc cur as the re sult of chronic
ex po sure and are com mon est in those who spend a 
lot of time out doors and whose skin is chron i cally
weather-beaten (10). The in ten sity of ex po sure is
also rel e vant. Thus, cer tain forms of ma lig nant mel -
a noma are most com mon in work ers en sconced in
their of fices or fac to ries most of the year, who in -
tensely ex pose their white, non-tanned skin to the
sun dur ing va ca tion and of ten burn (5).
The tim ing of ex po sure may be im por tant, since
much of the dam age may be done in child hood (3).
From the histologic point of view, UVB rays stim -
u late the di vi sion of cells, re sult ing in the epi der mis
be com ing thicker and more leath ery, lack ing luster.
Acanthosis is ac com pa nied by cel lu lar atypia, loss
of po lar ity, and marked ir reg u lar i ties in cell size and
stain ing prop er ties. Var i ous neo plas tic al ter ations
are ob serv able, such as so lar lentigines and early
ac tinic keratoses. Mel a nin is ac cu mu lated on the
sur face of all new cells and acts as a para sol
against sun light. This re sponse is what we call tan -
ning (3,18).
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In nor mal ag ing, cells in the dermis be come de -
pleted. Hypocellularity is the rule. Fibroblasts are
scanty and shrunken, and mast cells are more scat -
tered. The me tab o lism of fibroblasts slows down
with ag ing and their abil ity to syn the size extracel -
lular ma trix de creases, re sult ing in at ro phy of the
dermis. Si mul ta neously, the bal ance be tween ela -
stase and col la gen ase en zymes and their in hib i tors 
is dis rupted, lead ing to mod i fi ca tions of the skin me -
chan i cal prop er ties. One of the ma jor histologic
con se quences is al ter ation of the elas tic net work,
pre dom i nant pap il lary dermis. It not only thins down 
the dermoepidermal junc tion, but also con trib utes
to the skin loss in elas tic ity and re sil ience (10).
This con trasts photoaging, in which fibroblasts
are nu mer ous and hyperplastic, mast cells abun -
dant and par tially degranulated, and histiocytes and 
other mononuclear cells also in creased. One might
say that the photoaged skin is chron i cally in flamed,
a pro cess called heliodermatitis (2). 
While elastin in creases in photoaged skin, col la -
gen de creases. It is ev i dently solubilized by the en -
zymes pro duced by in flam ma tory cells, so that it
prac ti cally dis ap pears from most dam aged ar eas.
The for merly col la gen-con tain ing ar eas of ac tin i -
cally dam aged dermis are now oc cu pied mainly by
elas tic fi bers and glycosaminoglycans (GAGs). In
nor mal ag ing, col la gen, far from dis ap pear ing, be -
comes more sta ble and re sis tant to en zy matic di -
ges tion, and its bun dles be come larger, form ing
rope-like struc tures (1,2,10).
Finally, ac tinic ra di a tion is ex ceed ingly dam ag -
ing to the microcirculation. Many ves sels be come
com pletely oblit er ated, and few that sur vive are
vari ably di lated and scraggy; the nor mal hor i zon tal
plex uses are ex tin guished (2).
SKIN CANCER FORMATION
Skin can cers are among the most com mon of
hu man can cers. It is now well es tab lished that the
UV ra di a tion com po nents of sun light pro vide a ma -
jor con tri bu tion to skin tu mor in duc tion and de vel op -
ment (10,19,20)
Ac tinic rays, es pe cially in the sun burn ing range
(280-320 nm) are car ci no genic. Hu man ep i de mi o -
log i cal and an i mal ir ra di a tion stud ies strongly sug -
gest that chronic cu ta ne ous UVB and, to a lesser
ex tent, UVA ex po sure ei ther to sun light or to ar ti fi -
cial sources, are re spon si ble for the in duc tion of
most non-mel a noma skin can cers, and prob a bly of
mel a no mas as well, al though it has re cently been
sug gested that UVA may play a rel a tively more im -
por tant part in the lat ter (2). UVA ef fi ciently pen e -
trates the basal layer of the epi der mis where the ac -
tively di vid ing cells re side. UV ra di a tion acts by al -
ter ing the DNA and also the cell func tions in volved
in cell dif fer en ti a tion (6,21).
Photocarcinogenesis rep re sents the sum of
com plex, si mul ta neous and se quen tial bio chem i cal
events that ul ti mately lead to the oc cur rence of skin
can cer. The pho tons of sun light be gin a se ries of
ge netic events in the skin lead ing to can cer (19).
These events, ini ti ated by UV ra di a tion of ap pro pri -
ate wave length, in clude the for ma tion of DNA
photoproducts, DNA re pair dis tur bances, mu ta tion
of proto-onco genes and tu mor sup pres sor genes,
UV-pro duc tion of rad i cal spe cies with sub se quent
ef fects on mu ta tion and ex tra-nu clear func tion, and
other epigenetic events that in flu ence the course of
carcinogenesis. The epigenetic in flu ences may in -
clude im mune re sponses, an ti ox i dant de fenses,
and di etary fac tors (22).
Bi o logically, DNA ap pears to be the most im por -
tant tar get of ra di a tion-in duced dam age in the skin.
When DNA mol e cule ab sorbs the pho tons of UV
light, it reaches an ex cited state fol lowed by re ar -
range ment of elec trons to form a photoproduct
(23,24). The best de scribed photoproducts are two
dipyrimidine struc tures: cyclobutane dimers and
6-4 py rim i dine-pyrimidone ad ducts that re sult in
sin gle base-pair changes (or point mu ta tions) in the
ge netic se quence fol low ing DNA re pair. These two
photoproducts com prise 95% of UV-in duced le -
sions and are be lieved to be re spon si ble for most of
the car ci no genic ef fects of UV ra di a tion (23,24).
The cyclobutane (or py rim i dine) dimer is the pre -
dom i nant UV photoproduct, ac count ing for 85% of
pri mary le sions in UV treated DNA (23-25). It is
formed when UV pho tons are ab sorbed by the car -
bon-car bon dou ble bond at the 5-6 po si tion of two
ad ja cent py rimi dines, and re dis tri bu tion of elec trons 
re sults in sin gle bond ring clo sures be tween the two 
5-po si tions and two 6-po si tions, giv ing rise to a pair
of cyclobutane rings that are co va lently linked (22).
A clear re la tion ship be tween the for ma tion of py rim -
i dine dimers and carcinogenesis has been well es -
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tab lished in var i ous an i mal stud ies (26) and cell cul -
ture sys tems (19) in which en zy matic re pair of
these le sions re duced the in ci dence of tu mor for -
ma tion. The 6-4-py rim i dine-pyrimidone adduct is
the sec ond most com mon UV photoproduct, ac -
count ing for 10% of UV-in duced le sions (27). It is
formed when ab sorp tion of UV pho tons causes re -
ac tion of the car bon-car bon dou ble bond at py rim i -
dine 5-po si tion with the car bon-ni tro gen dou ble
bond of the ad ja cent 3’pyrimidine, and re dis tri bu -
tion of elec trons re sults in co va lent link age be tween 
the 6- and 4- po si tions of the re spec tive py rim i dine.
Both photoproducts lead to a mu ta tion that is vir tu -
ally pathognomonic for UV ra di a tion, as well as to
in com plete re pair of cel lu lar DNA dam age, im paired 
func tion through mu ta tion of the cu ta ne ous cell cy -
cle reg u lat ing intranuclear p53 pro tein, and pos si -
ble al ter ations in im mune sur veil lance (as ap par -
ently oc cur in ex ag ger ated form in the skin can cer-
 prone dis or der xeroderma pigmentosum). Other
photoproducts in clude re ac tive ox y gen spe cies
(7,8) and cy to sine photohydrates and pu rine
photoproducts (24,28), but these are less com mon
and have not been well de scribed (25).
In ad di tion, other le sions in clud ing sin gle-strand
breaks, dou ble-strand breaks (25), and DNA-pro -
tein crosslinks (26), can oc cur but these are usu ally
ir rep a ra ble and in ter fere with tran scrip tion and rep -
li ca tion, re sult ing in cell death (21).
Mu ta tions in the p53 tu mor sup pres sor gene
con trib ute to the de vel op ment of hu man and mouse 
UV-in duced skin can cers. Such mu ta tions are also
found in sun-dam aged skin and ac tinic keratosis,
sug gest ing that p53 mu ta tions arise early dur ing UV 
skin carcinogenesis. p 53 mu ta tions can serve as a
sur ro gate early bi o logic end point in skin can cer pre -
ven tion stud ies (27). UVB has been shown to af fect
p16 ex pres sion, which im pairs cell cy cle reg u la tion
in vi tro and in vivo. Al tered ex pres sion pat terns of
p16/CDKN2A fol low ing UVB ex po sure could be of
value for iden ti fy ing peo ple at an in creased risk of
UV-in duced skin can cer (29).
Sun burn cell for ma tion in the epi der mis is a
char ac ter is tic con se quence of UV ra di a tion ex po -
sure at doses around or above the min i mum er y -
thema dose. Sun burn cells have been iden ti fied
mor pho log i cally and bi o log i cally as keratinocytes
un der go ing apoptosis. There is ev i dence that sun -
burn cell for ma tion is a pro tec tive mech a nism to
elim i nate cells at risk of ma lig nant trans for ma tion
(30). The level of DNA photodamage is a ma jor de -
ter mi nant of sun burn cell in duc tion by a pro cess
con trolled by the tu mor sup pres sor gene p 53. UV
ra di a tion trig gers death re cep tors ei ther by di rect
ac ti va tion of these sur face mol e cules or by in duc ing 
the re lease of their lig ands, such as CD95 ligand or
tu mor ne cro sis fac tor. In duc tion of apoptosis in
keratinocytes by UV light is a crit i cal event in
photocarcinogenesis. UV light di rectly stim u lates
CD95 and thereby ac ti vates CD95 path way to in -
duce apoptosis in de pend ently of the nat u ral ligand
CD95L. These find ings fur ther sup port the con cept
that UV light can af fect tar gets at the plasma mem -
brane, thereby even in duc ing apoptosis. UV ra di a -
tion also in ter feres with skin ho meo sta sis, which is
main tained by a unique dis tri bu tion pat tern of
apoptosis-in duc ing and apoptosis-pre vent ing mol -
e cules (31).
Re cently, it has been dem on strated that kerati -
nocytes can re lease tu mor ne cro sis fac tor-alfa
(TNF-alfa), which is known to cause apoptosis in
par tic u lar cells. In ad di tion, it has been shown that
UVB light in duces the re lease of TNF-al pha by
keratinocytes and that keratinocytes ex press the
55-kD re cep tor for TNF-alfa (32).
Ox i da tive stress also ap pears to be in volved,
prob a bly via mi to chon drial path ways, re sult ing in
the re lease of cytochrome C. The sun burn cell with
its pyk notic nu cleus and eosinophilic cy to plasm is
char ac ter is tic of mam ma lian epi der mis af ter ex po -
sure to UVC and UVB ra di a tion or UVA ra di a tion in
the pres ence of psoralens ( 30). 
UV ra di a tion mod u lates the im mune sys tem of
the skin that is also im por tant for tu mor pro mo tion.
UVB and UVA ra di a tion can in duce DNA dam age
with the re sult ing squamous cell car ci noma and
ma lig nant mel a noma by caus ing mu ta tions as well
as immunosuppressive ef fects that pre sum ably
con trib ute to photocarcinogenesis (20). UVB ra di a -
tion-in duced immunomodulation ef fects are lim ited
to the epi der mis, whereas UVA ra di a tion af fects
both epi der mal and der mal cell pop u la tions. In par -
tic u lar, UV ra di a tion has been shown to af fect the
pro duc tion of sol u ble me di a tors and ex pres sion of
cell-sur face re cep tors, and to in duce apoptosis in
pathogenetically rel e vant cells (32).
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PHOTOPROTECTION
There is over whelm ing ev i dence that ex po sure
of hu man skin to UV ra di a tion leads to the de vel op -
ment of cu ta ne ous photoaging and neo plas tic
changes. This has led to the de vel op ment of skin
care prod ucts pro vid ing good pro tec tion against
UVA ra di a tion, as so ci ated with the high photo pro -
tective level against UVB ra di a tion (1,33). Pro tec -
tion from UV ra di a tion is an im por tant part of ev ery
pro gram to pre vent skin can cer (28). The mea sures 
that can be taken to di min ish the risk of UV ra di a tion 
ex po sure in clude: re duc tion through the lim i ta tion
of sun ex po sure, through the use of ap pro pri ate
cloth ing, and through the care ful use of sunscreen
prod ucts (4). So, dur ing daily ac tiv i ties, an ap pro pri -
ate pro tec tion against so lar ex po sure should pre -
vent the clin i cal and cel lu lar changes lead ing to
photoaging, photoimmunosuppression, and even -
tu ally photocarcinogenesis (10).
Sun Ex po sure Habits
For peo ple in de vel oped coun tries, most con se -
quences of UV ra di a tion oc cur by short, mul ti ple ex -
po sures of the hands, head, and neck (1). Suf fi cient 
re cur ring cu ta ne ous sun ex po sure re sults in skin
photoaging and in due course po ten tially in non-
 mel a noma skin can cers and per haps mel a noma in
all in di vid u als. Mod i fi ca tion of this ex po sure by ad -
just ing to the time of the day and year is likely to
have a ma jor im pact in re duc ing these dis or ders.
Clearly, en cour ag ing good sun ex po sure hab its in
chil dren at early age is par tic u larly vi tal from the sci -
en tific stand point, since adults have an es tab lished
be hav ior pat tern that is more dif fi cult to al ter (4).
Cloth ing As Sunscreen
Photoprotection with cloth ing is de mon stra ble in
pa tients with se vere dermatoheliosis on the ex -
posed ar eas as com pared with nor mal-ap pear ing
skin on the ar eas pro tected by cloth ing. Cloth ing re -
mains an ex cel lent means of sun pro tec tion. Cot ton
and poly es ter/cot ton blends are equally ef fec tive.
Lycra may block UV ra di a tion 100% when lax, but if
stretched, it is sig nif i cantly less ef fec tive, with a cal -
cu lated sun pro tec tion fac tor (SPF) 2. The color of
fab ric con trib utes to sun pro tec tion: dark col ors pro -
vide greater sun pro tec tion than light ones. Hats
and vi sors pro vide some pro tec tion for the head
and neck. Glass fil ters UVB, but to block UVA ra di a -
tion, pro tec tive coat ings are needed. Glass treat -
ment prod ucts are help ful ad juncts for pa tients with
mul ti ple skin can cers, trans planted pa tients with
skin can cers, and pa tients with pho to sen si tive der -
matoses. To max i mize sun pro tec tion us ing phys i -
cal means, one should wear a hat with a large brim
and cloth ing with suf fi ciently tight weaves, dark
color, loose fit, and dry ness. Shade de vices, such
as awn ings or um brel las, add fur ther to sun pro tec -
tion, but even shade may con tain 50% of am bi ent
UV light. Care must be taken to avoid ex po sure to
light-col ored re flec tive sur faces, in clud ing sand,
snow, and ice, to avoid re flected UV ra di a tion (1). 
Sunscreens
Sunscreens (SS) are UV ra di a tion-ab sorb ing
chem i cals that at ten u ate the amount and na ture of
UV ra di a tion reach ing vi a ble cells in the skin.
Chem i cal sunscreens have been shown to pre vent
UV in duced sun burn, ac tinic keratosis, photoaging,
and DNA dam age. Sunscreen strat e gies are use ful
for pro tec tion against UVB and short-wave UVA,
but com plete pro tec tion against long-wave UVA has 
not been achieved. Their reg u lar, ap pro pri ate, pro -
phy lac tic ap pli ca tion is an ef fec tive means to min i -
mize the short- and long-term ef fects of UV ra di a -
tion ex po sure. Ab sor bent prod ucts have tra di tion -
ally been most pop u lar; they act well against UVB
and are cos met ic ally sat is fac tory. How ever, some
us ers can de velop cu ta ne ous ir ri ta tion and oc ca -
sional con tact or photocontact der ma ti tis to such
prod ucts (34).
Ef fi cacy of sunscreens is typ i cally de noted by a
sun pro tec tion fac tor (SPF). It is the ra tio of the UV
ra di a tion ex po sure dose nec es sary to pro duce min -
i mally de tect able er y thema in sunscreen pro tected
skin com pared with that of un pro tected skin. The
im por tance of sun pro tec tion in child hood can not be 
over stated. It has been pre dicted that the use of an
SPF 15 for the first 18 years of life can po ten tially re -
duce the risk of non-mel a noma skin can cer by 78%. 
While photoaging would also pre sum ably be re -
duced, since reg u lar sunscreen use may re duce
life time UV ra di a tion ex po sure by 80%. Adults are
more likely to use sunscreens than chil dren, but
their peak sun ex po sure years have al ready passed 
by adult hood and the vis i ble signs of photoaging
have al ready be gun to ap pear (17). 
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Mod ern sunscreens and mois tur iz ers con tain ing 
sunscreens un dergo mas sive premarketing tox i co -
log i cal and clin i cal as sess ment to de ter mine their
ef fi cacy and safety. Ma jor man u fac tur ers pro vide
prod ucts which have short- and long-term ben e fits
in photoprotection (35).
There is in creas ing sci en tific ev i dence that peo -
ple should use sunscreens pro phy lac ti cally with ad -
e quate SPF (ICSS).
The pres ence of sig nif i cant lev els of UV ra di a -
tion-in duced mo lec u lar, cel lu lar and extracellular
dam age (from sin gle or re peated suberythematous
UV ra di a tion ex po sure) sug gests that suc cess ful
photoprotection from the chronic ef fects of so lar ex -
po sure may re quire SPFs sig nif i cantly greater than
those nec es sary to pre vent a min i mal er y thema
dose (4).
Sunscreen use pro tects against most UV-in -
duced non-mel a noma skin can cer and ac tinic
keratoses but its ac tiv ity against ma lig nant mel a -
noma is not clear. More stud ies with broad-spec -
trum sta ble sunscreens and better mod els for the
in ves ti ga tion of ma lig nant mel a noma are re quired
(34).
Sunscreens can en sure vari able pro tec tion but
they can not re pair the UV-in duced dam age at the
mo lec u lar level, which is the ini ti at ing event of the
bi o log i cal ef fects. The ul ti mate goal of photopro -
tection should be the sup pres sion of pho tons to
come in con tact with the skin sur face (17,34).
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FI NAL PRO GRAM AND BOOK OF AB STRACTS
HIS TOR I CAL SAT EL LITE SYM PO SIUM
VE NE REAL DIS EASE: RE AL ITY AND TA BOO
ON THE 20th AN NI VER SARY OF DEATH OF AC A DE MI CIAN FRANJO KOGOJ
Pal ace of the Cro atian Acad emy of Sci ences and Arts, Zagreb,
May 28, 2003, at 4.00 p.m.
CRO ATIAN ACAD EMY OF SCI ENCES AND ARTS
DE PART MENT OF MED I CAL SCI ENCES
IN STI TUTE OF HIS TORY AND PHI LOS O PHY OF SCI ENCES
DI VI SION OF HIS TORY OF MED I CAL SCI ENCES
CRO ATIAN SO CI ETY FOR HIS TORY OF MED I CINE OF THE CRO ATIAN MED I CAL AS SO CI A TION
and
CRO ATIAN DERMATOVENEROLOGICAL SO CI ETY OF THE CRO ATIAN MED I CAL AS SO CI A TION
or ga nize
Sym po sium with In ter na tional Par tic i pa tion
VE NE REAL DIS EASE: RE AL ITY AND TA BOO
In ves ti ga tions in ve ne real dis eases sur pass the lim its of med i cine and re veal the com plex ity in bi ol ogy as
much as in so ci ol ogy and cul ture. The Sym po sium will place a spe cial em pha sis on multidis cipli nary ap -
proach to the phe nom e non of ve ne real dis eases and dem on strate the in ter twin ing of med i cal and cul tural
fab ric, past as well as pres ent. Con tri bu tions will be ded i cated to the mem ory of Ac a de mi cian Franjo
Kogoj (1894-1983), the founder of dermatovenerology in Croatia, on the oc ca sion of the 20th an ni ver sary
of his death.
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Pal ace of the Cro atian Acad emy of Sci ences and Arts Con fer ence Hall
Trg Nikole Šubiæa Zrinjskog 11
Pro gram
16.00 – 16.20 Wel come Re cep tion
I. Ve ne real dis eases: re al i ties
16.20 -16.40 Mi chael Waugh (Leeds)
An his tor i cal study of why venerology and not derma -
tovenerology in Great Brit ain: an evo lu tion
16.40 – 17.00 Mar cia Ramos e Silva (Rio de Ja neiro) 
Fa cial and oral as pects of some ve ne real and trop i cal
dis eases
17.00 – 17.20 Mihael Skerlev (Zagreb)
The HPV gen i tal in fec tions – what do we re ally know,
what can we re ally do?
17.20 – 17.40 Josip Begovac (Zagreb)
The suc cess and fail ure in com bat ing the HIV/AIDS ep -
i demic
17.40 – 18.00 Dis cus sion
18.00 – 18.20 Cof fee break
II. Ve ne real dis eases: Ta boos
18.20 – 18.35 Aleksandar Štulhofer (Zagreb)
Re cent re search on sex ual risk tak ing in Croatia
18.35 – 18.50 Marija Ana Dürrigl, Stella Fatoviæ-Ferenèiæ
            (Zagreb)
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OS1
WHY VENEREOLOGY RATHER THAN
DERMATOVENEREOLOGY IN GREAT
BRIT AIN – AN EVO LU TION:
A HIS TOR I CAL STUDY
M. Waugh
Con sul tant Venereologist, Leeds Gen eral In fir mary, Leeds, UK
Eng land, an off shore part of the Brit ish Isles, tem per ate
in weather and not in clined to look to Con ti nen tal Eu rope,
has al ways had rather dif fer ent tra di tions to the rest of Eu -
rope.
From the 16th to the 20th cen tury, it was at war some of
the time with Spain, France, Hol land, and then the Cen tral
Powers. To day, it has a quaint re la tion ship within the Eu ro -
pean Eco nomic Com mu nity.
It built up the world’s larg est Em pire by the end of the
19th cen tury on pi racy, envy of Span ish gold, trade, dis like of
French im pe ri al ism, and Na po le onic cen trali sa tion: an envy
and then, an un der stand ing for Dutch busi ness acu men, the
loss of its Amer i can col o nies, the rise of sugar pro duc tion in
the slave is lands of the West In dies, the rise of the In dus trial
Rev o lu tion, the ne ces sity of find ing mar kets, the gain ing of
Em pire, i.e., In dia, Aus tra lia, Can ada, and New Zea land, and 
col o nies all round the World backed by the fi nan cial acu men
of the City of Lon don and the Brit ish Navy.
Eng land was there fore not re ally bound to fol low  Eu ro -
pean ways, and the Brit ish Isles, later the Em pire, was not
bound by Eu ro pean tra di tions.
Ve ne real dis eases and es pe cially knowl edge on syph i lis
from the 16th cen tury on wards were con ti nen tal con cerns
and new ideas were of ten late into Eng land. There is a mul ti -
tude of re cords of the rav ages of Morbus gallicus in Eng land
in the 16th cen tury. How ever, the name syph i lis, coined in
1530, had not come to Eng land un til 1686, when Nahum Tate 
trans lated Fracastor’s work. The first med i cal writer was
Dan iel Turner, who wrote on syph i lis in 1717.
Gon or rhoea, fol low ing the faulty teach ing of Paracelsus,
was thought to be part of the com mon ve ne real dis ease and
,as the poet Pope quotes in the 18th cen tury, “time that at last 
ma tures a clap to a pox”. John Hunter’s sci en tific ex per i ment
that went wrong did not re ally help mat ters in that be fore
Ricord, he con sid ered gon or rhoea to be in com mon with
syph i lis as part of the ve ne real dis ease. Sur geons not known
for in tel lec tual cu ri os ity looked af ter ve ne real dis eases. They
usu ally got their ex pe ri ence in the army or navy.
The amaz ing rev o lu tion and prog ress in 19th cen tury Eu -
rope in mi cro bi ol ogy and der ma tol ogy were in fact Eu ro pean
first and taken up slowly in Eng land.
What re ally star tled the med i cal es tab lish ment were the
sci en tific dis cov er ies, T.pallidum, se rol ogy for syph i lis, and
the magic bul let of Ehrlich, Sal var san. These were Ger man
dis cov er ies, Eng land was loosing out in the race.
Then along came the Royal Com mis sion on the Ve ne real 
Dis eases, which started to get ev i dence about the par lous
state of the pop u la tion with re gard to ve ne real dis eases from
1912 on wards. Since its re port in 1917, the sys tem of con fi -
den tial and free coun try wide STD De part ments has first
started to look af ter syph i lis and gon or rhoea, only to be come
a sep a rate spe cialty staffed by doc tors with train ing in in ter -
nal and gen i to uri nary med i cine look ing af ter STDs and
HIV/AIDS. Dermatovenereology in Eng land lost out about 80 
years ago, but der ma tol o gists in many parts of the world now
real ise they have to do more pub lic health med i cine if they
are to re gain the con fi dence of their gov ern ments and min is -
tries.
OS2
FA CIAL AND ORAL AS PECTS OF SOME
VE NE REAL AND TROP I CAL DIS EASES
M. Ramos-e-Silva
Sec tor of Der ma tol ogy HUCFF-UFRJ and School of
Med i cine, Fed eral Uni ver sity of Rio de Ja neiro, Brasil
Dis eases of the trop i cal ar eas in clude some ve ne real
dis eases, which are still prev a lent in some coun tries; Brazil is 
one of them. Some pa tients come from large cit ies like Rio de 
Ja neiro. How ever, at the Uni ver sity Hos pi tal of the Fed eral
Uni ver sity of Rio de Ja neiro, we also see pa tients who come
from the in te rior of the State of Rio de Ja neiro, or from other
states, to seek med i cal care at better equipped hos pi tals for
ther apy of this type of con di tion.
Ve ne real and trop i cal dermatoses have many dif fer ent
cu ta ne ous man i fes ta tions and may af fect skin in sev eral lo -
ca tions. The face is one of the af fected ar eas, es pe cially
when the dis ease has a pre di lec tion for car ti lage, oral and/or
na sal mu cosa. 
Al ter ations ob served on the fa cial skin and mu cosa of the 
mouth of the fol low ing trop i cal dis eases are pre sented and
dis cussed: syph i lis, donovanosis, leishmaniasis, paracoccidi -
oido my cosis, lep rosy, larva migrans, and myiasis.
OS3
THE HPV GEN I TAL IN FEC TIONS – WHAT
WE REALLY KNOW, WHAT CAN WE
REALLY DO?
M. Skerlev
De part ment of Der ma tol ogy and Venereology, Zagreb
Uni ver sity Hos pi tal Cen ter and School of Med i cine,
Zagreb, Croatia
Sex ually trans mit ted in fec tions (STIs) are as old as hu -
man his tory. Anogenital Hu man papillomavirus (HPV) in fec -
tions are most fre quently di ag nosed STIs of vi ral or i gin, and
the HPV types as so ci ated with such le sions have been stud -
ied ex ten sively over the last years. HPV-as so ci ated gen i tal
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pa thol ogy rep re sents one of the ma jor prob lems among
STIs, mostly due to the high re cur rence rate, dif fi cult erad i ca -
tion, and oncogenic po ten tial. Be sides, the young, sex u ally
ac tive pop u la tion in the gen er a tive pe riod is mostly af fected.
HPV gen i tal in fec tions are also among most fre quent di -
ag no ses in the Sex ually Trans mitted Dis eases (STD) Out pa -
tient Clinic of the De part ment of Der ma tol ogy and Venere -
ology at Zagreb Uni ver sity School of Med i cine. The fre -
quency of HPV gen i tal in fec tions ranged from 125 pa tients in
1991 to 175 in 2002. Care ful and friendly man ner of tak ing
med i cal his tory and per form ing clin i cal ex am i na tion showed
rather im por tant to ob tain the ex act data. Clin i cal vari a tions
ranged from var i ous types of gen i tal warts to bi zarre forms of
gi ant condyloma of Buschke-Löwenstein type. In spite of the
fun da men tal im por tance of the clin i cal ex am i na tion it self, we
wanted to iden tify the HPV DNA type in these le sions. Over
the last few years, dif fer ent di ag nos tic tools have been used
in pa tients with HPV gen i tal in fec tion, in clud ing pathohisto -
logy and, in some cases, penoscopy. How ever, the re sults
were not al ways pre cise enough to help us de cide whether
the le sion was HPV-in duced or not. Thus, we wanted to eval -
u ate the sig nif i cance of vi ral tests (PCR, in situ hy brid iza tion)
for anogenital warts in men. Hereby we pres ent the re sults of
HPV DNA de tec tion and typ ing of bi opsy spec i mens on the
anogenital lo ca tion in 100 men with HPV-in duced, clin i cally
vis i ble le sions (condylomata acuminata, condylomata plana,
and Buschke-Löwenstein). Ac cord ing to these re sults, HPV
16 and 18 can also be iso lated from “be nign" HPV-as so ci -
ated gen i tal le sions more than it is usu ally ex pected. There -
fore, the di ag nos tic ap proach to HPV gen i tal in fec tions
needs to be com plex, in clud ing HPV DNA typ ing when ever it
seems ap pro pri ate.
Dif fer ent meth ods for the treat ment of gen i tal warts are
pre sented, such as cryotherapy, podophyllotoxin, cu ret tage,
and imiquimod (in the smaller group, as com pared to other
treat ment mo dal i ties). So far, none of the treat ments has
been found clearly su pe rior.
Over the last de cades, the oncogenic prop er ties of HPVs 
have been in ten sively stud ied, and a sig nif i cant but prag mat -
i cally in suf fi cient prog ress has been achieved, es pe cially in
the field of HPV di ag nos tics. Treat ment should be pro vided in 
ac cor dance with avail able re sources, the ex pe ri ence of the
pro vider, and the pref er ence of the pa tient. Thus, the clin i cal
ap proach to HPV gen i tal in fec tions, com plex as it is, raises
many ques tions re gard ing HPV gen i tal in fec tions, which re -
main to be an swered.
OS4
THE SUC CESSES AND FAIL URES IN
COM BATING THE HIV/AIDS EP I DEMIC
J. Begovac
“Dr. Fran Mihaljeviæ”Uni ver sity Hos pi tal for In fec tious
Dis eases, Zagreb, Croatia
New ad vances in ba sic and clin i cal re search in hu man
im mu no de fi ciency vi rus (HIV) in fec tion have had a dra matic
im pact on the HIV/AIDS ep i demic in de vel oped coun tries.
HIV in fec tion is no lon ger per ceived as a pro gres sive and fa -
tal dis ease, it is now sought to be a treat able ill ness. New
anti-HIV drugs given in po tent com bi na tion reg i mens have
dem on strated im pres sive ef fi cacy in both clin i cal and lab o ra -
tory terms, and have pro vided ev i dence that ap pro pri ate
drugs can sup press HIV rep li ca tion and dis ease man i fes ta -
tions. New tech niques for mea sur ing HIV RNA have been
de vel oped, which al lowed more ac cu rate and ef fec tive clin i -
cal man age ment and short ened the time re quired to ac cu -
mu late ev i dence for drug ef fi cacy in a clin i cal trial. How ever,
there is still no vac cine. In ad di tion, ben e fits from re cent ad -
vances are not avail able to the ma jor ity of HIV-in fected peo -
ple in the world. More than 95% of all HIV-in fected peo ple
now live in de vel op ing coun tries and 95% of all deaths take
place in de vel op ing coun tries. The world has now en tered
the third de cade of the HIV/AIDS ep i demic and the ev i dence
of its im pact is un prec e dented. Wher ever the ep i demic has
spread un checked, it is now af fect ing the re sources and ca -
pac i ties of coun tries upon which both hu man se cu rity and de -
vel op ment de pend. In some re gions, HIV/AIDS, in com bi na -
tion with other cri ses, is driv ing ever-larger parts of na tions
to wards pov erty. Most of the time, the world stood si lently by
as HIV/AIDS swept through these coun tries. Ac cord ing to
UNAIDS es ti mates, the HIV/AIDS ep i demic claimed more
than 3 mil lion lives in 2002, and an es ti mated 5 mil lion peo ple 
ac quired HIV in fec tion in 2002 – bring ing the num ber of peo -
ple glob ally liv ing with the vi rus to 42 mil lion. By far the worst
af fected re gion, sub-Sa ha ran Af rica is now home to 29.4 mil -
lion peo ple with HIV/AIDS; ap prox i mately 3.5 mil lion new in -
fec tions oc curred in 2002, while the ep i demic claimed the
lives of an es ti mated 2.4 mil lion Af ri cans. Ten mil lion peo ple
aged 15–24 and al most 3 mil lion chil dren un der 15 years of
age are liv ing with HIV. Only a tiny frac tion of the mil lions of
Af ri cans in need of antiretroviral treat ment ac tu ally re ceive it.
Many mil lions are not re ceiv ing med i cines to treat op por tu -
nis tic in fec tions, ei ther. These fig ures re flect the world’s con -
tin u ing fail ure, de spite the prog ress made in re cent years, to
mount a re sponse that matches the scale and se ver ity of the
global HIV/AIDS ep i demic. In East ern Eu rope and Cen tral
Asia, the num ber of peo ple liv ing with HIV in 2002 was 1.2
mil lion. HIV/AIDS is ex pand ing rap idly in the Bal tic States,
the Rus sian Fed er a tion, and sev eral Cen tral Asian re pub lics. 
In Asia and the Pa cific, 7.2 mil lion peo ple live with HIV. The
growth of the ep i demic in this re gion is largely caused by the 
growth of ep i demic in China, where a mil lion peo ple live with 
HIV and of fi cial es ti mates fore see a man i fold in crease in
that num ber over the next de cade. There re mains con sid er -
able po ten tial for growth in In dia, too, where al most 4 mil lion 
peo ple live with HIV. In sev eral coun tries ex pe ri enc ing the
early stages of the ep i demic, sig nif i cant eco nomic and so cial
changes are giv ing rise to con di tions and trends that fa vour
the rapid spread of HIV, e.g., wide so cial dis par i ties, lim ited
ac cess to ba sic ser vices, and in ten si fied mi gra tion. Best cur -
rent pro jec tions sug gest that an ad di tional 45 mil lion peo ple will
be come in fected with HIV in 126 low- and mid dle-in come coun -
tries be tween 2002 and 2010—un less the world suc ceeds in
mount ing a dras ti cally ex panded, global pre ven tion ef fort. It is
now vi tal that HIV/AIDS-re lated ac tiv i ties be come an in te gral
part of world ef forts to pre vent and over come the hu man i tar -
44 ACTA DERMATOVENEROLOGICA CROATICA
 
Acta Dermatovenerol Croat 2003;11(1):42
ian cri ses. Also, pro vid ing antiretrovirals to pa tients in de vel -
op ing coun tries should be a global hu man i tar ian pri or ity and
fail ing in pro vid ing life-sav ing treat ment to those mostly af -
fected can not be jus ti fied.
OS5
SEX UAL RISK-TAKING RE SEARCH AND ITS 
SO CIAL IM PACT: THE CASE OF CROATIA
A. Štulhofer
As so ci ate Pro fes sor of So ci ol ogy, Zagreb Uni ver sity
Philo soph i cal Fac ulty, Zagreb, Croatia
A short his tory of sex ual risk-tak ing re search in Croatia
and its so cial im pact, par tic u larly in terms of HIV/AIDS pre -
ven tion cam paigns and sex ed u ca tion pro grams, are pre -
sented. The early be hav ioral and at ti tu di nal stud ies of ad o -
les cent sex u al ity car ried out in the 1970s are dis cussed, fol -
lowed by a de tailed anal y sis of a num ber of stud ies pub lished 
in the 1990s. The over view also in cludes the most re cent
RAR (rapid as sess ment and re sponse) study of HIV/AIDS-
 re lated risk be hav iors (2002).
The anal y sis of pre vi ous stud ies fo cuses pri mar ily on
their the o ret i cal short com ings and meth od olog i cal lim i ta -
tions, sug gest ing steps nec es sary for im prov ing fu ture re -
search in this area. Un der de vel oped in ter dis ci plin ary co op -
er a tion re mains a se ri ous im ped i ment to sex ual risk-tak ing
re search.
The sec ond part of the pre sen ta tion of fers a con cise
anal y sis of the (lack of) re search re lated to so cial out comes.
Two cases will be elab o rated: the enig matic HIV/AIDS pub lic
cam paign in tro duced in 1997 and a con spic u ous non-ex is -
tence of school-based sex ed u ca tion. In con clu sion, a pos si -
ble ex pla na tion is of fered for the lack of ties and co or di na tion
be tween re search and (sex u al ity re lated) health ini tia tives.
OS6
THE PER IL OUS LOVE: SI LENCE ON
SEX UAL MAT TERS IN CROATIAN
ME DI EVAL WRITING
M.A. Dürrigl1, S. Fatoviæ-Ferenèiæ2
1Old Church Sla vonic In sti tute and 2De part ment for the
His tory of Med i cine of the In sti tute for the His tory and
Phi los o phy of Sci ences, Cro atian Acad emy of Sci ences
and Arts, Zagreb
Me di eval writ ers were not ex plicit and were of ten us ing
rather “cryp tic” and for mu laic lan guage in men tion ing sex u al -
ity is sues. Al though there is al ways some how a “ca veat” for a 
per son writ ing about sex u al ity, there is no ab sence on such
is sues in Cro atian me di eval texts. In the Mid dle Ages, hu man 
sex u al ity fell within the do mains of phy si cian, nat u ral phi los o -
pher, mor al ist, and theo lo gian. This pa per sheds light on
some as pects of sex u al ity based on ev i dence from Cro atian
Glagolitic me di eval writ ing. An a lyzing lit er a ture, i.e. works
be long ing to the gen res of ha gi og ra phy, vi sions, exempla,
and the so-called Mir a cles of Our Lady from the 15th and
early 16th cen tury, we tried to pin-point their main char ac ter -
is tics and their re la tion to pre served med i cal com pi la tions
and set ting, which ar tic u lated no tions of sex and pun ish ment, 
body and spirit, dis ease and sin. Al though they be long to a
com pletely dif fer ent cul tural sphere, they can be used as ba -
sis in un der stand ing con cep tual frame work for re search on
stigma with a fo cus on health re search and se lected health
prob lems for which stigma is a ma jor con cern.
OS7
THE SKERLIEVO DIS EASE: BE TWEEN MYTH 
AND RE AL ITY
A. Muzur, A. Škrobonja
Rijeka Uni ver sity School of Med i cine, Rijeka
At the end of the 18th cen tury, the ep i demic of an un -
known dis ease broke up in West ern Croatia. It was named
“Skerlievo dis ease,” af ter a vil lage nearby the city of Rijeka.
The ill ness was spread ing quite rap idly and, at its peak, the
num ber of dis eased reached around 14.000. Dozens of pa -
pers, books, and dis ser ta tions were writ ten about it all over
Eu rope, try ing to elu ci date the na ture and cause of the ep i -
demic. By the end of the 19th cen tury, the dis ease mostly dis -
ap peared, but the ques tions re mained. In this brief over view,
we in tend not only to pres ent the rise and fall of a cu ri ous ill -
ness (now gen er ally ac cepted as en demic syph i lis), but also
of the rise and fall of fash ion able di ag nos ing. More over, the
story of the Skerlievo dis ease in nu mer ous ep i de mi o log i cal,
eth i cal, and pop u lar as pects re sem bles the story of AIDS.
OS8
AIDS IN PUB LIC JOUR NALS
A. Makoviæ
“Merkur” Uni ver sity Hos pi tal, Zagreb
The aim of this study was to in ves ti gate the topic of AIDS
in Cro atian pub lic jour nals, since the day it was first noted un -
til to day. The study in cluded 6 dif fer ent jour nals pub lished in
Croatia. The year to be gin with was 1978. Al though AIDS has 
been known since the late 1970s, in Cro atian me dia it was
first men tioned in 1983. On June 29, 1983, Vjesnik brought
high lights from the Bel gian press. Al though the dis ease be -
came wide spread in a very short time, there was not much in -
for ma tion about it in our pub lic jour nals un til the 1984, when
Rob ert Gallo and Luc Montagnier found a pos si ble caus ative
agent – a vi rus, which they named “a new retro virus”.
Show busi ness, film in dus try, and fa mous movie stars
were of ten used as a con vinc ing and ex pres sive me dium in
com mu ni cat ing mes sages in AIDS cam paigns. Pop u lar jour -
nals were an other im por tant ve hi cle for trans fer ring the in for -
ma tion. Their role was par tic u larly im por tant in spread ing
pub lic health ed u ca tion mes sages and un cov er ing cer tain
be hav ioral mech a nisms, stig mas, and ta boos in Croatia re -
gard ing AIDS. Al though of ten sen sa tional and in ac cu rate,
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pub lic jour nals were rec og nized as a good me dium for pub lic
ed u ca tion, pre sen ta tion of AIDS-re lated facts, and in tro duc -
tion of per ti nent news.
*The in ves ti ga tion was car ried out un der the su per vi sion
of As sist. Prof. Stella Fatoviæ-Ferenèiæ.
OS9
AIDS IN BIO MED I CAL JOUR NALS IN
CROATIA
M. Mišir
ER, De part ment of Emer gency Med i cine, Osijek
Ap pearing in the early 1980s, AIDS be came one of the
most threat en ing dis eases of our time. It brought fear of stig -
ma ti za tion and drama, which could be eas ily com pared to
sim i lar pan dem ics in past pe ri ods. Fear and traces of med i -
cal in ves ti ga tions on AIDS, rang ing from sur prise and help -
less ness to tri umph, are noted in a large num ber of med i cal
jour nals all over the world. This in ves ti ga tion dealt with
traces that AIDS re search has left on the pages of Cro atian
bio med i cal jour nals since the first ap pear ance of AIDS un til
to day.
The aim was to an a lyze the im pact and trans fer of in ter -
na tional med i cal in for ma tion on AIDS to Cro atian med i cal
jour nals, and to in ves ti gate the qual ity and struc ture of such
in for ma tion. The anal y sis in cluded 25 Cro atian bio med i cal
jour nals, found in the li brar ies of Zagreb School of Med i cine,
Andrija Štampar Zagreb School of Pub lic Health, Osijek Uni -
ver sity Hos pi tal, and Zagreb School of Stomatology.
Most Cro atian med i cal jour nals in cluded in the anal y sis
were a good source of qual ity in for ma tion, which im plies their 
im por tant role in pre par ing med i cal com mu nity to AIDS in our 
coun try long be fore first pa tients ap peared in our hos pi tals.
*The in ves ti ga tion was car ried out un der the su per vi sion
of As sist. Prof. Stella Fatoviæ-Ferenèiæ.
46 ACTA DERMATOVENEROLOGICA CROATICA
 
Acta Dermatovenerol Croat 2003;11(1):42
 
Un der the aus pices of the Cro atian Acad emy of Med i cal Sci ences
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Slide Re cep tion/Pre view Desk will be lo cated near by Con gress Hall 
For pre sent ers giv ing a lec ture or oral pre sen ta tion with slides, a slide re cep tion and pre view desk is avail able dur ing
the Con gress hours. Speakers are kindly re quested to hand in their slides at least one hour be fore the be gin ning of
this ses sion. Slides 5x5 cm must be fit ted in the plas tic frames. Spe cial ized per son nel will check the or der of the
slides to gether with the speaker, seal and la bel the car rou sel and take it to the Meet ing room. Dou ble pro jec tion will
be pro vided in all ses sions. LCD pro jec tion will be pro vided in Con gress hall.
If you are a Chair man
• Please be at your ses sion room 10 min utes prior to com mence ment of the ses sion. We would like to re mind you
that time al lot ted for pre sen ta tion is:
• 15-20 min utes for ple nary 
•  8- 15 min utes for other lec tures 
• You are kindly re quested to make sure that speak ers strictly ad here  to the time sched uled.  
If you are Speaker
• Please be cer tain that the length to your lec ture/oral pre sen ta tion stays within the al lot ted time given in Sci en tific
Pro gram. We re mind you that you should turn in your slides at least one hour be fore the com mence ment of the ses -
sion. You must col lect your slides from the slide re cep tion im me di ately af ter the end of the ses sion. Please fol low
the time sched ule for your pre sen ta tion.
In struc tions for PC
• Con gress Hall will be fully equipped with the nec es sary equip ment for pre sen ta tion through PC. Speakers are
kindly re quested to bring their dis kette or CD Rom with their pre sen ta tion.
Tech ni cal equip ment:
• Sin gle slide pro jec tion (carusell 24x36), dou ble slide pro jec tion (carusell 24x36), over head pro jec tion, LCD pro jec -
tion (PC Power Point).
Posters & Meet ing Hall
• All post ers will be on dis play for the en tire du ra tion of the Meet ing. Each poster board is 1 me ter wide x 1,50 me ters
high. Each board will be la beled with your poster pre sen ta tion num ber, which is as signed to you (re fer to your per -
sonal let ter). 
• Ma te rial for mount ing post ers (dou ble-sided Scotch tape) will be avail able at the Con gress Sec re tar iat.
Poster mount ing and re moval sched ule:
• Mount ing:  Thurs day, May 29, 2003, be tween 8,00 - 19,00
• Re moval:   Sat ur day, May 31, 2003, be tween 16.00 - 18.00
• Poster Award for the best three post ers, Sat ur day, May 31, 2003 at 17.00
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SCI EN TIFIC CON GRESS PRO GRAM
Thurs day, May 29, 2003.
14,00-20,00 Reg is tra tion at the Reg is tra tion Desk in front the Re cep tion of the Ho tel Jezero 
Poster set up in the Ex hi bi tion area
Main hall ho tel Jezero
17,30-17,45 Open ing Cer e mony in the Con gress Hall
Wel come: J. Lipozenèiæ, Pres i dent of the Cro atian Dermatovenerology So ci ety of the
         Cro atian Med i cal As so ci a tion and Con gress Pres i dent
Wel come: L. E. Millikan, Sec re tary and trea surer gen eral of In ter na tional Acad emy of Cos metic Der ma tol ogy
17,45-18,00 Short video pro gram on the Na tional Park Plitvice on the oc ca sion of the Open ing Cer e mony
18,00-19,00 PLE NARY LEC TURES
18,00-18,20 I. Dobriæ, S. Murat-Sušiæ: Ba sic prin ci ples of lo cal ther apy in dermatovenerology
18,20-18,40 H .P . M. Gollnik: Pathogenesis and cur rent global treat ment strat e gies for acne - rec om men da tions
of the global al li ance to im prove out comes in acne
18,40-19,00 M. Ramos-e-Silva: Eth nic skins and their man age ment
19,00-20,00  Sat el lite sym po sium OKTAL PHARMA
Hair and scalp prob lems
V. Siboud: Androgenetic al o pe cia and hair fol li cle growth - an up date
M. Skerlev: Mi cro bi o log i cal back ground, pathogenesis and treat ment of dan druff
Im por tance of cos metic der ma tol ogy
A. Stanimiroviæ: Cos metic der ma tol ogy: in stead of cos me tics or better of cos metic
20,00-22,00 Wel come re cep tion
Fri day, May 30, 2003.
8,00-20,00 Reg is tra tion at the Reg is tra tion Desk in front the Re cep tion of the Ho tel Jezero
 Main hall ho tel Jezero
1. THE ROLE OF LO CAL TREAT MENT IN DER MA TOL OGY
09,00-10,45
Chair per sons: H. Nakayama, M. Ramos-e-Silva, R. Wolf, V. Milavec-Puretiæ
08,45-09,00 V. Milavec-Puretiæ, I. Lakoš-Jukiæ: Op ti mi za tion of the top i cal ther apy in der ma tol ogy
09,00-09,15 S. Murat-Sušiæ, K. Husar: Neo na tal and in fant skin care
09,15-09,30 I. Nola, K. Kostoviæ, L. Kotrulja, L. Lugoviæ: Emol lients as so phis ti cated ther apy in der ma tol ogy
09,30-09,50 R. Wolf, H. Matz, E. Orion: Sunscreens – the ul ti mate cos metic
09,50-10,00 J. Lipozenèiæ: What’s new in top i cal ther apy?
10,00-10,15 C. R. Celebi: The pro ject of con sumer at ti tudes on cos metic prodicts and ap pli ca tions in Balkanian
                      coun tries
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10,15-10,30 M.Ramos-e-Silva: Photoaging – myths and facts
10,30-10,45 Dis cus sion
10,45-11,00 Cof fee break
11,00-12,00 Sat el lite sym po sium SPIRIG
       Ex tem po ra ne ous pre scrip tions
       M. Gloor: Up date on ex tem po ra ne ous pre scrip tions in der ma tol ogy 
       P. Huber: Qual ity man age ment in ex tem po ra ne ous pre scrip tions
12,00-14,00 Lunch time and poster view ing
2. THER APY OF IN FLAM MA TORY SKIN DIS EASES
14,00-16,00
Chair per sons:J. Ring, A. Pašiæ, G. Trevisan, J. Lipozenèiæ
14,00-14,20 J. Ring, U. Darsow: New ap proaches in treat ment of atopic ec zema
14.20-14.35 I. Lawrance: Tacrolimus oint ment is safe and ef fec tive in the treat ment of atopic der ma ti tis: Re sults
          of 2 large long term open la bel study in pe di at ric and adult pa tients
14,35-14,50 F. Kokelj, G. Trevisan: UV com bined ther apy in pso ri a sis
14,50-15,05 V. Kuzmanovska, L. Biserkoska-Atanasovska: A new com bi na tion in lo cal treat ment for pso ri a sis
          vulgaris
15,05-15,15 P. Vržogiæ, A. Pašiæ, T. Podobnik-Takaè, J. Lipozenèiæ: Pso ri a sis vulgaris et ar thri tis psoriatica
          gra vis mutilans – case re port
15,15-15,30 Z. Jukiæ, V. Barišiæ-Druško, I. Ruèeviæ, N. Šustiæ, D. Biljan, A. Ageel, R. Vukadin: Lo cal ther apy
          of pso ri a sis vulgaris-his tor i cal re view
15,30-15,45 A. Pašiæ, R. Èeoviæ, D. Hrsan: The light in the treat ment of dermatoses
15,45-16,00 Dis cus sion
16,00-17,00 Sat el lite sym po sium VICHY
Improving our Knowl edge of Healthy Skin: UV-Induced Skin Dam age and Public Awareness of
Photoprotection
I. Bartenjev: The im por tance of photoprotection 
A. Bakija-Konsuo, Z. Bukviæ-Mokos, M. Kaštelan, L. Prpiæ-Massari, I. Sjerobabski-Masnec, L.
Stojanoviè, B. Žgavec: Ed u cat ing peo ple about the harm ful ef fects of the sun and the im por tance of
photoprotection: Re sults of the “Sun Pre ven tion Cen ter” cam paign
17,00-17,30 Cof fee break
3. TREAT MENT OF VI RAL, BAC TE RIAL AND PAR A SITIC DIS EASES AND STD
17,30-19,00
Chair per sons: A. Horváth, A. Stary, M. Waugh, M.Šitum, V. Hegyi
17,30-17,50 A. Horváth, K. Nagy: Un usual cases of immunodermatologic dis eases: retroviral back ground?
17,50-18,05 M. Waugh: Syph i lis in Eu rope set ting the scene
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18,05-18,20 R. Wolf, H. Matz, E. Orion: Sca bies: The di ag no sis of atyp i cal cases and their treat ment
18,20-18,35 A. Stary: An ti bi otic re sis tance in gono coc cal in fec tion
18,35-18,45 M. Potoènik: The ef fi ciency of lo cal treat ment in gen i tal le sions
18,45-19,00 Dis cus sion
19,00-20,00 Sat el lite sym po sium BELUPO
Itrac 3 in Der ma tol ogy
M. Skerlev: The novel treat ment strat e gies sig nif i cance of Itraconazol
20,30 Gala Din ner with live mu sic
Sat ur day, May 31, 2003.
Main hall ho teL Jezero
4. TREAT MENTS AND MIS TREAT MENTS IN COS ME TOL OGY
09,00-12,30
Chair per sons: H. P. M. Gollnik, A. Basta-Juzbašiæ, A. D. Katsambas, L. Oremoviæ, F. Gruber
09,00-09,20 H. Nakayama: Melasma: Its cau sa tion and treat ment
09,20-09,40 A. D. Katsambas: Top i cal corticosteroids old and new guide lines
09,40-09,55 A. Basta-Juzbašiæ: Pro et con tra top i cal corticosteroids on the face
10,10-10,25 L. Oremoviæ, I. Sjerobabski Masnec, L. Lugoviæ, G. Novak Biliæ: Cos metics and acne vulgaris
10,25-10,40 N. Arslanagiæ, R. Arslanagiæ: Side ef fects of lo cal glucocorticosteroids ther apy on the skin of the face
10,40-11,00 V. Hegyi, L. Hegyiva: La ser in der ma tol ogy, past, pres ent and fu ture
11,00-11,10 I. Sjerobabski Masnec, L. Oremoviæ, L. Kotrulja, I. Nola, J. Meštroviæ-Štefekov: Mis treat ment in
          acne ther apy – a case re port
11,10-11,20 N. Puizina-Iviæ, T. Stipiæ, A. Èarija, S. Periæ-Sušak, V. Gotovac: Peel ings of age ing skin: what’s new?
11,20-11,35 I. Bartenjev: La ser in der ma tol ogy
11,35-11,50 M. Šitum: Ap proach to dermatosurgery in Croatia
11,50-12,10 L .E. Millikan: Sur gi cal treat ment-cos metic
12,10-12,20 S. Ljubojeviæ, J. Lipozenèiæ, A. Basta-Juzbašiæ, V. Milavec-Puretiæ: Con tact sen si tiv ity in fa cial der ma ti tis
12,20-12,30 Dis cus sion
12,30-13,30 Sat el lite sym po sium URIAGE-Formasana 
Atopic der ma ti tis and skin care
J. Lipozenèiæ: Etiopathogenesis of atopic der ma ti tis - the phe nom e non of dry and ir ri ta ble skin
S. Murat-Sušiæ: Treat ment and skin care of pa tients with atopic der ma ti tis
S. Škrinjar: URIAGE prod ucts in skincare of dry and atopic skin
13,30-14,00 AN NUAL MEETING OF THE CROATIAN DERMATOVENEROLOGICAL SO CI ETY
14,00-15,00 Lunch time and poster re view ing
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15,00-16,00 Sat el lite sym po sium BEIERSDORF 
New Scar Re ducer Ther apy
B. Marinoviæ: Com mon scars and kel oids
J. Lipozenèiæ: Hansaplast - scar re ducer in pre ven tion of kel oids
5. TREAT MENTS AND MIS TREAT MENTS IN DERMATOMYCOLOGY
16,00-17,00
Chair per sons: M.Skerlev, A.Prohiæ, V.Barišiæ-Druško, N.Arslanagiæ
16,00-16,20 M. Skerlev: The ap pro pri ate and in ap pro pri ate teatment of dermatomycoses
16,20-16,30 A. Prohiæ, M. Kantor: Tinea in cog nita caused by Trichophyton verrucosum
16,30-16,40 J. Radoš, M. Skerlev, D. Celiæ, I. Dobriæ: What do we re ally know about tinea in cog nita ? – a case re port
16,40-16,50 D. Biljan, V. Barišiæ-Druško, Z. Jukiæ, N. Šustiæ, I. Ruèeviæ, R. Vukadin, A. Ageel: Clin i cal
           ex pe ri ence with promogran
16,50-17,00 Dis cus sion
17,00-17,15 M. Sijerèiæ, F. Gruber, M. Šitum: Poster award for the best three post ers
17,15 J. Lipozenèiæ: Fi nal Con clu sion and Closing Cer e mony
Closing Cocktail
Posters:
1. T. Batinac, J. Lipozenèiæ, G. Zamolo, F. Gruber, A.
Stašiæ, M. Lenkoviæ: P53 and ki-67 in proliferative
skin dis eases
2. I. Kuljanac, E. Kneževiæ, H. Cvitanoviæ: Er y thema
annulare centrifugum (a case re port)
3. I. Kuljanac, E. Kneževiæ, H. Cvitanoviæ: Li chen
planus linearis – a case re port
4. J. Lipozenèiæ, D. Bobek, V. Milavec-Puretiæ, J.
Jakiæ-Razumoviæ, A. Basta-Juzbašiæ, S. Ljubojeviæ:
Ex pres sion of  CD30+ and CD45+ Ro in atopic der -
ma ti tis le sions
5. L. Lugoviæ, J. Lipozenèiæ: Mixed and pure atopic der -
ma ti tis
6. I. Manola, S. Ljubojeviæ, J. Lipozenèiæ, N. Pustišek:
Nae vus commedonicus – a case re port and re view of
ther a peu ti cal ap proach
7. S. Simeonova, V. Lazarevic, L. Biserkoska-
 Anasovska, M. Nikolovska: Com pli ca tions in tat too -
ing with dif fer ent aproaching in heal ing
8. M. Šitum, Ž. Buèan, S. Levanat: Gorlin’s syn drome
and therapeuthical pos si bil i ties
9. M. Šitum, Ž. Buèan, K. Kostoviæ, D. Štulhofer Buzina:
Con gen i tal gi ant ne vus- ther a peu tic ap proach
10. I.Vukšiæ, N. Puizina-Iviæ, D. Marasoviæ, D.
Anðelinoviæ, T. Stipiæ, D. Pezelj, G. Pavièiæ, V.
Gotovac, A. Èarija, S. Periæ-Sušak: The ef fi cacy of
ta ble sugar in treat ment of ve nous ul cers
11. K. Kostoviæ, Ž. Buèan, I. Nola, N. Troskot: Vitiligo -
new ap proaches in phototherapy
12. I. Ruèeviæ, V .Barišiæ-Druško, D. Biljan, Z. Jukiæ, N.
Šustiæ, R. Vukadin, A. Ageel: Convatec in lo cal ther -
apy-case re port
13. J. Meštroviæ-Štefekov, M.Šitum, B.Marinoviæ, G.Novak- 
Biliæ, L.Kotrulja, I.Nola: Ther a peu tic dif fi cul ties in di ag -
no sis of pemphigus foliaceus
14. G.Novak-Biliæ., M.Šitum, A.Soldo-Belic, J.Meštroviæ- 
Štefekov, L.Kotrulja, L.Lugoviæ: Vasculitis with mu ti la -
tion; part of lep rosy clin i cal find ings?
15. L. Kotrulja, L. Oremoviæ, I. Sjerobabski Masnec, M.
Šitum, M. Vurnek, Ž. Buèan, M. Tadinac Babiæ, N.
Jokiæ Begiæ, R. Gregurek: Cor re la tion be tween qual -
ity of life and psy cho log i cal im pact of pa tients in acne
vulgaris
16. H. Cvitanoviæ, E. Kneževiæ, I. Kuljanac: Dermatomy -
coses in Karlovac county 1995-2002 
17. J. Lipozenèiæ, S. Ljubojeviæ, N. Pustišek, T. Batinac: 
Erythromelalgia pro voked by influenca vac cine
18. A. Smeh-Skrbin, I. Dobriæ, G. Krnjeviæ-Peziæ, P.
Vržogiæ: Naphthalan in the treat ment of pa tients
with atopic der ma ti tis (neurodermitis)
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AWARDS
On 111 Gen eral As sem bly of the Cro atian Med i cal As so ci a tion (CMA) in Zagreb, Feb ru ary 22, 2003,
the fol low ing ac tive Mem bers of CMA and Cro atian Dermatovenerological So ci ety were awarded:
Prof. Franjo Gruber for “Ladislav Rakovac”;
Prof. Jasna Lipozenèiæ and Prim. Aida Pašiæ, MD, for “Di ploma”; and
Bogumil Cezaroviæ, MD for “Zahvalnica”.
The Cro atian Dermatovenerological So ci ety of the Cro atian Med i cal As so ci a tion, Zagreb
and
“Naftalan” Spe cial Hos pi tal for Re ha bil i ta tion, Ivaniæ Grad, Croatia
or ga nize
In ter na tional Sym po sium
Cur rent State on Pso ri a sis and Naphthalanotherapy
Ivaniæ Grad, Croatia
Sep tem ber 19, 2003.
Bus trans por ta tion from Zagreb to Ivaniæ Grad will be or ga nized for all par tic i pants of the Sym po sium.
Con tin u ing Med i cal Ed u ca tion Course on
Sex u ally Trans mit ted Dis eases and In fec tions
Zagreb, Croatia
No vem ber 21-22, 2003
The Con tin u ing Med i cal Ed u ca tion Course is or ga nized by the Chair of Dermatovenerology, Uni ver sity School of
Med i cine Zagreb and the Cro atian Dermatovenerological So ci ety of the Cro atian Med i cal As so ci a tion un der the aus -
pices of Acad emy of Med i cal Sci ences of Croatia.
There has been a re sur gence of sex u ally trans mit ted in fec tions (STIs) in all age groups, which makes di ag nos tic pro ce -
dures in venerology ever more im por tant. Great ef forts are needed in ser vice pro vi sion, health pro mo tion, and re search
to iden tify the in ter ven tions most likely to suc ceed. The prev a lence of the most fre quent STIs will be dis cusses on the
Course.
World known ex pert in the field of STIs, Prof. James Bingham will also par tic i pate in Course.
Con tact:
Prof. Jasna Lipozenèiæ
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Main top ics:
• New as pects in etiopathogenesis of pso ri a sis
• Immunohistopathologic di ag no sis in prog no sis of
pso ri a sis
• Antiproliferative ef fect of naphthalan com bined ul -
tra vi o let B (UVB) light and naphthalan ther apy
• Other ther a peu tic op tions in treat ment of pso ri a sis.
Con tact:
Prof. Jasna Lipozenèiæ





10th AN NI VER SARY OF THE CROATIAN 
DERMATOLOGICAL SO CI ETY OF THE
CROATIAN MED I CAL AS SO CI A TION
AND
10th AN NI VER SARY OF THE FIRST PRO FES SIONAL JOUR NAL IN THE HIS TORY OF
THE CROATIAN DERMATOVENEROLOGISTS - ACTA DERMATOVENEROLOGICA
CROATICA
July 10, 1992- July 10, 2002
It has been ten years since the foun da tion of the
Cro atian Dermatologic So ci ety (CDS) of the Cro -
atian Med i cal As so ci a tion (CMA) and Acta Derma -
to ve ne rologica Croatica (ADC), the first pro fes -
sional jour nal in the his tory of the Cro atian derma -
tovenerologists.
To mark this oc ca sion, on July 10, 2002, the Pro -
fes sional Board or ga nized a cele bra tory meet ing at
the De part ment for Der ma tol ogy and Venerology of
the Zagreb Uni ver sity Hos pi tal Cen ter and Zagreb
Uni ver sity School of Med i cine. The agenda ran as
fol lows:
1. Read ing the ex cerpts from the re port pub lished in 
ADC No 1, pages 3-4 and 37, on the foun da tion
of the CDS-CMA and the foun da tion of the pro -
fes sional jour nal ADC. Dr. Mirna Bradamante,
the youn gest res i dent at our De part ment, read
the texts;
2. Re port by Dobriæ I, Labar B, Pašiæ A, Skerlev M:
“Graft-ver sus-Host Dis ease – Dermatological
As pects”;
3. Prof. Dobriæ per son ally con grat u lated Prof.
Jasna Lipozenèiæ, the cur rent Head of Cro atian
Dermatovenerological So ci ety, and ex pressed
his hopes for the con tin u a tion of the So ci ety’s
suc cess ful work, as well as the suc cess of the
ADC jour nal.
At the end of the meet ing, Prof. Dobriæ read a fax 
by Prof. Mario Gligora from Rijeka who con trib uted
greatly to the foun da tion of the CDS, but could not
at tend the meet ing.
As it was agreed at the meet ing, Prof. Dobriæ
would write a short ar ti cle for ADC re gard ing this
an ni ver sary.
Our in ten tion was not only to cel e brate the an ni -
ver sary, but also to re mem ber these events of cul -
tural sig nif i cance. Ten years of Acta Dermatove ne -
rologica Croatica have been very suc cess ful. The
Jour nal, pub lished in Eng lish and in dexed in In dex
Medicus/MEDLINE and Excerpta Medica/EMBASE,
with an in ter na tional Board of Ed i tors, is our con tri -
bu tion in terms of cul ture as well as in terms of de -
vel op ing cul tural re la tions be tween our county and
other coun tries in the world.
Af ter the first ten years, we are fac ing the fu ture
de ter mined not to give up.
Ines Lakoš-Jukiæ, MD
Pro fes sor Ivan Dobriæ, MD, PhD
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Emer gency States in Allergology and Clin i cal Im mu nol ogy in 
Der ma tol ogy and Venerology
A con tin u ous med i cal ed u ca tion course “Emer -
gency States in Allergology and Clin i cal Im mu nol -
ogy in Der ma tol ogy and Venerology” for dermato -
vene rologists, res i dents in der ma tol ogy and vene -
ro logy, and gen eral prac tice spe cial ists was held at
the Zagreb Uni ver sity School of Med i cine on Oc to -
ber 25-26, 2002, un der the aus pices of the Acad -
emy of Med i cal Sci ences of Croatia. The Course
was or ga nized by the Chair of Der ma tol ogy and
Venerology, Zagreb Uni ver sity School of Med i cine,
and Cro atian Dermatovenerological So ci ety of the
Cro atian Med i cal As so ci a tion.
The Course was at tended by 115 phy si cians
from Croatia, Bosnia and Herzegovina, and Slove -
nia. Pro fes sors Werner Aberer from Graz and Karl
Holubar from Vi enna were in vited lec tur ers from
abroad. The sci en tific pro gram in cluded lec tures,
sem i nars, mod er ated dis cus sions, printed ma te rial, 
and con clu sive ques tion naire. The par tic i pants
were in tro duced into the lat est con cepts in the eti ol -
ogy, pathogenesis, mod i fied en vi ron men tal fac tors,
and par tic u larly ap pro pri ate treat ment of emer -
gency states as well as pre ven tion of al ler gic dis -
eases. Con sidering the in creas ing in ci dence of al -
ler gic dis eases, mod ern di ag nos tic meth ods and
es pe cially emer gency ther a peu tic pro ce dures were 
pre sented.
The fol low ing top ics were cov ered: emer gency
states in der ma tol ogy and venerology; SSS vs toxic 
epi der mal necrolysis; acute vasculitides; cur rent
ap proach to ur ti caria/angioedema and ther a peu tic
pro ce dure; bullous dermatoses; al ler gic re ac tions
to in sect stings and emer gency in ter ven tion; acute
man i fes ta tions of ste roid der ma ti tis; cur rent in vi tro
di ag no sis of al ler gic dis eases; the role of CAST-
 ELISA test in di ag no sis and man age ment of al ler gic 
dis eases; new con cepts in the di ag no sis and treat -
ment of atopic der ma ti tis; pri mary photoderma to -
ses; test ing for UV hy per sen si tiv ity; he red i tary angi -
o edema; in fec tious dermatoses – acute states and
man age ment; acute man i fes ta tions and treat ment
of medicamentous exanthemas; and spe cific immu -
no therapy.
The ex perts from par tic u lar fields pre sented
novel con cepts from the lit er a ture as well as their
own re sults and rec om men da tions for ap proach to
and treat ment of the afore men tioned dermatologic
con di tions. The ob jec tive of the Course was to de -
velop the al go rithm for emer gency states in der ma -
tol ogy and venerology. Ac cord ing to the ques tion -
naire dis trib uted to the par tic i pants at the end of the
Course, the meet ing was ap praised as highly suc -
cess ful and use ful. The next course, ded i cated to
sex u ally trans mit ted dis eases, will be held on No -
vem ber 21-22, 2003.
The Cro atian Dermatovenerological So ci ety of
the Cro atian Med i cal As so ci a tion takes ac tive part
in the con tin u ous ed u ca tion of der ma tol o gists and
venerologists as one of the Course or ga niz ers.
The Chair of Der ma tol ogy and Venerology at
Zagreb Uni ver sity School of Med i cine de voted this
year’s Course to the 10th an ni ver sary of both the
Cro atian Dermatovenerological So ci ety and Acta
Dermatovenerologica Croatica, the of fi cial jour nal
of the So ci ety.
Prof. Jasna Lipozenèiæ, MD, PhD
Course Di rec tor
Pres i dent of the Cro atian So ci ety of Dermatovenerology
Head of the Chair of Der ma tol ogy and Venerology
Zagreb Uni ver sity School of Med i cine
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Mel a noma Malignum – New Find ings and the Co or di na tion
of Treat ment Pro to cols
The Sym po sium on Co or di na tion of Mel a noma
Malignum Treat ment Pro to cols took place at
“Dubrava” Uni ver sity Hos pi tal in Zagreb, Croatia,
on De cem ber 13, 2002, un der the spon sor ship of
Cro atian So ci ety of Plas tic, Re con struc tive and Es -
thet ics Sur gery, Cro atian Dermatovenerological
So ci ety of the Cro atian Med i cal As so ci a tion, and
Cro atian Med i cal Cham ber. The sym po sium was
or ga nized by the De part ment for Plas tic, Re con -
struc tive and Es the tic Sur gery, Dubrava Uni ver sity
Hos pi tal, and De part ment for Dermatovenerology,
Sis ters of Mercy Uni ver sity Hos pi tal. The chairs
were San dra Stanec and Mirna Šitum.
The event was at tended by a large num ber of
phy si cians, spe cial ists in der ma tol ogy, sur gery, pa -
thol ogy, on col ogy, cy tol ogy, maxillofacial sur gery,
and ENT.
In their wel come speech, Prof. J. Lipozenèiæ,
Pres i dent of Cro atian Dermatovenerological So ci -
ety, and Prof. Z. Stanec, Pres i dent of Cro atian So ci -
ety of Plas tic, Re con struc tive and Es the tic Sur gery,
em pha sized the im por tance of multidisciplinary ap -
proach in the treat ment of mel a noma. Chairs of the
Sym po sium, Mirna Šitum and San dra Stanec,
pointed out the in creased in ci dence of this ma lig -
nant tu mor and the need for hav ing a unique ther -
apy pro to col in all Clin i cal Cen ters.
The pro gram was di vided into morn ing and af -
ter noon ses sions, as fol lows:
• Ep i de mi ol ogy and eti ol ogy of mel a noma
malignum (Pašiæ A)
• Mo lec u lar bi ol ogy of mel a noma malignum
(Levanat S)
• Pathohistological forms of mel a noma
malignum (Lambaša S)
• Prob lems in dif fer en tial di ag no sis of mel a -
noma malignum (Krušlin B)
• Clin i cal find ings, risk fac tors, and pre ven tion
of mel a noma malignum (Šitum M)
• TNM clas si fi ca tion and prog no sis of mel a -
noma malignum (Stanec Z)
• Sur gi cal ther apy of dif fer ent stages of mel a -
noma malignum (Unušiæ J)
• Sen ti nel lymph node bi opsy (Stanec M)
• Mel a noma malignum of the head and neck
(Virag M)
• Ther apy pro to col in Slovenia (Arnež Z)
• Ra dio ther apy and che mo ther apy of mel a -
noma malignum (Šantek F)
• Immunotherapy and genetherapy of mel a -
noma malignum (Ðakoviæ N)
• Lo cal recidives – con trol of the pa tients with
mel a noma malignum (Nola I)
Each pre sen ta tion was fol lowed by an ed u ca tive 
dis cus sion, with spe cial ists from var i ous fields shar -
ing their ex pe ri ence and pre sent ing their cases.
Col leagues from Slovenia also took an ac tive part in 
the sym po sium, show ing their re sults and ex pe ri -
ence in di ag nos tic meth ods and ther apy of mel a -
noma malignum. 
A round ta ble at the end of the meet ing was at -
tended by Stanec Z, Virag M, Arnež Z, Unušiæ J,
Pašiæ A, Lambaša S, Krušlin B, Levanat S, Ðakoviæ
N, and Šantek F. The pur pose of the round ta ble
was to work up the pro to col for mel a noma malig -
num treat ment ac cord ing to the world stan dards.
The dis cus sion that de vel oped was very fruit ful and
de spite cer tain dis agree ments, the group even tu -
ally came up with the ac cept able pro to col. It still
needs to be im proved, though, as some ques tions
re mained un an swered. How ever, we be lieve that
the par tic i pants will have the an swers needed by
the next meet ing in 2003, when the pro to col will be
com pleted and, hope fully, in tro duced into prac tice
soon af ter wards.
As sis tant Pro fes sor Mirna Šitum, MD, PhD
Co-organizer of the Symposium
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Marko Polo´s Di ary
Stella Fatoviæ-Ferenèiæ, ESHDV rep re sen ta tive of Croatia
On close neigh bour hoods, on Zlata Praha,
and green eyes 
The com plex ity of skin, the larg est body or gan,
kept me again in touch with the world this year. The
ter ror ist at tack on Amer ica oc curred just be fore last
year’s Mu nich EADV Con gress, and this year we
were faced with gen eral flood in un dat ing vast ar eas 
of Cen tral and East ern Eu rope. Prague, the venue
of our 2002 EADV meet ing was badly over flown
dur ing the sum mer, but it did not stop the or gan is ers 
of 11th Con gress of the EADV to con tinue with prep -
a ra tions. East ern coun tries were po lit i cally sep a -
rated from the rest of Eu rope and the lib er a tion af ter 
the col lapse of Berlin wall started the chain of po lit i -
cal changes in dif fer ent parts of East ern Eu rope. In
Croatia, we ex pe ri enced a war and paid for our lib -
erty in blood and suf fer ing. Af ter the Vel vet Rev o lu -
tion, Czechs started de vel op ing a rapid re turn to
Eu rope, al though they, like Croats, never re ally left
it as far as their cul ture, his tory, and spirit were con -
cerned.
11th EADV Con gress, Prague, Oc to ber 2-6,
2002
The EADV was a West ern ori en tated derma -
tological so ci ety. The event in Prague was the first
one that took place in one of the for mer So viet block 
coun tries, the Czech Re pub lic. An other re mark able 
fact, for the first time in the his tory of EADV, there
was a lady pres i dent of the meet ing – Jana
Hercogova. Dur ing the 14th cen tury, the Em peror
and King Charles IV turned Prague much into a
mag nif i cent me trop o lis, the Zlata Praha of leg end -
ary fame, of peo ple like Jan Hus and Jan Žižka,
Antonín Dvoøák, Leoš Janáèek, and Franz Kafka.
Prague got its uni ver sity in 1348, 16 years be fore
Krakow, or 17 years be fore Vi enna. This Alma ma -
ter Carolina Pragensis hosted the par tic i pants of
the 11th Con gress EADV un der the pa tron age of the 
Rec tor Magnificus. The Charles Uni ver sity med als
were given at this oc ca sion to prom i nent in ter na -
tional der ma tol o gists, as well as hon or ary mem ber -
ships of the Czech So ci ety of der ma tol ogy. A unique 
ex pe ri ence in deed, for all par tic i pants of this mag -
nif i cent cer e mony.
The His tory Day, as usual, be gan with meet ing
friends and col leagues and sight see ing. The ex cur -
sion went onto the ob ser va tory tower of the
Klementinum, the old Je suit mon as tery and uni ver -
sity. It was a beau ti ful sunny day. The sight of the
golden hun dred-tow ered city spread ing be fore our
eyes was worth ev ery step of end less old stair way
that took us all the way up to the top. Af ter that, we
crossed Charles Bridge and touched Saint Ioannes
Nepomucenus Me mo rial, ut ter ing wishes. Our
meet ing pro ceeded with the 3rd Alibert Ora tion de -
liv ered by Prof. Mauricio Goihman Yahr from Ca ra -
cas, Ven e zuela and, of course, ended with a de li -
cious lunch. When the joy of see ing new places and 
mak ing ac quain tances em braces me at dif fer ent
cor ners of the world, I com pletely for get that the his -
tory was too of ten a bloody mat ter, ac tu ally. I rather
see it as a se quence of events, and in med i cine, as
a net work of overt or hid den re la tions. These re la -
tions mo ti vate com pe ti tions, am bi tions, they in spire
the in tel lect and work, and with out them noth ing
would ever be the same. Dermatovenerology in
Croatia, for ex am ple, was closely linked to dermato -
venerology in Czechia. Suf fice it to men tion that
Cro atian pi o neers in der ma tol ogy, Pavel Šavnik
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and Franjo Kogoj, were ed u cated in Prague’s clin -
ics and stu dents of Pro fes sor Šamberger.
Dur ing that stay in Prague, I was in vited at the
meet ing of the Ed i to rial Board JEADV. Jean-Paul
Ortonne, Nice, took over ed i to rial of fice of the jour -
nal from Torello Lotti, Flor ence. It was de cided that
hence forth there would be a new sec tion in the
JEADV – His tory of Med i cine. Karl Holubar, Vi enna, 
and me would be sec tion ed i tors.
Prague’s EADV Con gress, the first one held in
East ern Eu rope, was rather over whelm ing, but
emo tions are usu ally those that move our spirit.
Upon my re turn to Zagreb, I was im me di ately
swal lowed by daily rou tine. The con fer ence on Tu -
ber cu lo sis, its past and pres ent, which I or gan ised
in the Cro atian Acad emy of Sci ences and Arts on
Oc to ber 10th ful filled my ex pec ta tions: more than a
hun dred peo ple gath ered to hear the lec tur ers. 
In No vem ber I went to Vi enna. The tra di tional
Jahrestagung this year hosted Cro atian dermato -
ve ne rologists, an other step in get ting closer to our
clos est neigh bours. We are all look ing for ward to
our coun try hav ing no bor ders that sep a rated us for
more than half a cen tury from our nat u ral neigh -
bours and to open our selves to Eu rope.
The end of 2002 is ap proach ing, per spec tives
re gard ing world peace are not op ti mis tic. Wars are
waged, bioterrorism is a com mon is sue. In 2003, it
would be 730 years since Marko Polo was pass ing
through what is now Af ghan i stan. He noted and de -
scribed beau ti ful mar ble houses in Balkh one of the
world’s old est cit ies, alas de stroyed later. Since
then, par tic u larly in last two de cades, de struc tion
has been very much a syn onym for Af ghan i stan,
and the Afghan ref u gee Sharbat Gula’s eyes, like
those of a threat ened wild an i mal, are cer tainly the
most mov ing and sym bolic re flec tion of it. The
green shine of these eyes and the re flec tion of fear
in them are in grained in my mem ory. Hardly any
other mes sage I ever saw urg ing the world to keep
piece was so pain ful and strik ing.
ACTA DERMATOVENEROLOGICA CROATICA 59
 Acta Dermatovenerol Croat
Marko Polo‘s Diary 2003;11(1):56-57
ANNOUNCEMENTS
5th Sym po sium on Sex ually Trans mitted Dis eases with in ter na tional par tic i pa tion, Opatija, Croatia, April 14-16,
2003. Con tact: Jasminka Blaha, “Dr. Fran Mihaljeviæ” Uni ver sity Hos pi tal for In fec tious Dis eases, Mirogojska 8,
Zagreb; e-mail: jblaha@bfm.hr
Prague Dermatological Days, Prague, Czech Re pub lic, April 25-26, 2003. Con tact: Dr. Jana Hercogova, e-mail:
jana.hercogova@infmotol.cuni.cz
IX In ter na tional Con gress Al lergy, Asthma, Im mu nol ogy and Global Net work, Antalya, Tur key, April 27-30, 2003.
Con tact: acicis@ibch.ru; http://www.isir.ru
7th CSCC (Cro atian So ci ety of Cos metic Chem ists) Meet ing 2003, Hvar, Croatia, May 7-10, 2003. Con tact: Vera
Sekuliæ, M. Gupca 2, Osijek, Croatia; e-mail: vera.sekulic@saponia.hr
3rd World Con gress of the In ter na tional Acad emy of Cos metic Der ma tol ogy, Beijing, China, May 15-17, 2003. Con -
tact: IACD2003 Sec re tar iat, Chi nese Med i cal Meet ings In ter na tional, 42 Dongsi Xidajie, Beijing 100710, China;
e-mail: lillian.lee@263.nrz; www.chinamed.com.cn/IACD
14th  Ljudevit Jurak In ter na tional Sym po sium on Com par a tive Pa thol ogy, Zagreb, Croatia, June 6-7, 2003. Con tact: 
Prof. Mladen Belicza, M.D., Ph.D., De part ment of Pa thol ogy, Sis ters of Mercy Uni ver sity Hos pi tal, Vinogradska cesta 
29, 10000 Zagreb, Croatia; www.kbms.hr/Jurak/sym po sium.htm; e-mail: juraks@kbsm.hr
XXII Con gress of  the Eu ro pean Acad emy of Allergology and Clin i cal Im mu nol ogy, Paris, France, June 7-11, 2003. 
Con tact: Congrex Swe den AB, Attn: EAACI 2003, P.O. Box 5619, SE-11486 Stock holm, Swe den; e-mail:
eaaci2003@congrex.se, www.congrex.com/eaaci2003
9th In ter na tional Pso ri a sis Sym po sium, New York, USA, June 17-22, 2003. Con tact: Skin Dis ease Ed u ca tion Foun da -
tion, 233 East Erie Street, Suite 700, Chi cago, Il li nois 60611; e-mail: sdef@sdefmail.com; www.sdefderm.com
Sec ond Der ma tol ogy Up date, Na tional Skin Cen tre Sin ga pore, Sin ga pore, June 28-29, 2003. Con tact: www.ilds.org
First World Con gress on Work-Re lated and En vi ron men tal Al lergy (1st WOREAL) & Fourth In ter na tional Sym po -
sium on Ir ri tant Con tact Der ma ti tis, Hel sinki, Fin land, July 9-12, 2003. Con tact: sec re tar iat@woreal.org;
www.woreal.org
In ter na tional short course in dermoscopy, Graz, Aus tria, July 15-19, 2003. Con tact: Lorenzo Cerroni, De part ment of
Der ma tol ogy, Uni ver sity of Graz, Auenbruggerplatz 8, A-8036 Graz.
Sum mer Acad emy of Dermatopathology, Graz, Aus tria, July 21-25, 2003.  Con tact: Lorenzo Cerroni, De part ment of
Der ma tol ogy, Uni ver sity of Graz, Auenbruggerplatz 8, A-8036 Graz.
15th Bi en nial Con gress of the In ter na tional So ci ety for Sex ually Trans mitted Dis eases Re search (ISSTDR), Ot -
tawa, Can ada, July 27-30, 2003. Con tact: 2003 ISSTDR Con gress Sec re tar iat, 251 Bank Street, Suite 401, Ot tawa,
Can ada; e-mail: in for ma tion@isstdr.org; www.confersense.ca
In ter na tional Sym po sium on Atopic Der ma ti tis, Rome, It aly, Au gust 29-31, 2003. Con tact: Alberto Giannetti,
giannett@unimore.it; Giampiero Girolomini, giro@idi.it
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XVIII World Al lergy Or ga ni za tion Con gress ICACI, Vancuver, Can ada, Sep tem ber 7-12, 2003. Con tact: Sally Kolf,
611 East Wells Street, Mil wau kee, WI 53202, USA; e-mail: con gress@worldallergy.org; www.worldallergy.org
Cur rent State on Pso ri a sis and Naphtalanotherapy, In ter na tional Sym po sium or ga nized by Cro atian Dermato -
venerological So ci ety of the Cro atian Med i cal As so ci a tion and Spe cial Hos pi tal for Re ha bil i ta tion “Naftalan”, Ivaniæ
Grad, Croatia, Sep tem ber 19, 2003. Con tact: Prof. Jasna Lipozenèiæ, Šalata 4, 10000 Zagreb, Croatia. Tel./Fax:
+385-1-4920-014; e-mail: jasna.lipozenèiæ@zg.tel.hr
12th Con gress of Eu ro pean Acad emy of Der ma tol ogy and Venerology, Bar ce lona, Spain, Oc to ber 15-18, 2003.
Con tact: Unicongress, Calvet, 55, Baixos, 08021 Bar ce lona, Spain. www.eadv.org. E-mail: eadv2003@unicongress. 
com
6th  Tergestinum Sym po sium on Pso ri a sis and 2nd Alpe Adria Meet ing on Pso ri a sis, Bibione, It aly, No vem ber 7-8,
2003. Con tact: Or ga nizing Sec re tar iat, Via San Nicolo 14, 34121 Trieste, It aly. Tel +39 40 368343, Fax: +39 40
368808
Sex ually Trans mitted Dis eases and Infections, Con tinuing Med i cal Ed u ca tion Course or ga nized by the Cahir of
Dermatovenerology, Zagreb Uni ver sity School of Med i cine and Cro atian Dermatovenerological So ci ety of the Cro -
atian Med i cal As so ci a tion, Šubiæeva 9, 10000 Zagreb, Croatia, No vem ber  21-22, 2003. Con tact: Prof. Jasna
Lipozenèiæ, Šalata 4, 10000 Zagreb, Croatia. Tel./Fax: +385-1-4920-014; e-mail: jasna.lipozenèiæ@zg.tel.hr
9th Alple-Adria-Dan ube Con gress of Sex ually Trans mitted Dis eases and In fec tions of the Skin, Prague, No vem -
ber 27-30, 2003. Con tact: jana.hercogova@lfmotol.cuni.cz
4th World Con gress of IACD, Cairo, Egypt, April 12-18, 2004.
9th In ter na tional Con gress of Der ma tol ogy, Beijing, China, May 2004. Con tact: ICD2004 Sec re tar iat, Dept. of For eign
Re la tions, Chi nese Med i cal As so ci a tion, 42 Dongsi Xidajie, Beijing 100710, China. www.chinamed.com.cn/der ma -
tol ogy. E-mail: ICD2004@chinamed.com.cn
23rd Con gress of the Eu ro pean Acad emy of Allergology and Clin i cal Im mu nol ogy, Am ster dam, Neth er lands, June
12-16, 2004. Con tact: Dept. Allergology, Uni ver sity Hos pi tal Rot ter dam, dr. Molewaterplein 40, NL-3015 GD Rot ter -
dam, The Neth er lands. www.congrex.com/eaaci2004. E-mail: degroot@algo.azr.nl
X World Con gress of Pe di at ric Der ma tol ogy, Rome, It aly, July 7-10, 2004. Con tact: Tri umph Congressi, Via Lucilio,
60, 00136 Rome, It aly; e-mail: der mo@gruppotriumph.it, www.gruppotriumph.it
Amer i can Acad emy of Der ma tol ogy, Acad emy ’04, New York, USA, July 28-Au gust 1, 2004.
13th Con gress of the Eu ro pean Acad emy of Der ma tol ogy and Venerology, Flor ence, It aly, No vem ber 17-21, 2004.
E-mail for con tact: pres i dent@eadv2004.org; info@eadv2004.org
10th World Con gress on Can cers of the Skin, Vi enna, Aus tria, March 19-23, 2005. Con tact: Elfriede Pomp, De part -
ment of Der ma tol ogy, Uni ver sity of Vi enna, Vi enna Gen eral Hos pi tal, Waehringer Guertel 18-20, A-1090 Vi enna.
www.wccs.at. E-mail: info@wccs.at
6th World Con gress on Mel a noma, Van cou ver, B.C., Can ada, Sep tem ber 2-9, 2005. Con tact: Venue West Con fer ence
Ser vices Ltd., Van cou ver, B.C., Can ada; e-mail: con gress@venuewest.com
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IN STRUC TIONS TO AU THORS
ACTA DERMATOVENEROLOGICA CROATICA (ADC)
is a quar terly peer-re viewed jour nal, in dexed in In dex Medi -
cus/MEDLINE and Excerpta Medica/EMBASE. It pub -
lishes orig i nal sci en tific ar ti cles, short sci en tific com mu ni -
ca tions, clin i cal ar ti cles, case re ports, re views, re ports,
news and comments, and an nounce ments in the fields of
der ma tol ogy and venerology.
Gen eral Guide lines
Type the com plete manu script dou ble-spaced, on one 
side of A4 bond pa per, with a left side mar gin of at least 4
cm.
The manu scripts should not ex ceed 12-15 typed
pages in case of orig i nal sci en tific pa pers, and 6-8 pages
in case of short com mu ni ca tions, clin i cal ar ti cles, case re -
ports, and re views.
The manu scripts should be writ ten in Eng lish. The au -
thors are re spon si ble for en sur ing that the Eng lish used is 
suit able for pub li ca tion. All ma te rial is as sumed to be sub -
mit ted ex clu sively to this jour nal.
All manu scripts are sub ject to peer re view.
Prep a ra tion of Manu scripts for Sub mis sion
Ti tle Page
The ti tle page should carry (a) the ti tle of the pa per,
which should be con cise but in for ma tive; (b) full name of
each au thor, with in sti tu tional af fil i a tion; (c) name(s) of de -
part ment(s) and in sti tu tion(s) to which the work should be
at trib uted; (d) name and ad dress (with tele phone and fax
num bers as well as the e-mail adress) of the au thor to
whom re quests for re prints should be ad dressed; (f)
source(s) of sup port in the form of grants, equip ment,
drugs, or all of these; and (g) a short run ning head of not
more than 40 char ac ters (count let ters and spaces) at the
foot of the ti tle page.
Sec ond Page
The sec ond page should carry a sum mary of not more 
than 250 words, fol lowed by three to six key words from
the Med i cal Sub ject Head ings (MeSH) list of In dex
Medicus.
Manu script
The text of ob ser va tional and ex per i men tal is usu ally,
but not nec es sar ily, di vided into sec tions with the head -
ings In tro duc tion, Ma te rial (Pa tients) and Methods, Re -
sults, and Dis cus sion. Long ar ti cles may need sub head -
ings within some sec tions to clar ify their con tents, es pe -
cially Re sults and Dis cus sion sec tions. Other types of ar -
ti cles, such as case re ports, re views, and ed i to ri als, are
likely to need other for mat.
Ab bre vi ated terms should be writ ten in full the first
time they are used in the text, with ab bre vi a tion in pa ren -
the ses.
Un der line the words that must be printed in italic.
Ref er ences should be iden ti fied in the text by arabic
nu mer als in pa ren the ses, and be num bered and listed
con sec u tively at the end of the manu script in the or der in
which they are first cited in the text.
In di cate in the text where the il lus tra tions (fig ures and
ta bles) should be in serted. 
Ta bles and fig ures should be pro vided each on a sep -
a rate sheet of pa per af ter the ref er ences. De scrip tive leg -
ends to fig ures should be typed dou ble-spaced on a sep -
a rate sheet of pa per, whereas fig ures should be sub mit -
ted in an en ve lope, with the num ber, the name of the (first) 
au thor, and ti tle of the manu script on the back: each ta ble
should be typed on a sep a rate sheet of pa per, num bered
in the or der in which they are first cited in the text, with a ti -
tle and de scrip tive leg end. Terms used in ta bles should
not be ab bre vi ated.
Eth ics
When re port ing ex per i ments on hu man sub jects, in di -
cate whether the pro ce dures were in ac cor dance with the
eth i cal stan dards of the re spon si ble com mit tee on hu man 
ex per i men ta tion (in sti tu tional or re gional) or with the Hel -
sinki Dec la ra tion from 1975 as re vised in 1983. Do not
use pa tients, names, ini tials or hos pi tal num bers, es pe -
cially any il lus tra tive ma te rial.
Sta tis tics
De scribe sta tis ti cal meth ods and pro vide enough data 
to en able a knowl edge able reader to as sess the re ported
re sults him or her self. Please state the sta tis ti cal pack age 
(ver sion, man u fac turer) used for sta tis ti cal anal y sis.
Ac knowl edge ments
Please spec ify: (a) con tri bu tions that need ac knowl -
edg ing but do not jus tify au thor ship, such as gen eral sup -
port by a de part men tal chair man; (b) ac knowl edge ments
of tech ni cal help; (c) ac knowl edge ments of fi nan cial and
ma te rial sup port, spec i fy ing the na ture of sup port; (d) fi -
nan cial re la tion ship that may be a source of con flict of in -
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ter est. Tech ni cal help should be ac knowl edged in a sep a -
rate para graph as well as other con tri bu tions.
Ref er ences
Ref er ences should be typed dou ble-spaced on a sep -
a rate sheet of pa per. The Van cou ver style, pro posed by
the In ter na tional Com mit tee of Med i cal Jour nal Ed i tors, is
used (Engl J Med 1991,324:421-8, BMJ 1991,302:338-41, 
or www.icmje.org) . Ex am ples of cor rect forms of ref er -
ences are given be low:
Jour nal ar ti cle
Stan dard jour nal ar ti cle (list all au thors, but if their
num ber ex ceeds six, give six fol lowed by et al.)
You CH, Lee KY, Chey RY, Menguy R. Electrogastro -
graphic study of pa tients with un ex plained nau sea, bloat -
ing and vom it ing. Gastroenterology 1989;79:311-4.
Chap ter in a book
Weinstein L, Swartz MN. Patho logic prop er ties of in -
vad ing mi cro or gan isms. In: Sodeman WA Jr, Sodeman
WA, ed i tors. Patho logic phys i ol ogy: mech a nisms of dis -
ease. Phil a del phia: Saunders; 1974. p. 457-72.
Ar ti cle not in Eng lish
Massone L, Borghi S, Pestarino A, Piccini R, Gambini
C. Lo cal isa tions palmaires purpuriques de la dermatite
herpetiforme. Ann Dermatol Venerol 1987;114:1545-7.
Con fer ence pa per
Harley NH. Com paring ra don daugh ter dosimetric
and risk mod els. In: Gammage RB, Kaye SV, ed i tors. In -
door air and hu man health. Pro ceed ings of the Sev enth
Life Sci ences Sym po sium; 1984 Oct 29-31; Knox ville
(TN). Chelsea (MI):Lewis, 1985:69-78.
Disertation
Youssef NM. School ad just ment of chil dren with con -
gen i tal heart dis eases (dis ser ta tion). Pitts burgh (PA):
Uni ver sity of Pitts burgh; 1988.
Sub mis sion of Manu scripts
Manu scripts should be printed on pa per and sub mit -
ted in trip li cate, with one copy on a floppy disk, and sent
to:
Ed i to rial Of fice
De part ment of Der ma tol ogy and Venerology
Zagreb Uni ver sity Hos pi tal Cen ter
Šalata 4, 10000 Zagreb, Croatia
e-mail: jasna.lipozencic@zg.tel.hr
Manu scripts on Disks
Floppy disks should be 3.5-inch (1.44 MB) IBM for -
mat ted and la beled with the name of the au thor.
The file, the word-pro cess ing pro gram, and ver sion
used should be in di cated by pen. MS-Word for Win dows
is pre ferred, al though manu scripts pre pared us ing any
other IBM-com pat i ble word-pro ces sor are ac cept able.
Avoid com plex for mat ting; the text will be styled ac -
cord ing to the ADC de sign spec i fi ca tions. Do not use
bold, cap i tal ized text, or a run ning head. Do not use foot -
notes or endnotes. Sub mit the text, ta bles, and il lus tra -
tions as sep a rate files. For ta bles, al ways use ta ble ed i tor
func tion; en sure that each data point is con tained within a
unique cell, i.e. do not use car riage re turns within cells.
For il lus tra tions, the pre ferred for mats are TIFF of 300 dpi 
res o lu tion, al though any for mat in gen eral use is ac cept -
able pro vided it is not ap pli ca tion-spe cific. If MS Excell is
used for charts make sure to en close orig i nal Excell file.
ACTA DERMATOVENEROLOGICA CROATICA 63
Instructions Acta Dermatovenerol Croat
to Authors 2003;11(1):62-63
